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Using frequent self-report assessments throughout the day, Experience Sampling Method (ESM) 
studies have shown that psychotic symptoms fluctuate within short periods of time. These fluctuations 
are preceded by negative affect, worrying, sleep problems, or aberrant salience. The overarching goal 
of the present thesis was to use these insights from ESM studies to improve the treatment of psychosis 
and the prediction of relapses. For this purpose my colleagues and I developed a modular Internet 
intervention (EviBaS), which targets not only psychotic symptoms but several psychosis-related 
problems derived from ESM, such as worrying, depression and poor sleep. Studies 1 to 3 report the 
intervention’s efficacy and its potential mechanisms of action. To address the high rates of psychotic 
relapse using knowledge from ESM studies, we conducted a one-year observational study, which 
examined ESM-derived variables as warning signs of symptom deterioration and psychotic relapses. 
Due to different inclusion criteria, the EviBaS-related studies 1 (n = 101), 2 (n = 124) and 3 (n = 55) 
varied in sample size. EviBaS was efficacious in reducing psychotic symptoms, as indicated by a 
significant time x group interaction in the mixed model ANOVA comparing an eight-week treatment 
with EviBaS to a waitlist control condition (p = .047, d = -0.37). Linear mixed model analyses of 
study 2 indicated that the efficacy of EviBaS did not rely on improving worrying, negative affect, self-
esteem, self-reported cognitive biases, and quality of sleep, as the course of these variables did not 
differ between groups. Likewise, the effect of said predictors on subsequent symptoms did not differ 
between groups. However, within the EviBaS intervention (i.e., without considering group 
differences), worrying (pcorrected = .030) and quality of sleep (pcorrected = .003) predicted subsequent 
psychotic symptoms. Thus, when participants worried more or slept worse, they reported more severe 
subsequent psychotic symptoms, suggesting that these variables would have been worthwhile 
treatment targets. Study 3 only considered voice hearers from the EviBaS Project and compared the 
intervention’s mindfulness module to waitlist using an ANCOVA with mediation analysis. 
Completing the mindfulness module did not result in lower distress by auditory verbal hallucinations 
(p = .598, ηp2 = 0.006) but it improved mindfulness (p = 0.015, ηp2 = 0.115) and hallucinations overall 
(p = 0.001, ηp2 = 0.214). The effect on hallucinations was mediated by improved mindfulness. Study 4 
(n = 30) incorporated a one-week ESM phase followed by a one-year Follow Up period encompassing 
bi-weekly assessments. Negative affect (pcorrected = .003) as well as aberrant salience (pcorrected < .001) 
predicted subsequent short-term paranoia. Interestingly, aberrant salience was likewise a significant 
predictor of bi-weekly fluctuations of paranoia (pcorrected < .001). No variables predicted relapse.  
In sum, ESM findings offer promising starting points to improve the treatment and the prediction of 
psychotic symptoms. Our Internet intervention targeting ESM-derived variables was efficacious – but 
not via the expected pathways. Whereas mindfulness was associated with the intervention’s efficacy, 
negative affect, worrying, or sleep were not. This pattern of results suggests that it would be 
worthwhile to improve EviBaS to target a wider range of outcomes. Regardless of its modes of action, 
however, the efficacy of EviBaS represents an important finding because it shows that Internet 
interventions for people with psychosis, which are currently very rare, represent a promising treatment 
approach. Study 4 suggests that people with psychosis should monitor feelings of aberrant salience 
continuously after remission because these can forecast deteriorations of paranoia two weeks in 
advance. Due to insufficient power, relapse analyses require replication and aberrant salience 
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A methodological approach, which targets a putative causal factor in an 
intervention in order to assess whether the manipulation of the causal factor 
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targeted worrying in an intervention and observed whether persecutory 
delusions improved as a consequence in a randomized controlled trial. 
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regression 
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MAAS Short for “Mindful Attention and Awareness Scale”, a scale measuring 
mindfulness, which was a core outcome of study 3.  
MCT Short for “Metacognitive Training”, a therapeutic intervention developed by 
Moritz and colleagues addressing cognitive biases. 
MINI Short for “Mini International Neuropsychiatric Interview”, a structured 
clinician-administered diagnostic interview.  
Negative affect A composite measure of different negative mental states, such as feeling 
down, anxious, or lonely. Its components may differ from study to study. 
NICE Short for “National Institute for Health and Care Excellence”, national 
treatment guidelines from the United Kingdom.  
Non-affective 
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Psychosis that does not occur as a secondary feature of an affective disorder 
(e.g., depression). 
PANSS Short for “Positive and Negative Syndrome Scale”, a clinician-administered 
rating tool to assess the symptom severity of schizophrenia and other 
psychotic disorders (“PANSS-PF” refers to the positive symptom factor of 
the PANSS). 
Paranoia-CL Short for “Paranoia Checklist”, a self-report questionnaire assessing paranoia. 
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participants only if they completed the trial as planned. 
Psychosis In this thesis, psychosis is defined as occurrence of either hallucinations, or 
delusions, or both. 
RCT Short for “Randomized Controlled Trial”, an experimental research design 
comparing groups (often a treatment of interest compared to a control 
condition) to which participants are randomly allocated. This procedure 
eliminates sources of bias using chance.  
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spectrum 




Schizotypy Personality trait characterized by a predisposition to experience psychotic-
like experiences. Related to the concept of the continuum hypothesis of 
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Is it possible to identify warning signs that forecast the worsening of psychotic symptoms or even 
relapses? And would treating these warning signs help to improve psychotic symptoms indirectly? My 
co-authors and I (in the following referred to as “we” also when I was the first author) conducted four 
studies to address these questions. In order to identify candidate warning signs of psychotic symptoms, 
we drew on knowledge from so-called ESM studies, which examine moment-to-moment symptom 
variability in the daily lives of participants, and applied this knowledge to new contexts. Given the 
large and diverse body of research on psychotic disorders, I will begin by defining important terms, 
first and foremost psychosis. 
1.1 Psychosis 
The terminology in research on psychosis can be confusing. The latest edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-V; American Psychiatric Association, 2013) separates 
numerous disorders from the so-called schizophrenia spectrum, ranging from substance-induced 
psychotic disorder to delusional disorder, schizoaffective disorder or schizophrenia. Not only are 
diagnoses manifold, there can also be considerable heterogeneity in terms of symptoms between two 
patients with the same diagnosis (Sadock et al., 2017, pp. 1409 - 1410). To bring order to this 
heterogeneity, it is worthwhile to focus on specific symptoms rather than diagnoses. In fact, all of the 
aforementioned disorders share a common set of symptoms, namely delusions or hallucinations, also 
referred to as psychosis (Arciniegas, 2015). Hence, for the sake of clarity, I will refer to all study 
participants in the present thesis as people with psychosis, irrespective of their individual diagnosis. 
The only restriction that my co-authors and I applied across studies was that participants’ psychotic 
disorders were not substance induced, not due to a neurological/organic disease and not due to a 
primary affective disorder. Consequently, this thesis refers to people with psychosis as people of 
different non-affective schizophrenia spectrum diagnoses who show at least one of the core psychotic 
symptoms delusions or hallucinations.  
As mentioned before, hallucinations and delusions are at the core of this thesis, symptoms that are 
also referred to as positive symptoms in the context of schizophrenia. Hallucinations and delusions are 
probably the most fascinating features of psychotic disorders as they reflect the distorted perception of 
reality (i.e, impaired reality testing; Arciniegas, 2015). Hallucinations are defined as sensory 
perceptions in the absence of a corresponding external or somatic stimulus (Arciniegas, 2015). 
Depending on the sensory domain, hallucinations can be auditory, visual, olfactory, or tactile. On a 
side note, hallucinations are only classified as psychotic by the American Psychiatric Association 
(2013) if they occur without insight. As self-report scales were used across all studies, the present 
thesis defines hallucinations and delusions as psychotic even if participants show enough insight to 
report them in self-report scales (for the concordance with clinician-rated assessments, see Lincoln et 
al., 2010b). Auditory verbal hallucinations are one of the most common types of hallucinations with 
approximately three in four people with schizophrenia or schizoaffective disorder experiencing voice 
hearing at least once in their life (Thomas et al., 2007). Besides hallucinations, the present thesis 
focuses on delusions in all included studies. Delusions are fixed false beliefs, such as the false belief 
that one is being harmed, followed, or spied on. Delusions are maintained despite evidence that 
obviously and incontrovertibly contradicts the belief (Arciniegas, 2015). The aforementioned 
description is very rigorous in that delusional ideas are supposed to be imperturbable ideas that are 
held with full conviction, which is not always the case (Appelbaum et al., 2004); see section 1.2 for a 
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description of temporal dynamics of delusions. As for hallucinations, I therefore propose a more 
liberal definition of delusions in the present thesis, which considers false beliefs (e.g., paranoia) as 
psychotic, even if they are not held with full conviction continuously and even if participants can 
report them in self-report scales. The conceptualization of delusions and hallucinations in this thesis is 
influenced by the so called continuum hypothesis of psychosis. The continuum view emerged in 
response to the issue of discriminating between “healthy” and “ill” participants, and it suggests that 
rather than dichotomizing these categories, symptoms are best described on a continuum ranging from 
no symptoms to severe psychosis with a gradual course in between (van Os & Reininghaus, 2016). 
General population studies support this notion, indicating that psychotic experiences of varying 
intensity occur frequently outside of people with schizophrenia or other severe mental disorders 
(Rossler et al., 2015).  
1.2 Fluctuating psychotic symptoms and their precursors 
Interestingly, longitudinal studies (i.e., studies using repeated measures) indicate that there is not only 
a continuum of symptom severity between persons but also within a person, meaning that psychotic 
symptoms fluctuate over time. Appelbaum et al. (2004) conducted a longitudinal analysis on the 
stability of delusions, a symptom traditionally considered unalterable and stable over time (American 
Psychiatric Association, 2013). The authors recruited currently hospitalized patients with delusions 
and followed them up with psychiatric interviews in 10-week intervals over the period of one year. 
Only one third of the initially delusional participants reported delusions 10 weeks later, and only 15% 
showed delusions consistently across all assessments (Appelbaum et al., 2004). It is important to note 
that the sample consisted of people with different affective or substance induced diagnoses. 
Regardless of the heterogeneity of diagnoses, however; the temporal variability of delusions was 
striking. Smeets et al. (2013) conducted far less frequent assessments of delusions and hallucinations 
in a general population sample, but over a longer period of time. The authors conducted assessments 
in the years 1996, 97 and 99 to examine the long-term temporal stability of psychotic symptoms. Only 
6.5% of people who displayed delusions at baseline, showed delusions at all three measurements. For 
people, who displayed hallucinations only, the proportion showing consistent hallucinations across 
measurements was 14.2%. People who suffered from both symptoms, showed the highest consistency 
of symptoms across time points (33.1%), indicating that the temporal stability of symptoms could 
depend on the severity of symptoms. So et al. (2012) compared the conviction of delusions 12 months 
apart and found a reduction for 38.4% of participants, an increase for 18.9%, and constant conviction 
for only 42.7%.  
1.2.1 The Experience Sampling Method  
The afore reviewed studies on the temporal variability of psychotic symptoms used assessments that 
were 10 weeks, one year, or even two years apart. One might argue that it is not surprising to find 
fluctuations of psychotic symptoms across such long time spans because many factors can affect the 
course of symptoms, such as psychiatric treatment with antipsychotics (e.g., Kahn et al., 2008) or 
psychotherapy (Bighelli et al., 2018; Jauhar et al., 2014). In order to get the full picture of symptom 
variability in psychosis, one must “zoom in” (Myin-Germeys et al., 2018) on the variability of 
symptoms in shorter periods of time. The so-called Experience Sampling Method (ESM; Myin-
Germeys et al., 2009) provides the tools to do exactly that (see Figure 1). ESM studies (also referred to 
as EMA, Ecological Momentary Assessment) use highly frequent self-report assessments to capture 
momentary symptoms, emotions, thoughts, but also contextual factors, such as the current activity or 
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whereabouts (Myin-Germeys et al., 2009). Comparable to a structured diary, participants report 
variables of interest as they occur in their daily lives. ESM relies on the idea that behavior is driven by 
the momentary context (ecological psychology; Heft, 2013), which implies that it is important to 
measure behavior, emotions, and symptoms when they occur in everyday life. ESM assessments can 
be event-contingent (participants complete an ESM assessment when a certain event occurs), time-
contingent (participants complete ESM assessments based on a time schedule), or a combination of 
both. Time schedules can be fixed or (pseudo-) random, the latter prevents that participants adapt their 
daily routines in response to the assessments, resulting in a more representative sample of 
assessments. ESM questionnaires need to be short so that they cause as little disruption of daily 
routines as possible, and items aim at capturing current states (e.g., “at the moment, I feel…”). Early 
ESM studies used booklets to capture momentary variables on short paper and pencil questionnaires, 
prompted by a beep, for example by a timer on a watch (e.g., Myin-Germeys et al., 2001). As part of 
technological advances, more recent studies used handheld computers or smartphones (e.g., 
Westermann et al., 2017), which are commonly used today (Myin-Germeys et al., 2018).  
Baseline  
 
- Usually, studies start with a 
baseline assessment before ESM 
assessments start, including 
sociodemographic assessments 
- At baseline, participants receive 
a smartphone and instructions 
(booklets or handheld computers 
in earlier studies) 
- In clinical studies, baseline 
assessments incorporate an 










Typically, 10 alarms per day for ca. 7 
days 
 
- Typically, alarms occur pseudo-
randomly throughout the day 
(i.e., at random times during 
predefined periods) 
- Participants respond to the same 
items repeatedly over time 
- Items may include current 
symptoms, emotions, or 
contextual factors 
Figure 1 – Illustration of a typical ESM study design.  
1.2.2 Using ESM to detect short-term symptom fluctuations  
ESM studies offer the possibility to shed light on the short-term variability of symptoms (i.e., 
fluctuations across days or within the same day), and have thus enabled researchers to examine how 
people with psychosis experience their symptoms during the day rather than across years (Smeets et 
al., 2013) or weeks (Appelbaum et al., 2004). Oorschot et al. (2012) found that auditory and verbal 
hallucinations occur in episodes during the day rather than being present consistently. Out of 184 
participants with schizophrenia spectrum diagnoses, 10 participants reported visual hallucinations 
only, 25 reported auditory hallucinations only, and 38 reported both visual and auditory hallucinations, 
highlighting the interconnection of these experiences. Hallucinations occurred at 22% of assessments, 
accumulating to M = 4.1 episodes on average over a six-day period. The results by Oorschot et al. 
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(2012) illustrate how ESM studies can grant insight into hallucinatory experiences and their variability 
that would remain undetected in other designs. As for hallucinations, the ESM method likewise helped 
to uncover the temporal variability of delusional experiences (Ben-Zeev et al., 2011). In a sample 
consisting of 144 participants with schizophrenia or schizoaffective disorders, 49% reported paranoia 
at least once over a one-week period (4 assessments per day). Rather than being present consistently 
for all patients (as one would expect given the DSM-V definition), paranoia occurred only at certain 
occasions during the one-week period. The frequency of paranoia differed between participants, 
ranging from 1 to 21 occasions with a mean of approximately 5. Interestingly, the likelihood 
experiencing paranoia was higher when a participant had experienced paranoia at the previous 
measurement, indicating that delusional experiences occur in episodes, similar to hallucinations. That 
means that once persecutory ideation occurs, it is very likely that it is still present three to six hours 
later. For other delusional subtypes (delusions of control, reference, and grandiosity), a very similar 
picture emerged (Ben-Zeev et al., 2012). Although there are occasional participants who report 
delusions consistently, the findings by Ben-Zeev et al. (2012) suggest that delusions occur in episodes 
during the week rather than being present consistently – similar to hallucinations.  
1.2.3 Using ESM to uncover predictors of psychotic symptom variation 
As reviewed above, ESM studies helped to uncover the short-term temporal dynamics of 
hallucinations and delusions. However, the method has many more advantages beyond the 
identification of temporal fluctuations. First, experience sampling enables researchers to conduct 
assessments that are ecologically valid (Myin-Germeys et al., 2018), meaning that participants respond 
to items in their real life rather than the laboratory. It allows to capture contextual factors, such as the 
place, the activity or the people that one interacts with, uncovering interactions of the individual with 
their environment. Unlike retrospective assessments, ESM is not dependent on the participant’s ability 
recall certain events. This can be beneficial when participants suffer from cognitive impairments 
(Schaefer et al., 2013). To illustrate, the momentary assessment of affect in psychosis does not 
correlate with retrospective assessments when controlling for memory deficits (Blum et al., 2015), 
indicating that retrospective assessments can be flawed when memory deficits are prevalent. Finally 
and most importantly, ESM studies grant insight into underlying processes of symptom formation and 
variability over time. The following section reviews findings from ESM studies that helped us 
understand how psychotic symptoms emerge in the daily life of participants with psychosis. 
One of the first studies in the field of ESM research in psychosis demonstrated that people with 
psychosis show increased negative emotional responses following daily life stressors when compared 
to first-degree relatives and control participants (Myin-Germeys et al., 2001). Different types of stress 
(i.e., event-related, activity-related, thought-related, and social stress) predicted momentary negative 
emotional responses; and for all effects, there was a significant interaction with group (Myin-Germeys 
et al., 2001). This finding, which was replicated in subsequent studies (e.g., Reininghaus et al., 2016) 
brought attention to an “affective pathway” of psychosis (Myin-Germeys & van Os, 2007). Myin-
Germeys and colleagues established the term negative affect as a composite of different negative 
mental states, namely feeling down, guilty, insecure, lonely, and anxious, which was central to many 
following publications (as well as the present thesis). The pioneering work by Myin-Germeys et al. 
(2001) paved the way for many subsequent ESM studies, which further investigated associations of 
negative affective states and psychotic symptoms. To date, the effect of negative affect on paranoia 
has been replicated in several independent ESM studies, both in clinical and non-clinical samples 
(Ben-Zeev et al., 2011; Kramer et al., 2014; Luedtke et al., 2017; So et al., 2018). For example, in one 
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study anxiety and sadness significantly predicted the occurrence of persecutory ideation (i.e., 
impression that someone is spying on the person or plotting against them) at the following assessment, 
controlling for prior occurrences of persecutory ideation (Ben-Zeev et al., 2011). Adding alcohol or 
substance use as a covariate did not influence the effects. In addition, anxiety predicted subsequent 
levels of conviction and stress associated with the persecutory ideation, whereas sadness predicted 
distress only. The effect of negative affect on psychotic symptoms is well-established but its mediators 
and moderators are not clear, so far. ESM findings indicate that women with psychotic disorders show 
stronger increases in negative affect and stronger decreases in positive affect due to daily stressors 
than men with psychotic disorders (Myin-Germeys et al., 2004). Cognitive impairments, on the other 
hand, cannot explain the increased emotional reactivity to daily stressors, as indicated by studies that 
show no or negative associations of cognitive impairments and stress reactivity (Morrens et al., 2007; 
Myin-Germeys et al., 2003). Likewise, cognitive biases do not mediate the effect of negative affect on 
paranoia (Luedtke et al., 2017). 
Not only did the work by Myin-Germeys and colleagues inspire several investigations of negative 
affect in ESM designs, it also gave rise to a plethora of subsequent ESM studies which examined other 
theory-driven candidate predictors of momentary psychotic symptoms that are – in part –related to 
negative affect. A seminal theoretical model, which has influenced the choice of candidate predictors 
in ESM studies, was the cognitive model of persecutory delusions (Freeman & Garety, 2014; Freeman 
et al., 2002; Garety et al., 2001). In short, the latest version of the model states that there are six 
proximal causal factors for the development of persecutory delusions, namely 1) a worry thinking 
style, 2) negative beliefs about the self, 3) interpersonal sensitivity, 4) sleep disturbance, 5) anomalous 
internal experience, and 6) reasoning biases (see Table 1). Of note, Freeman and Garety (2014) 
acknowledge daily stressors and major life events in their model as well, illustrating the overlap with 
the work by Myin-Germeys and van Os (2007). As reviewed in the following, ESM studies have 
provided evidence for many of the proposed causal factors that Freeman and Garety suggest in their 
model. The reviewed ESM studies conducted so-called lagged regression analyses, which allow the 
prediction of momentary psychotic symptoms through variables measured at a previous point in time 
(i.e., at a preceding ESM assessment). 
Worrying: Momentary levels of worry and rumination predict not only subsequent persecutory 
delusional ideation, but also auditory hallucinations and the distress associated with these symptoms 
(Hartley et al., 2014).  
Self-esteem: Udachina et al. (2014) showed that fluctuating momentary self-esteem (in contrast to 
stable self-esteem examined by Ben-Zeev et al., 2012) predicts subsequent paranoia throughout the 
day.  
Sleep: Several ESM studies have investigated the effect of the quality of sleep on psychotic symptoms 
at the following day. Kasanova et al. (2020) found that poor self-reported quality of sleep predicted 
both morning paranoia as well as negative affect in a sample consisting of paranoid patients, non-
paranoid people with psychosis, and people scoring high on schizotypy traits. In a similar setting, 
Mulligan et al. (2016) could show that reduced subjective and objective sleep efficiency preceded 
next-day auditory hallucinations in a sample of people with schizophrenia, while objective sleep 
fragmentation assessed via actigraphy as well as reduced subjective sleep quality predicted greater 
paranoia and delusions of control. In a similar study, low actigraphy-derived sleep efficiency predicted 
 
6 
persecutory symptoms at the next day in a sample consisting of both healthy controls and individuals 
with persecutory delusions (Kammerer et al., 2021). 
Anomalous internal experiences: Ben-Zeev et al. (2012) examined different types of delusions 
(delusions of control, reference, and grandiosity) and their predictors in lagged ESM analyses. 
Hallucinations, which can be conceptualized as anomalous experiences, predicted the occurrence of 
subsequent delusions, irrespective of their type.  
Reasoning biases: In addition to time-varying variables, Ben-Zeev et al. (2012) examined the effect of 
stable variables on the occurrence of delusions, namely self-esteem and the Jumping to Conclusions 
bias (JTC). JTC refers to the amount of evidence that participants gather in a probabilistic reasoning 
task, in that people with psychosis base decisions on insufficient evidence (for detailed information, 
see Dudley et al., 2016). The term stable means that the authors assessed said variables only once and 
not repeatedly over time. Trait JTC predicted delusions of control. Whereas Ben-Zeev et al. (2012) 
considered JTC a stable variable, Luedtke et al. (2017) examined JTC as a time-variant predictor that 
fluctuates over time and found that variable JTC predicted subsequent paranoia.  
Most of the aforementioned studies were conducted in samples consisting of people with psychosis or 
schizotypy, which might give the impression that negative affect, worrying, or sleep are associated 
with psychotic experiences predominantly in people with severe psychiatric disorders. However, this 
is not the case. Rather, many of these effects are not exclusive to people with psychiatric diagnoses. 
For example, effects of negative affect (Kramer et al., 2014) or quality of sleep (Hennig & Lincoln, 
2018) are universal rather than specific to psychosis.  
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Table 1 – The causal factors contributing to persecutory delusions proposed by the cognitive model of 
persecutory delusions (Freeman & Garety, 2014).  
CAUSAL FACTOR DESCRIPTION   
A WORRY THINKING 
STYLE 
Worrying is the “expectation of the worst happening” and consists of 
repeated negative thoughts about potential adverse outcomes 
(Freeman et al., 2015a). Putatively, worry causes paranoia because it 
makes people think about implausible ideas repetitively. 
NEGATIVE BELIEFS 
ABOUT THE SELF 
Also referred to as low self-esteem. People who feel bad about 
themselves (e.g., “I am worthless”) can develop feelings of being 
different or apart and hence vulnerable, which can lead to paranoia. 
INTERPERSONAL 
SENSITIVITY 
Interpersonal sensitivity is defined as ‘feeling vulnerable in the 
presence of others due to the expectation of criticism or rejection’ 
(Bell & Freeman, 2014). Fears of social evaluation putatively lead to 




Unexplained arousal, depersonalization (i.e., feeling detached from 
oneself), or perceptual disturbances (e.g., illusions; Horga & Abi-
Dargham, 2019). Misinterpretations of these experiences can lead to 
paranoia when a person tries to make sense of them.  
INSOMNIA/ SLEEP 
DISTURBANCE 
Insomnia (i.e., difficulties initiating or maintaining sleep; Riemann et 
al., 2017) but also other sleep disturbances lead to paranoia by 
increasing negative affect and anomalous experiences. 
REASONING BIASES A “Jumping to Conclusions” (JTC; Dudley et al., 2016) reasoning bias 
in psychosis leads to the acceptance of delusional ideas on the basis of 
insufficient information. The model further considers belief 
confirmation (Nickerson, 1998) and less use of analytic reasoning as 
contributors of paranoia.  
Note. The model also acknowledges stress, drug use, negative affect, and other factors in the development of paranoia but 
this table only depicts the six central factors. 
 
In addition to the aforementioned cognitive model of persecutory delusions, another important model 
of psychosis formation influenced the variables that were addressed in ESM research, namely Kapur’s 
model of psychosis as a state of aberrant salience (Kapur, 2003); for a description see Table 2. In a 
nutshell, the model assumes that stimulus-unrelated bursts of dopamine lead to the aberrant attribution 
of salience to stimuli that are not inherently salient. The resulting experiences can lead to 
hallucinations or delusions. Several ESM studies were based on this model by examining whether 
momentary fluctuations of aberrant salience predict subsequent psychotic symptoms. An emerging 
body of research suggests that increased aberrant salience predicts increases of subsequent psychotic 
symptoms (a composite of both hallucinatory and delusional experiences) across healthy participants, 
participants at risk for psychosis and first episode psychotic patients (Klippel et al., 2017; Reininghaus 
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et al., 2016; Reininghaus et al., 2019). Moderation analyses revealed stronger effects of aberrant 
salience on psychotic symptoms for people at risk for psychosis compared to non-clinical controls 
(Reininghaus et al., 2016). In order to confirm the proposed direction of effects (i.e., aberrant salience 
preceding rather than following psychotic symptoms), So et al. (2018) tested both directions of effects 
and could show that aberrant salience in fact predicts paranoia, but not vice versa. This finding further 
strengthens the validity of aberrant salience as a predictor of paranoia.  
A final candidate predictor of psychotic symptoms that received limited recognition in ESM studies so 
far is experiential avoidance. Experiential avoidance is defined as a) the unwillingness to remain in 
contact with private experiences, such as bodily sensations, thoughts, and emotions, and b) attempts to 
eliminate such experiences (Hayes et al., 2004). To simplify this rather bulky definition, one can think 
of experiential avoidance as the counterpart of a mindful and accepting engagement with negative 
experiences. Theoretical considerations suggest that experiential avoidance is implicated in a wide 
range of clinical problems and disorders. The underlying rationale is that a person who tries to 
suppress or otherwise avoid negative emotions that occur in response to stressors is unable to deal 
with negative emotions in a healthy way. Engaging in unhealthy coping strategies, such as worrying 
or even substance use to avoid negative feelings, eventually leads to psychological disorders. A coping 
strategy is “an action, a series of actions, or a thought process used in meeting a stressful or unpleasant 
situation or in modifying one’s reaction to such a situation” according to the dictionary for psychology 
by the American Psychological Association. Udachina et al. (2009) proposed a specific pathway of 
paranoia formation through experiential avoidance. The authors suggest that people with psychosis use 
experiential avoidance in response to highly unstable self-esteem, in an attempt to avoid feelings of 
low self-worth (Bentall et al., 2001; Murphy et al., 2018). In experience sampling studies, experiential 
avoidance predicts momentary paranoia both in healthy participants (Udachina et al., 2009) as well as 
paranoid patients with psychosis (Udachina et al., 2014). In addition, experiential avoidance partly 
mediates the effect of low self-esteem on paranoia, supporting the proposed hypothesis. However, the 
authors likewise found support for the opposite direction of effects, namely self-esteem mediating the 
effect of experiential avoidance on momentary paranoia. Interestingly and in accordance with 
theoretical considerations, the negative effect of experiential avoidance increased under high stress 
(Udachina et al., 2014).  
To summarize, the pioneering work by Myin-Germeys et al. (2001) initiated a series of ESM studies, 
which examined theory driven predictors of momentary psychotic symptoms in mostly time-lagged 
analyses of symptom variability throughout the day. The majority of predictors can be described as 
negative states of affect (e.g., anxiety, sadness), cognition (e.g., worry), or behavior (e.g., sleep), all of 
which are transdiagnostic problems. Aberrant salience is an exemption hereof as it is not a negative 
mental state per se but rather a qualitatively different state, which appears to be specific to psychosis. 
The resulting ESM studies have helped psychological research on psychosis to advance because they 
uncovered temporal symptom dynamics and time-lagged predictors of these fluctuations. Not only 
were these findings important to better understand psychoses, they also gave rise to a crucial follow-
up question: Is it possible to treat predictors of momentary psychotic symptoms in order to prevent 
psychotic symptoms from occurring?  
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Table 2 – The model of psychosis as a state of aberrant salience (Kapur, 2003) 
MODEL ASSUMPTIONS DESCRIPTION   
DOPAMINE AS A 
MEDIATOR OF SALIENCE 
According to the model, (mesolimbic) dopamine is a crucial 
component in the attribution of salience, meaning that stimuli 
(events but also thoughts) grab attention, drive action, and 
influence goal-directed behavior. Through this process, the 
neural representation of a neutral external stimulus turns into a 





Dopamine only mediates the aforementioned process of salience 
attribution, meaning that a stimulus becomes salient through 
dopaminergic processes because it is actually contextually 
relevant. In psychosis however, a dysregulated dopamine 
transmission leads to a stimulus-independent release of 
dopamine. In turn, this release of dopamine causes aberrant 
assignment of salience to external objects and internal 
representations. Dopamine becomes the cause rather than the 
mediator of salience. 
CONSEQUENCES OF 
ABERRANT SALIENCE – 
EARLY STAGES 
The model proposes that an increased release of dopamine 
precedes psychotic episodes. In this phase, patients experience 
exaggerated importance of certain percepts and ideas.  
ABERRANT SALIENCE 
AND DELUSIONS 
Delusions are a top-down cognitive explanation for the 
experiences of aberrant salience in an effort to make sense of 
them. The content of the delusion depends on the 
“psychodynamic” themes relevant to the individual as well as the 
patient’s context. Arriving at a delusional explanation provides 
“insight relief” or “psychotic insight”, and the patient searches 
for further confirmatory evidence.  
ABERRANT SALIENCE 
AND HALLUCINATIONS 
The model explains hallucinations as abnormally salient internal 
representations of percepts and memories.  
ANTIPSYCHOTICS 
DAMPEN SALIENCE 
The effectiveness of antipsychotics, which uniformly block 
dopamine, relies on their ability to dampen salience. However, 
antipsychotics likewise dampen salience of objects and ideas that 
one loves and desires, which explains why recipients of 
antipsychotics find them unpleasant. 
 
1.3 Treating predictors of psychotic symptoms  
ESM studies are regression-based, meaning that they do not encompass experimental manipulations of 
variables but only “natural” variability between and within participants. Consequently, ESM studies 
do not allow drawing causal conclusions. Nonetheless, the temporal ordering of predictors and 
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outcomes in ESM studies as well as the strong theoretical foundation of many predictor variables 
(Freeman & Garety, 2014; Kapur, 2003) suggest that ESM-based predictors represent worthwhile 
treatment targets for psychological interventions. The rationale behind this interventionist causal 
model approach (Kendler & Campbell, 2009) is to treat a predictor of symptoms in order to indirectly 
reduce the psychotic symptoms which the predictor causes (tentatively). Not only allows this approach 
to examine associations between putative causal factors and symptoms experimentally, it also 
coincides well with wishes and needs of people with psychosis who perceive the treatment of 
neuropsychological and affective problems as important (Freeman et al., 2019; Moritz et al., 2017). 
Accordingly, in many respects it seems worthwhile to target ESM-derived correlates of psychosis in 
psychological treatments. So far, there are few but very promising trials. Freeman et al. (2015a) 
examined a brief intervention based on cognitive behavioral therapy (CBT; for a description, see Table 
3) targeting worry. The intervention led to reduced worrying and persecutory delusions in people with 
non-affective psychosis displaying persistent persecutory delusions. Reduced worrying mediated the 
effect on persecutory delusions. For sleep problems, findings are less coherent. In a randomized 
controlled trial, a CBT-based 10-week sleep intervention reduced insomnia, paranoia, and 
hallucinations in healthy participants, and insomnia mediated the effect on both paranoia and 
hallucinations (Freeman et al., 2017). In people with psychotic disorders, CBT-based sleep 
interventions likewise improved sleep but not psychotic symptoms (Freeman et al., 2015b; Hwang et 
al., 2019). However, it must be noted that these interventions targeted psychotic symptoms only as 
secondary outcomes, so the effect of sleep interventions on delusions and hallucinations remains open 
to question. CBT-based treatments for depressive symptoms in psychosis are rare despite their 
capability to improve functional outcome in psychosis (Upthegrove et al., 2017). A first trial found 
effects of a depression-focused intervention on depressive symptoms only whereas psychotic 
symptoms remained unaffected (Moritz et al., 2016). Other interventions have targeted cognitive 
biases, such as JTC, which served as a predictor of momentary psychotic symptoms in one ESM trial 
(Luedtke et al., 2017). The metacognitive training (MCT; Moritz & Woodward, 2007) aims at 
ameliorating psychotic symptoms by reducing, inter alia, participants’ proneness to cognitive biases. 
Whereas early meta-analyses yielded mixed findings (e.g., van Oosterhout et al., 2016), the latest 
meta-analyses suggests that the metacognitive training improves psychotic symptoms (Eichner & 
Berna, 2016; Liu et al., 2018; Philipp et al., 2019). Finally, several studies have examined 
mindfulness- and acceptance-based interventions in psychosis. Mindfulness-based interventions aim at 
improving psychosis-related distress by targeting several of the aforementioned predictors, such as 
worry and rumination (Nolen-Hoeksema et al., 2008) and experiential avoidance (Vilardaga et al., 
2013). Experiential avoidance is defined as the counterpart of the mindfulness-based emotion 
regulation strategy “experiential acceptance”, which is characterized by a non-reactive, accepting, and 
mindful awareness of one’s own perceptions. One early meta-analysis found that mindfulness-based 
interventions are effective at reducing hospitalization rates but also negative and affective symptoms 
in psychosis (Khoury et al., 2013), whereas a second meta-analysis found effects on total psychotic 
symptoms and positive symptoms, but not on negative symptoms of schizophrenia (Cramer et al., 
2016). A recent meta-analysis concluded that acceptance- and mindfulness-based approaches 
effectively improve overall symptomatology and hospitalization rates, with improvements on a wide 
variety of symptoms, such as negative symptoms, depression, social functioning, mindfulness, and 
acceptance, but no effects on positive symptoms (Jansen et al., 2020). From a theoretical point of 
view, mindfulness interventions help participants to embrace present experiences in a nonjudgmental 
way without avoiding or suppressing them (Khoury et al., 2013) thereby reducing distress, for 
example, caused by auditory verbal hallucinations (Vilardaga et al., 2013). Conceptually, mindfulness 
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should help people who experience auditory verbal hallucinations to be aware of the potentially 
unpleasant sensation. For example, mindfulness is negatively correlated with hallucinations and 
associated distress (Strauss et al., 2015). Taken together, there is emerging evidence that targeting 
ESM-derived predictors of psychotic symptoms in psychological interventions can be beneficial for 
patients.  
Referring back to the question at the end of section 1.2.3 (“can we improve psychotic symptoms by 
treating ESM based predictors?”), the answer would be “partly”. For some predictors, evidence is 
convincing (e.g., worrying), for others there is so far no evidence that the indirect approach leads to 
reductions of psychotic symptoms (e.g., depression). Nonetheless, it seems worthwhile to address all 
ESM based predictors of psychotic symptoms because all of the reviewed interventions resulted in 
some benefit for patients – even if it was not an immediate measurable improvement of psychotic 
symptoms.  
1.3.1 Internet interventions 
The previous section illustrated that it is worthwhile to target predictors of psychosis in psychological 
interventions. But how should such an intervention be delivered? In a conventional face-to-face setting 
or in an online setting? The vast majority of afore reviewed interventions are delivered in a face-to-
face setting whereas only a fraction of the interventions are delivered via the Internet (e.g., Freeman et 
al., 2017), perfectly illustrating the general scarcity of Internet interventions in psychosis. This 
shortage represents an important treatment gap because an online format seems very worthwhile to use 
the Internet to improve the dissemination of psychological treatments – especially in psychosis. The 
following section provides an overview on this topic.  
Today, a large body of research has accumulated indicating that established variants of CBT for 
psychosis effectively reduce positive symptoms, both in research settings (Morrison et al., 2014; 
Tarrier et al., 1998) and in clinical practice (Krakvik et al., 2013; Lincoln et al., 2012). Although effect 
sizes are lower than for other disorders, such as depression (for a review on CBT in adult depression, 
see Cuijpers et al., 2013), CBT for psychosis is recommended in national guidelines (e.g., the NICE 
guidelines; see Kuipers et al., 2014) just as it is for other disorders. Despite these similarities, the 
dissemination of CBT-based interventions via the Internet differs drastically between psychosis and 
other diagnoses. For depression (Karyotaki et al., 2017) as well as anxiety disorders (Domhardt et al., 
2019), numerous Internet-based interventions have been developed and evaluated over the past years 
(in the following, the term Internet intervention is used). In contrast, Internet interventions for 
psychosis are very rare (e.g., Gottlieb et al., 2017; Gottlieb et al., 2013) and their efficacy remains 
unclear to date. The shortage of evidence-based Internet interventions delivering CBT for people with 
psychosis is problematic because Internet interventions have great potential to improve the 
dissemination of psychological interventions for psychosis, which is poor currently (Haddock et al., 
2014). Internet interventions can reach people who do not have access (or chose not to use) face-to-
face psychotherapy, which make up approximately 40% of patients with psychosis (Mojtabai et al., 
2009). 
1.3.1.1 Properties of Internet interventions according to Anderson (2016) 
Several definitions of Internet interventions exist. Barak et al. (2009) proposed the definition “a 
primarily self-guided intervention program that is executed by means of a prescriptive online program 
operated through a website and used by consumers seeking health- and mental-health related 
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assistance. The intervention program itself attempts to create positive change and or improve/enhance 
knowledge, awareness, and understanding via the provision of sound health-related material and use of 
interactive web-based components” (Barak et al., 2009, p. 5). Andersson et al. (2008) define Internet 
interventions as “a therapy that is based on self-help books, guided by an identified therapist which 
gives feedback and answers to questions, with a scheduling that mirrors face to face treatment, and 
which also can include interactive online features such as queries to obtain passwords in order to get 
access to treatment modules” (Andersson et al., 2008, p. 164). The definition of Anderson and 
colleagues is stricter in that it includes guidance as a feature of Internet interventions. Guidance refers 
to personal support by a moderator during the intervention, in the form of feedback, answers to open 
questions, or reminder messages (Andersson, 2016).  
Usually, Internet interventions require an online platform (i.e., a website) through which participants 
enter the intervention with personal login data. Using an online platform to access the intervention 
comes with several advantages when compared to classical face-to-face therapy. Participants can 
contact moderators via text messages (embedded within the intervention) whenever necessary rather 
than only during face-to-face meetings. Also, a history of personal communication is saved within the 
system, enabling the participant to access previous conversations. The participant can use the 
intervention whenever they want and there is no need for scheduled appointments. Then again, an 
important disadvantage of Internet interventions is that there is no direct contact between a therapist 
and the client. Therefore, contents of the intervention can be misunderstood and negative reactions by 
the client (e.g., elevated negative affect in response to a module of the intervention) might remain 
undetected. Most Internet interventions convey contents via text, either on screen or as a 
downloadable file. Further they can contain video files, audio files, or pictures. Regarding their 
content, Internet interventions mostly present self-help materials in an online format. Thus, most 
Internet interventions can be described as interactive self-help books, enriched with several 
advantages, such as the contact with a moderator, or the usage of other media formats. Similar to 
classical psychotherapy, Internet interventions usually encompass treatment durations of 5 to 15 weeks 
and they follow a modular structure, with each module addressing a certain topic. Some Internet 
interventions require participants to complete all modules, others allow tailoring, meaning that 
participants may choose which modules they wish to complete.  
1.3.2 The EviBaS intervention 
ESM studies have identified numerous predictors of symptom fluctuations (e.g., worry; Hartley et al., 
2014), which can be targeted successfully in psychological interventions (e.g., Freeman et al., 2015a). 
At the same time, Internet interventions are a highly accessible and effective way of delivering self-
help materials for various disorders (e.g., anxiety and depression; Andrews et al., 2018). 
Consequently, it seems reasonable to provide people with psychosis with an Internet intervention that 
targets one or more evidence-based predictors of psychotic symptoms to improve not only correlates 
of psychosis (e.g., improve self-esteem) but potentially also psychotic symptoms. The Internet-based 
format could be particularly suited for people with psychosis because many people with psychosis 
have neuropsychological deficits (Schaefer et al., 2013), so that they could benefit from the possibility 
to repeat modules and to re-read self-help materials. Further, people with psychosis are a stigmatized 
group (Dickerson et al., 2002), so the anonymity of Internet interventions could circumvent treatment 
barriers of face-to-face approaches.  
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Given the numerous potential benefits that come with an online-based intervention targeting predictors 
of psychotic symptoms, we have developed a comprehensive psychological Internet intervention titled 
EviBaS (short for: Evidence Based Self-Help). The principal investigators Prof. Westermann, Prof. 
Moritz, Prof. Berger, and the corresponding working groups at the University of Bern, Switzerland, 
and University Medical Center Hamburg, Germany, collaborated on the development of the EviBaS 
intervention. The CBT-based intervention is guided, meaning that trained and supervised study staff 
with at least a bachelor’s degree in psychology assist participants through a secure messaging system. 
The EviBaS intervention encompasses 11 modules in total – one introductory module, one module on 
relapse prevention and nine modules targeting persecutory delusions, auditory verbal hallucinations, as 
well as worrying, low levels of mindfulness, poor social competence, low self-esteem, depression, 
sleep problems, and cognitive biases. Hence, the intervention (a) addresses psychotic symptoms 
directly and (b) targets potential predictors of psychosis to ameliorate symptoms indirectly (seven 
modules). Modules contain educational components and exercises conveyed via text, audio, and video 
files. Paper 1 of this thesis presents findings from a multi-center randomized controlled trial evaluating 
the efficacy of EviBaS in a sample of people with verified psychotic disorders.  
The evaluation of EviBaS in a randomized controlled trial can reveal whether EviBaS is efficacious in 
reducing psychotic symptoms because it compares the course of symptoms over time between an 
intervention group and a waitlist control group. However, the trial does not reveal the underlying 
processes through which the intervention is efficacious. Therefore, the current thesis incorporates two 
further papers that are concerned with EviBaS. These papers report findings regarding potential 
mechanisms of symptom change during the intervention. Paper 2 presents analyses using an ESM-like 
methodology of repeated measures during the 8-week randomized controlled trial to reveal predictors 
of momentary psychotic symptoms over time. As EviBaS covers a wide range of ESM-based 
predictors, the analyses of paper 2 aimed at investigating which of the targeted variables predict the 
course of psychotic symptoms during the intervention. If, for example, within-participant fluctuations 
of negative affect predict subsequent symptom fluctuations, then one can assume that improving affect 
is an important treatment target in an online intervention such as EviBaS. Paper 3 reports findings 
from a different approach to investigate mechanisms of change during the EviBaS trial. As described 
in section 1.2.3, experiential avoidance (the counterpart of mindfulness-based experiential acceptance) 
is associated with psychotic symptoms in ESM assessments and mindfulness interventions are 
associated with numerous positive outcomes in psychosis. As the stress-reducing features of 
mindfulness should be particularly beneficial for people who experience hallucinations, which cause 
considerable distress (Birchwood & Chadwick, 1997), we examined whether EviBaS improved 




Table 3 – The basic principles of cognitive behavior therapy (CBT) according to Wright (2006). 
PRINCIPLES  DESCRIPTION   
ORIGINS OF CBT Aaron Beck introduced the theory behind CBT in the 1960s, focusing 
mainly on depression and anxiety. Today, there are variants of CBT for 
many other conditions, including psychotic disorders.  
THE CBT MODEL The CBT model assumes that a person’s emotions and behavior are 
influenced by the cognitive appraisal of situations. Hence, not the situation 
itself, but the interpretation of a situation influences one’s behavior and 




The therapeutic relationship in CBT can be described as collaborative 
empiricism, which means that the therapist and client collaborate as a team 
to identify maladaptive cognitions and behavior, test the validity of these 
cognitions and behaviors, and to revise them. The aim is to gain skills to 
manage one’s problems. As other therapies, CBT relies on nonspecific 
elements of the therapeutic relationship, such as rapport, understanding, or 
empathy. Furthermore, CBT is very structured, including agenda setting, 




The most important technique is to ask questions that encourage the client 
to break patterns of dysfunctional thinking (e.g., Socratic questioning). 




The most common techniques in depression treatment are the scheduling of 
activities. In anxiety, the key behavioral method is exposure to feared 
stimuli, accompanied by relaxation or breathing techniques – the latter 
being universal and applicable to other disorders as well. 
 
 
1.4 Using ESM-findings to improve the prediction of relapse 
Insights from ESM studies can not only inform the treatment of symptoms, they can potentially also 
help to prevent symptoms from re-emerging. Paper 4 reports analyses, in which we examined whether 
short-term symptom predictors from ESM studies represent worthwhile candidate predictors of relapse 
in psychosis.  
The risk of relapse is high in people with psychosis. Depending on the time frame, relapse rates range 
from 49% within 3 years (Pelayo-Teran et al., 2017) to 82% within 5 years (Robinson et al., 1999). 
This very pessimistic view regarding the course of psychosis is not new. In fact, more than a century 
ago Emil Kraepelin stated that dementia praecox, as he termed schizophrenia, would inevitably 
deteriorate (for a review on the history of relapse research, see Taylor & Jauhar, 2019). Given the high 
rates of relapse, it is not surprising that there are numerous studies that examined predictors of relapse, 
summarized in reviews (e.g., Olivares et al., 2013) or even meta-reviews (e.g., Lecomte et al., 2019). 
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Olivares et al. (2013) concludes that medication non-adherence as well as stress, depression, and 
substance abuse are associated with a higher risk of relapse. The studies reviewed by Olivares and 
colleagues provide very important information about general risk factors. For example, a person who 
is non-adherent to medication is at higher risk to relapse over a certain period of time when compared 
to an adherent person. However, such between-person risk factors do not tell us anything about the 
momentary triggers of relapse (i.e., within-person time-variant predictors). In fact, only a small 
fraction of the existing literature on relapse predictors deals with within-person time-variant predictors 
of relapse, such as prodromal symptoms that forecast relapse, in prospective repeated-measures 
studies. Unlike stable predictors of relapse (e.g., age of psychosis onset; Pelayo-Teran et al., 2017), 
time-variant predictors can help to gauge the risk of an upcoming relapse at any given time. Referring 
back to the example of medication adherence, a time variant predictor would inform us about the risk 
of relapse when a person stops taking their medication at a certain point in time rather than the risk of 
relapse comparing adherent and non-adherent persons. Eisner et al. (2013) reviewed available studies 
on time-variant predictors of relapses. The authors focused on the sensitivity and specificity of 
prodromal symptoms, also referred to as early signs of relapse (e.g., anxiety, dysphoria, or insomnia). 
Sensitivity values ranged from 10% to 80% (median = 61%) and specificity values ranged from 38% 
to 100% (median = 81%). One of the studies that Eisner et al. reviewed included up to bi-weekly 
diagnostic meetings in 339 outpatients over two years (Gaebel & Riesbeck, 2007). The authors found 
that participants reported trouble sleeping prior to a relapse (sensitivity = 39%, specificity = 78%), as 
well as being tense and nervous (sensitivity = 37%, specificity = 79%). More recent approaches that 
tried to identify what happens before a relapse occurs used passive smartphone data to detect 
anomalous behavior (Barnett et al., 2018; Buck et al., 2019). The quantity and duration of outgoing 
calls as well as the amount of total text messages changed prior to a relapse in one study (Buck et al., 
2019).  
The challenge in research on relapse is to identify variables that change within a person before a 
relapse occurs (i.e., warning signs of relapse). From a methodological point of view, ESM studies aim 
at something very similar; the only difference being that ESM focuses on warning signs of momentary 
symptoms rather than relapses. In ESM studies, repeated measures allow examining fluctuations of 
symptoms within participants over time, which can be predicted through preceding time-variant 
warning signs. If we could apply this methodology to the framework of relapse prediction, ESM could 
hence provide a very suitable assessment method. Interestingly, there is in fact considerable overlap of 
short-term ESM predictors and the early signs of relapse that Eisner et al. (2013) identified in their 
review. Sleep problems (Kasanova et al., 2020), but also negative affective states, such as anxiety or 
depressed mood (Ben-Zeev et al., 2011; Luedtke et al., 2017) predict upcoming subsequent 
momentary symptoms in ESM studies. All of these variables likewise serve as warning signs of 
relapse (e.g., Gaebel & Riesbeck, 2007). The overlap of ESM-predictors and previously identified 
relapse predictors suggests that the underlying processes of short-term symptom fluctuations and long-
term relapse formation could be the same. Although relapse and paranoia represent different 
outcomes, we nonetheless set up the hypothesis for paper 4 that we can use ESM-derived predictor 
variables to predict long-term symptom fluctuations and hopefully even occurrences of relapse.  
Study 4 incorporated a 7-day ESM phase followed by a one-year assessment phase with bi-weekly 
online-questionnaires designed to monitor the course of symptoms and candidate predictors. This 
design enabled us to directly compare short- and long-term associations of predictor variables and 
psychotic symptom fluctuations. At the same time, it allowed us to capture relapses over the one-year 
 
16 
period and to examine their predictors. Since the repertoire of ESM-based candidate predictors is 
extensive, my colleagues and I had to make a choice on the variables that were most promising as 
relapse predictors in the planning phase of study 4. Out of the established ESM-based predictors I 
chose negative affect (i.e., sadness, anxiety, low self-esteem, and worrying) and aberrant salience as 
candidates for the long-term prediction of symptoms and relapses. This choice was made because 
aberrant salience has a strong theoretical foundation (Kapur, 2003), is introspectively accessible 
(Cicero et al., 2010), and a well-established precursor in ESM studies (Reininghaus et al., 2016; So et 
al., 2018). Further, aberrant salience is theoretically (Kapur, 2003) and empirically (Miyata, 2019) 
associated with dopamine functioning (see also Table 2). Thus, aberrant salience may signal the 
emergence of subsequent symptoms or relapses through underlying dopaminergic processes. Finally, 
aberrant salience is specific to psychosis rather than a correlate of general psychopathology, such as 
sleep problems or depression. Negative affect, on the other hand, is by far the most well-established 
predictor of psychotic symptoms in ESM studies, researched for 20 years (Myin-Germeys et al., 
2001). Consequently, study 4 incorporated it as the second candidate relapse predictor because it can 
be considered a promising warning sign.  
1.5 Aims of the thesis 
The overarching goal of the present thesis was to apply the knowledge from ESM studies to the 
treatment of psychosis as well as the prediction of psychotic relapse. Study 1 presents findings from a 
randomized controlled trial, which evaluated EviBaS, a psychological Internet intervention for people 
with psychosis. What is special about EviBaS is that it targets not only psychotic symptoms but also a 
variety of ESM-based variables that represent important predictors of psychotic symptoms in 
participants’ everyday lives, such as depressed mood, poor sleep, poor self-esteem, low mindfulness, 
and others. Thus, the aim of paper 1 was to examine whether treating ESM-based predictors of 
psychotic symptoms (as well as psychotic symptoms themselves) results in a reduction of psychotic 
symptoms. Due to the heterogeneity of the targeted constructs in the EviBaS intervention, paper 1 
cannot tell us about the mechanisms of change that occur during the intervention. Studies 2 and 3 
address this research question by examining which processes occur during the EviBaS intervention. 
Paper 2 aims at answering this question by applying an ESM-like methodology to data obtained during 
the EviBaS Project. Using short intermediate online assessments, study 2 examines whether EviBaS 
improves ESM-derived predictor variables (e.g., sleep, worry, negative affect) and whether these 
variables predict subsequent fluctuations during the intervention. If changes of certain predictor 
variables precede subsequent psychotic symptom fluctuations, then one can assume that these 
predictor variables represent the most important treatment targets in a comprehensive intervention 
such as EviBaS. Study 3 tried to achieve the same goal as study 2 but using a different method. Using 
a mediation approach, study 3 examined whether improvements of mindfulness represent a 
mechanism of change in the treatment of distressing auditory verbal hallucinations. For this purpose, 
we drew a subsample of people from the EviBaS trial who reported auditory verbal hallucinations. 
Further, we only considered participants who used the mindfulness section of EviBaS. We 
hypothesized that EviBaS would lead to reduced distress by auditory verbal hallucinations and that 
this effect would be mediated by improved mindfulness.  
Whereas studies 1 to 3 deal with the treatment of ESM-derived predictors of psychotic symptoms, 
study 4 examined a different application for findings from ESM studies. Given the high rates of 
relapse in psychosis, study 4 aimed at identifying predictors of long-term fluctuations of psychotic 
symptoms (measured bi-weekly over a period of one year) and potentially even relapse. ESM studies 
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are very similar to prospective studies on warning signs of relapse: Using repeated measures, both 
types of research designs try to identify within-participant changes of variables that precede a 
symptom exacerbation. The only (yet striking) difference is that ESM studies examine effects that 
occur over very short periods of time whereas relapse prediction studies examine effects across weeks. 
We hypothesized that we could use ESM-based predictors in bi-weekly online assessments to predict 
long-term symptom fluctuations and potentially relapses. In study 4, we made use of established ESM 
variables (e.g., worry or aberrant salience) but also of established methods from ESM research, such 
as short self-report scales and lagged regression based analyses.  
2 Methods 
The present thesis incorporates four papers. Three of these papers belong to the same overarching 
project, namely the EviBaS Project, a multi-center research project evaluating the efficacy of the 
EviBaS intervention. Although the samples for paper 1 to 3 are not identical due to differing inclusion 
and exclusion criteria for each trial, the samples do overlap considerably. Paper 4, on the other hand, 
reports findings from an independent study, unrelated to the EviBaS Project. Samples of all four 
studies consist of participants with lifetime non-affective psychotic symptoms, verified with the Mini 
International Neuropsychiatric Interview (MINI; Lecrubier et al., 1997). Thus, participants across 
studies represent a homogeneous group of people in terms of symptoms. Table 4 provides an overview 
of the four included studies.  
To avoid confusion regarding the names/labels of each study, I will briefly introduce the wording that 
I am going to use throughout. The EviBaS Project refers to the overarching project that resulted in 
studies 1 to 3. The EviBaS Project is not the same as the EviBaS Efficacy Study (although this study is 
unequivocally the central study of the project). Rather, the EviBaS Project is comprised of all three 
EviBaS-related studies, aiming at not only assessing EviBaS’ efficacy but also its mechanisms of 
change. In contrast to the EviBaS Project, I will refer to each of the individual studies conducted 
within the project as study 1 (EviBaS Efficacy Study), study 2 (EviBaS Intermediate Assessment 
Study), and study 3 (EviBaS Mindfulness Study). Although these studies originate from the same 
project, I believe that it is justified to call them stand-alone studies because of their unique features, as 
described in the following sections. I will refer to the last study simply as study 4 (ESM Study). There 
is no need to differentiate between the terms “project” and “study” because the ESM Study is a stand-
alone study. To summarize, I will use the term EviBaS Project when I am referring to the entirety of 
studies 1 to 3, and I will use the respective term study 1, 2, 3, or 4 when I am referring to the 
individual studies that are reported in separate papers. 
2.1 Participants and recruitment 
The EviBaS Project’s primary goal was to evaluate an Internet intervention, so it was sensible to 
recruit participants mainly through the Internet. For this purpose, we set up a webpage, which listed 
information on the trial, data security, and contact information. We advertised the project in online 
forums for people with mental health problems and we used e-mails to reach out to former study 
participants who wished and consented to be informed about studies. Further, we advertised the 
project online using “google ads”. We reached out to candidate participants in Germany and 
Switzerland. In contrast to the EviBaS Project, the ESM Study incorporated a face-to-face assessment, 
which required participants to be present at the study site in Hamburg, Germany. Consequently, we 
focused our recruitment efforts on the area of Hamburg and surrounding areas. We reached out to 
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former participants, we contacted psychiatric wards of local hospitals, self-help groups, and assisted 
living facilities. We advertised the study using leaflets, posters, and within a local newspaper. Again, 
we used online advertisements (google ads) but restricted recruitment efforts to the relevant area in 
and around Hamburg rather than nation-wide.  
Table 4 – Overview of included studies 
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Notes. EviBaS is the name of the psychological Internet intervention (Ruegg et al., 2018), which targets hallucinations, 
persecutory delusions, and ESM-derived predictors of psychosis in 11 web-based modules. ESM = Experience Sampling 
Method, RCT = Randomized controlled trial. The symptom threshold of the EviBaS Efficacy Study refers to a score of 3 or 
higher on current delusions, hallucinations, or suspiciousness/persecution. PANSS-PF = positive factor (according to van der 
Gaag et al., 2006) of the Positive and Negative Syndrome Scale (Kay et al., 1987). LSHS-R = Launay–Slade Hallucination 
Scale (Launay & Slade, 1981; Lincoln et al., 2009). Paranoia CL = Paranoia Checklist (Freeman et al., 2005). DV-SA = 




We conducted all studies in accordance with the Declaration of Helsinki. All participants provided 
informed consent before the study and we obtained ethical approval of respective ethics committees 
before we conducted the studies. As the EviBaS Project incorporated study sites in Germany and 
Switzerland, we obtained ethical approval from ethics committees in both countries from the Ethics 
Committee of the Canton of Bern, Switzerland (KEK 03/14) and the German Psychological Society 
(SM052015_CH). The ESM Study was approved by the ethics committee of the German 
Psychological Association (ID: SM082017). In accordance with good clinical practice, the EviBaS 
Efficacy Study was prospectively registered with clinicaltrials.gov (ID: NCT02974400, November 28, 
2016). Likewise, we registered the analyses for the EviBaS Intermediate Assessment Study 
(https://osf.io/gn8u5, registered February 27, 2019) as well as the ESM Study (https://osf.io/em6v9, 
registered September 12, 2018) with osf.io. Only study 3 (EviBaS Mindfulness Study) was not 
registered.  
Figure 2 displays the recruitment process and the overlap of samples of all included studies. Papers 1, 
2, and 3 all relied on data from the EviBaS Project (depicted on the left-hand side of Figure 2) but the 
focus on different research questions resulted in varying sample sizes. Detailed inclusion criteria for 
each study are as follows.  
Study 1 (EviBaS Efficacy Study): We included participants if they were (a) 18 years old or older, (b) 
showed sufficient command of the German language, (c) had access to the Internet, (d) provided 
informed consent, (e) fulfilled criteria for the diagnosis of a schizophrenia spectrum disorder, (f) 
received simultaneous pharmacological and/or regular psychiatric or psychological care (for reasons 
of safety), and (g) fulfilled criteria for at least mild (≥ 3) delusions, hallucinations, or 
suspiciousness/persecutory delusions according to the PANSS (Kay et al., 1987; for a description, see 
section 2.4.1). We excluded participants in case of (a) acute suicidality, (b) an acute danger for others, 
(c) a neurological disease of the central nervous system that requires treatment, and (d) unwillingness 
to formulate an “emergency plan”. The mandatory emergency plan listed persons that participants 
could contact in case of an emergency (e.g., a local psychiatrist).  
Study 2 (EviBaS Intermediate Assessment Study): The inclusion criteria for study 2 were identical to 
study 1 (i.e., 18 or older, Internet access, command of German language, concurrent psychiatric 
treatment, no neurological disease, no suicidality, no danger towards others, and an emergency plan). 
However, there are two differences to study 1. First, participants had to fulfill the diagnosis of a 
psychotic disorder according to the MINI interview rather than a schizophrenia spectrum diagnosis. 
This difference is very subtle and affected only n = 2 people that were part of study 1 but not of study 
2. The MINI requires two symptoms from the psychosis spectrum for a diagnosis of a psychotic 
disorder. Hence, participants with isolated psychotic symptoms (e.g., only auditory verbal 
hallucinations) in the absence of other psychotic symptoms do not receive the diagnosis although they 
are part of the schizophrenia spectrum. See section 2.4.1 for a description of the MINI interview. The 
second difference to study 1 was that we included participants who did not fulfill the symptom 
severity threshold of study 1 regarding delusions, hallucinations, or suspiciousness/ persecutory 
delusions.  
Study 3 (EviBaS Mindfulness Study): Paper 3 presents analyses in a subgroup of participants from the 
EviBaS Efficacy Study (study 1). Hence, inclusion and exclusion criteria are identical to the EviBaS 
Efficacy Study (including the symptom severity threshold), with two additional criteria. First, we only 
considered participants who reported lifetime auditory verbal hallucinations because the main outcome 
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of the study was hallucination-related distress. Second, we only considered participants from the 
EviBaS group if they completed the mindfulness module because the paper focused on the 
intervention’s effect on mindfulness.  
Study 4 (ESM Study): Participants for study 4 were sampled independently from the EviBaS Project 
but inclusion criteria were almost identical. We included participants (a) if they were 18 to 65 years 
old, (b) if they showed sufficient command of the German language, (c) if they reached a verbal IQ 
score of ≥ 85 (according to the WST; Schmidt & Metzler, 1992), and (d) if they fulfilled criteria for a 
non-affective psychotic disorder according to the MINI (Lecrubier et al., 1997). We excluded 
participants with a diagnosis of dementia or a severe neurological disease, and if they fulfilled the 
diagnostic criteria of a severe substance use disorder or high suicidality according to the MINI. 
Finally, we excluded participants who refused to fill in the aforementioned emergency plan.  
21 
Figure 2 – Overview of the four samples, their recruitment, and their overlap 
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2.2 Study design  
2.2.1 Design of studies 1, 2, and 3 (EviBaS Project) 
For the sake of parsimony, the following section summarizes the study designs for papers 1 to 3 
because they are all part of the EviBaS Project. Interested persons learned about the study and visited 
the study website. Directly after providing informed consent, candidate participants completed an 
online assessment consisting of several self-report questionnaires (implemented in QuestBack 
Unipark®, www.unipark.com). Within the online assessment, participants completed several 
sociodemographic questions as well as multiple questionnaires on psychotic symptoms (see section 
2.4). If necessary, the survey platform automatically excluded participants who did not meet inclusion 
criteria (e.g., if they reported to be younger than 18). When a participant successfully completed the 
online assessment, the study coordinator inspected the participant’s responses to the online assessment 
and assigned an independent assessor who contacted the participant for a diagnostic telephone 
interview (including inter alia the MINI and the PANSS). Assessors received extensive training 
(approximately 8 hrs.) and continuous supervision. They showed good interrater agreement as 
indicated by an intraclass correlation coefficient of .82. Setting up the emergency plan was also part of 
the telephone interview. After the telephone interview was completed, the study coordinator decided 
whether a participant could be included and randomized on the basis of the combined information 
from the online assessment and the telephone interview. If participants fulfilled all inclusion criteria 
except the current symptom severity threshold (see section 2.2.1), participants were randomized within 
a secondary track of the project (these participants were later considered in analyses for paper 2). We 
randomized participants using an electronic randomization service (www.random.org). From 
December 2016 to May 2018, n = 140 participants were randomized to the waitlist condition or the 
EviBaS condition, n = 101 of which were part of the EviBaS efficacy trial.  
We allocated participants randomly to one of two conditions. One group received immediate access to 
the EviBaS intervention, whereas the second group received delayed access. The immediate access 
group received access to EviBaS and an accompanying smartphone application for eight weeks. The 
delayed access group received access to EviBaS after a waiting period which lasted 8 weeks for 
participants of the EviBaS efficacy trial (study 1) and 6 months for the asymptomatic participants who 
were part of the EviBaS immediate assessment study (study 2). After eight weeks, all participants 
completed a second online assessment (post assessment), which was accompanied by a second 
telephone interview for participants of the EviBaS efficacy trial but not for asymptomatic participants. 
Between the baseline and post assessment all participants completed so-called intermediate 
assessments that we used to monitor the course of psychotic symptoms and their predictors over time 
using frequent online assessments. Participants of the immediate access group completed the 
intermediate assessments when they logged into the EviBaS intervention (with a maximum frequency 
of twice in six days), whereas the delayed access participants completed the intermediate assessments 
once per week (we invited them via e-mail). The ESM-like intermediate assessments were 
programmed as short online assessments and they are at the core of paper 2. 
The primary outcome for paper 1 was a composite score of positive symptoms of psychosis, which 
encompassed two self-report scales as well as the PANSS interview. Consequently it was crucial that 
assessors were blind to a participants’ group allocation to avoid biased ratings. To ensure blinding, we 
asked participants to keep their group allocation confidential when talking to the assessors during the 
post assessment telephone interview. After each interview, assessors guessed which group a 
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participant belonged to and we compared their guesses to the actual allocation. Assessors were unable 
to correctly guess group allocation, indicating that blinding was successful. 
2.2.2 Design of study 4 
The design of study 4 differed considerably from studies 1 to 3 because it was purely observational. 
Study 4 aimed at identifying predictor variables of short- as well as long-term symptom fluctuations 
and potentially even relapses in psychosis. The study consisted of four distinct parts that are depicted 
in Figure 3. Candidate participants completed a structured face-to-face baseline interview including 
the MINI and the PANSS (for a description, see section 2.4.1) to assess inclusion and exclusion 
criteria as well as relevant diagnoses and psychotic symptom severity. After the baseline assessment 
(and if inclusion criteria were met), the participant received a study smartphone (Motorola G3, 5-inch 
screen), which they kept for approximately one week to complete an ESM assessment phase. The 
experimenter explained the functions of the smartphone as well as the ESM items. The ESM 
assessments were designed to capture the predictors negative affect and aberrant salience (for a 
detailed description, see section 2.4.2.4) as well as momentary psychotic symptoms repeatedly 
throughout the day. By doing so, we aimed at identifying predictors that forecast subsequent 
fluctuations of psychotic symptoms. The alarms that signaled a due ESM assessment occurred pseudo-
randomly ten times per day between 9:00 a.m. and 9:00 p.m. with a minimum distance of 30 minutes 
in between. Participants could additionally activate ESM assessments manually. After approximately 
one week, participants returned the smartphone and completed a brief post-ESM assessment. After the 
post-ESM assessment, the Follow Up phase started, consisting of up to 24 online assessments over the 
course of one year (every two weeks). These bi-weekly Follow Up assessments included the same 
items as the ESM smartphone assessments (plus few additional items) and served the same purpose, 
namely identifying predictors of fluctuating psychotic symptoms – this time with a considerably larger 
distance between measurements. Every two months, the Follow Up assessment included an extensive 
assessment of psychotic relapse (for a detailed description, see section 2.4.2.4). Hence, the design of 
study 4 allowed us to not only to identify predictors of short- and long-term symptom fluctuations but 
also of relapses.  
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1. Baseline  
 
- Face-to-face meeting, ca. 2 hrs. 
- Interview (MINI, PANSS) and self-report 
questionnaires 




- 70 scheduled assessments, 10 per day for 
7 days, 98 sec.  
- ESM Items: paranoia, verbal 
hallucinations, aberrant salience, negative 
affect… 
Post-ESM assessment took place when participants returned smartphone after ca. 7 days 
3. Post-ESM  
 
- Face-to-face meeting, ca 20 min.  
- Questionnaire: Experiences ESM 
- Instructions Follow Ups 
Follow Ups started ca. one week after the Post-ESM assessment 
4. Follow Up 
 
distance 
- 24 scheduled assessments, bi-weekly for 
one year, 13 min. duration 
- ESM items (identical to ESM) 
- Follow Up items: Sleep, medication 
adherence, relapse-expectation, etc. 
- Bi-monthly relapse assessments, 43 min., 
questionnaires identical to baseline 
Figure 3 – Overview of the trial design of study 4 (ESM Study) 
2.3 The EviBaS intervention 
The EviBaS intervention was at the core of the majority of papers that are part of the present thesis. 
For a general description of the intervention, please see section 1.3.2. The following section provides a 
more in-depth illustration with a specific focus on the mindfulness module, which was relevant for 
paper 3. The EviBaS intervention encompasses eleven modules (introduction, paranoid ideation, voice 
hearing, self-esteem, sleep hygiene, metacognition, depression, mindfulness, worrying, social 
competence, and relapse prevention). The working groups of the principal investigators Stefan 
Westermann, Steffen Moritz, and Thomas Berger collaborated its development. All contents of the 
intervention are based on established CBT-models and techniques (for an overview of CBT principles, 
please see Table 3). The authors of the modules used evidence-based treatment manuals as templates 
and selected suitable exercises, which they then adapted for an online self-help format. For example, 
the module on depression relied on materials on behavioral activation by Schaub et al. (2013) as well 
as cognitive restructuring techniques (i.e., the correction of depression-related thinking styles) from 
the metacognitive training for depression (D-MCT; Jelinek et al., 2013). The module authors wrote 
text passages, inserted suitable pictures, designed worksheets, and – if applicable – recorded audio 
files and video files to provide psychoeducation or instructions for exercises. An optional smartphone 
application accompanied the intervention, which enabled participants to complete exercises in their 
daily lives. Participants could for example use a scheduling plan within the app in order to plan 
activities, to record their mood before and after their activities, and to note obstacles that might keep 
them from completing planned activities. As mentioned in section 1.3.2, the rationale of the EviBaS 
intervention was to target individual symptoms and predictors of psychotic symptoms rather than a 
disorder as a whole (Freeman & Garety, 2014). Another important principle of the intervention was 
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autonomy. As psychoses are severe mental disorders often characterized by a lack of insight (see 
section 1.1), many patients report little involvement in decisions about their treatment (for a review, 
see Stovell et al., 2016) although they are motivated to avoid being patronized by others (Westermann 
et al., 2015). To address this issue, the EviBaS intervention enabled participants to choose which 
modules they would like to complete. Only the introductory module as well as the final module on 
relapse prevention were mandatory. Also the wording of the modules continuously emphasized 
autonomy. For example, modules introduced models or exercises as “suggestions” that participants 
could adopt if they related to them. The intervention encouraged users to critically examine whether 
they considered a proposed model plausible. Given this background, we did not expect participants to 
complete all 11 modules. Instead, we considered eight modules as full adherence (corresponding to 
one module per week during the eight week intervention period). For a description of each module, 
see Table 5. 
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Module introduces ABC schema (thoughts, emotions, and actions interact) 
and leverage points for treatment; encourages reflection on values/goals 
PARANOID 
IDEATION 
Module refers to ABC schema; normalizes feelings of persecution; introduces 
a psychological model of delusions as a result of search for meaning due to 
abnormal experiences (Freeman & Garety, 2014; Kapur, 2003)  
VOICE 
HEARING 
Module normalizes voice hearing; introduces a psychological model of 
voices and distress; offers coping strategies (e.g., detached mindfulness); 
encourages cognitive disputation of interpretations of voices  
SLEEP Module introduces a vicious cycle model of sleep problems; discusses sleep 
hindering thoughts or environmental factors and how to reduce them 
SELF- 
ESTEEM 
Module provides psychoeducation on self-worth; helps to visualize personal 
strengths; challenges automatic thoughts that reduce self-esteem 
META- 
COGNITION 
Module focuses on cognitive biases such as Jumping to Conclusions using 
playful exercises derived from the MCT (Moritz & Woodward, 2007) 
DEPRESSION Module introduces the spiral model of depressive thoughts, feelings and 
behaviors; offers leverage points: behavioral activation (planning of 
activities) and challenging depressive thoughts (e.g., negative filter) 
MINDFULNESS Module provides information on mindfulness; differentiates mindful from 
evaluative thoughts; provides mindfulness exercises 
WORRYING Module differentiates solvable and unsolvable problems; discusses meta-
cognitions regarding worry (positive attitudes towards worrying, etc.); 
introduces problem-solving skills 
SOCIAL 
COMPETENCE 
Module differentiates assertive, unsecure and aggressive social behaviors; 
discusses implicit social behavior rules  
RELAPSE 
PREVENTION 
Module emphasizes importance of balancing stress and relaxation; helps to 
identify relapse warning signs and to develop prevention plan 
 
The following example illustrates how it was for participants to work with the EviBaS intervention. A 
participant would visit the study website and log in using their individual login data (participants set 
their own username and password). Upon the first login, participants can watch a video, which 
provides an overview of the program’s functions. On the home screen (for a screenshot, see Figure 5), 
the participant can choose from various modules (on the left-hand side of Figure 4) or worksheets 
(depicted on the right-hand side of Figure 4). The program saves participant’s progress from previous 
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sessions, so that participants can continue from where they left. A typical module consists of 21 
webpages and takes about 30 to 60 minutes to complete. When starting a module, a participant 
receives information on the respective topic (e.g., on mindfulness) without a particular focus on 
psychosis. Participants then learn more about how the topic is relevant for their mental health and how 
they can improve their well-being by practicing related skills (e.g., being more mindful in everyday 
life). The module contains exercises which help the participant to apply contents to their personal life 
and to implement skills regularly. The worksheets are comparable to homework in classical CBT. The 
smartphone application summarizes the worksheets from the intervention to facilitate implementation 
into everyday life. Whenever a participant wishes to download a webpage, they can export a pdf file. 
This can be particularly helpful if participants prefer reading printed versions of the web pages. Also, 
they can highlight pages (using a little star-symbol) as personal favorites within the program. At the 
end of each module, the main points are summarized, and users can write feedback and ask questions, 
which the moderator addresses within few days.  
 
Figure 4 – Translated screenshot of EviBaS home screen showing 8 out of 11 modules 
Whenever a participant had a question or when they encountered a problem, they could contact their 
personal moderator using a secure messaging system within the EviBaS program. At least once a 
week, moderators checked participants’ progress, gave feedback, and sent reminder e-mails if 
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necessary – always ensuring participants’ autonomy. Moderators had at least a bachelor’s degree in 
psychology and received supervision by an experienced CBT therapist.  
In order to ensure data security, the communication between client’s devices and the server, which 
encompassed the EviBaS intervention, was SSL encrypted. Further, participants could only access the 
intervention using a personal username and password (which they set themselves upon first login). 
Finally, we instructed participants not to enter any identifying information in EviBaS worksheets or 
messages to the moderator (i.e., no names, e-mail addresses etc.).  
2.3.1 The mindfulness module 
For paper 3, we conducted a subgroup analyses in which we considered intervention participants only 
if they completed the mindfulness module of the EviBaS intervention. The module consists of 24 web 
pages, which contain text passages, pictures, and audio files (recorded by an experienced CBT 
therapist). Over the first 13 pages, the module provides psychoeducation on mindfulness, illustrates its 
historical origins and its effects on psychological health as well as presumed associations with 
psychosis. Subsequently, the module introduces mindfulness exercises, such as breathing exercises, 
the “S.T.O.P.” exercise (stop, take a mindful breath, observe your feelings and thoughts and proceed 
with your activity), and the “body scan” exercise (a mindful observation of bodily sensations). Figure 




Figure 5 – Screenshot of the mindfulness module (part of EviBaS intervention) 
2.4 Measures 
Despite small differences regarding inclusion and exclusion criteria (see section 2.2), the target 
population was the same across all studies of this thesis, namely people with lifetime non-affective 
psychotic symptoms. The following section therefore summarizes baseline measures for all studies. In 
contrast, outcome measures differed between studies so that separate sections for each study are 
necessary. For the sake of parsimony, the following section will focus on measures that are relevant 
for the analyses presented here. We provide comprehensive lists of measures in the respective study 




2.4.1 Baseline measures of psychopathology 
Across studies, we used the Mini International Neuropsychiatric Interview (MINI; Lecrubier et al., 
1997) to assess relevant psychiatric disorders in a structured diagnostic interview. The MINI allows 
verifying diagnoses according to the DSM-V criteria (American Psychiatric Association, 2013). The 
MINI interview shows similar reliability and validity compared to extensive clinical interviews but 
can be administered in shorter time (mean 18.7 ± 11.6 minutes, median 15 minutes). It is organized in 
modules corresponding to different diagnostic categories (e.g., psychotic disorders) so that one can 
select a subset of modules if needed. For all included studies, we used the MINI to verify diagnoses of 
psychotic disorders. Further, the MINI allowed us to assess disorders, which resulted in exclusion, 
such as affective disorders with psychotic features (all studies) or severe alcohol- or substance use 
disorders (study 4). In order to measure psychotic and global symptom severity, we included the 
Positive and Negative Syndrome Scale in all studies (PANSS; Kay et al., 1987). The PANSS measures 
a wide range of positive, negative, and global symptoms of psychosis and showed good internal 
consistency in the present studies (e.g., Cronbach’s α = .85 in study 2). The interviewer rates PANSS 
symptoms using detailed rating criteria on a scale from 1 to 7. Seven items are designed to capture 
positive symptoms (delusions, disorganization, hallucinations, etc.), another seven items are designed 
to assess negative symptoms (blunted affect, emotional withdrawal, poor rapport, etc.), and 16 items 
capture global symptoms, such as anxiety or feelings of guilt. Interestingly however, empirical data do 
not confirm the originally intended three-factor solution for the PANSS, so we relied on a five-factor 
solution by van der Gaag et al. (2006) for studies 1 and 4. The positive symptom factor according to 
van der Gaag and colleagues, which was part of the composite outcome in study 1, consists of 
delusions (P1) + hallucinations (P3) + suspiciousness/persecution (P6) + grandiosity (P5) + somatic 
concern (G1) + unusual thought content (G9) + lack of judgment and insight (G12) + active social 
avoidance (G16) – difficulty in abstract thinking (N5), with a total score ranging from 1 to 55. For all 
other studies, the PANSS merely served as a descriptive measure of symptom severity rather than an 
outcome. As PANSS total scores can be difficult to interpret, we refer to Leucht et al. (2005) to 
categorize PANSS total scores into categories, such as mildly or moderately ill. We administered the 
MINI and PANSS interview in a face-to-face setting in the ESM Study (study 4) and via telephone in 
the EviBaS Project (studies 1-3). Administering the PANSS via telephone made it difficult to rate 
certain aspects of psychopathology. For example, assessors had to rate blunted affect using only the 
verbal cues that a participant provided, and they had to omit the item on mannerisms and posturing 
(G5) because it was impossible to judge habitual gestures.  
2.4.2 Predictors and outcome measures  
2.4.2.1 Outcome measures of the EviBaS efficacy trial (study 1) 
The EviBaS intervention’s main goal was to reduce positive symptoms of psychosis and associated 
burden, so the outcome of study 1 comprised a composite of positive symptom measures. The 
composite score consisted of the positive factor of the PANSS (PANSS-PF according to van der Gaag 
et al., 2006), the Launay–Slade Hallucination Scale (LSHS-R; Launay & Slade, 1981; Lincoln et al., 
2009), and the Paranoia Checklist (Freeman et al., 2005; Lincoln et al., 2010a; Lincoln et al., 2010b). 
As mentioned before, the positive factor of the PANSS comprised the items P1 + P3 + P5 + P6 + G1 + 
G9 + G12 + G16 – N5, with an ICC of 0.84 (95% confidence interval: 0.70 to 0.95; two-way mixed, 
single measures, conservative absolute agreement). The LSHS-R has adequate psychometric 
properties and an internal consistency of α = .79 (Lincoln et al., 2009). The internal consistency was α 
= .87 in our sample. On 12 items, the LSHS-R measures subclinical as well as pathological 
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hallucinatory experiences on 5-point Likert scales ranging from 0 (certainly does not apply to me) to 4 
(certainly applies to me). Scores range from 0 to 48 with higher scores reflecting more severe 
symptoms. The Paranoia Checklist measures the frequency, conviction and associated distress of 
paranoid thoughts. The three subscales show excellent internal consistency (Cronbach’s α = .9 or 
higher; Freeman et al., 2005), which was confirmed in the EviBaS Efficacy Study (Cronbach’s α = .95 
or higher). In order to obtain the composite outcome measure, we first standardized each continuous 
outcome (PANSS-PF, LSHS-R, and Paranoia Checklist) by subtracting the mean at baseline and 
dividing by the baseline standard deviation (i.e., z-scores). Subsequently, we averaged the three 
standardized scores. The main reason for computing the composite score was to reduce the number of 
confirmatory tests. However, it also enabled us to consider participants in analyses who did not 
provide data for one of the individual outcomes at post assessment because we computed the 
composite when at least two of the three outcomes were present. After assessing the effect on the 
composite score, we examined each individual outcome in secondary analyses.  
In addition to the primary outcome of positive symptoms, the EviBaS Efficacy Study examined a 
multitude of secondary outcomes, which aimed at measuring improvements of predictor variables of 
psychotic symptoms. The majority of these secondary outcomes is not relevant for the present thesis 
so that they are only mentioned briefly in Table 6. One exception is a questionnaire which measures 
mindfulness that was at the core of paper 3 of this thesis (for a description, see section 2.4.2.3).  
Table 6 – Secondary outcomes of the EviBaS Project 
TARGET  MEASURE DESCRIPTION 
PSYCHOTIC 
SYMPTOMS 
Delusion and Voices Self-Assessment 
(DV-SA; Pinto et al., 2007) 
Self-report measure for delusions and 
auditory verbal hallucinations 
SLEEP Insomnia Severity Index (ISI; Bastien, 
2001) 
7 items, satisfactory psychometric 
properties (Bastien, 2001) 
SELF- 
ESTEEM 
Rosenberg Self-Esteem Scale (RSES; 
Rosenberg, 1965) 
Self-esteem measure, satisfactory internal 
consistency (Roth et al., 2008) 
DEPRESSION Patient Health Questionnaire (PHQ-9; 
Kroenke et al., 2001) 
9-item depression questionnaire, excellent 
internal consistency (Kroenke et al., 2001) 
MINDFULNESS Mindful Attention Awareness Scale 
(MAAS; Brown & Ryan, 2003)  
6-point Likert scales, measures ability to 
mindfully experience current moment 
WORRYING Penn State Worry Questionnaire – 
Abbr. (PSWQ-A; Hopko et al., 2003) 
8 items, good to excellent internal 
consistency (Crittendon & Hopko, 2006) 
SOCIAL SKILLS Interpersonal Competence 
Questionnaire (ICQ; Coroiu et al., 
2015) 
We used two ICQ subscales: Initiation of 
relationships (α = .73) and negative 
assertion (α = .75; Coroiu et al., 2015) 
MOTIVES  Incongruence questionnaire (K-INK; 
Grosse Holtforth & Grawe, 2003) 
Measures the realization of motivational 





WHO Quality of Life (WHO-QoL-
BREF; Harper et al., 1998) 
Measures quality of life, Cronbach’s α = 
.66 – .84 (Harper et al., 1998) 
STIGMA Internalized Stigma of Mental Illness 
(ISMI; Boyd et al., 2014) 
We used the short version, excellent 
internal consistency (Sibitz et al., 2013) 
TREATMENT 
EVALUATION 
Client Satisfaction Questionnaire 
(CSQ; Attkisson & Zwick, 1982) 
Satisfaction with treatment, Cronbach’s α = 
.93 (Attkisson & Zwick, 1982) 
SIDE EFFECTS Questionnaire Side Effects Psychosis 
and Internet (QueSPI) 
Negative effects of Internet interventions 
for psychosis (newly developed) 
REASONING Box Task (Andreou et al., 2015) Probabilistic reasoning paradigm to assess 
cognitive biases 
 
2.4.2.2 Predictors and outcome measures of the EviBaS Intermediate Assessment 
Study (study 2) 
Within the EviBaS Project, participants completed a series of intermediate assessments, which we 
included in order to obtain a fine-grained view on fluctuations of psychotic symptoms and putative 
causal factors over time (analyzed in paper 2). Intermediate assessments consisted of 14 items with 
visual analogue scales. Two items (α = .42) captured psychotic symptoms, ‘I feel suspicious’, adapted 
from previous ESM trials (Kramer et al., 2014; So et al., 2018) and ‘I hear voices that no one else can 
hear’, which was self-generated. One item assessed worry ‘My worries overwhelm me’, adapted from 
the aforementioned Penn State Worry Questionnaire (Stober & Bittencourt, 1998). We measured 
negative affect using two items (α = .80). The first item ‘I am feeling down, depressed, or hopeless’ 
stems from the Patient Health Questionnaire-9 (Kroenke et al., 2001). The second item ‘I feel anxious’ 
was based on previous ESM trials (Kasanova et al., 2020; Kramer et al., 2014). The item on self-
esteem ‘I am satisfied with myself’ was adapted from the Rosenberg Self-Esteem Scale (Rosenberg, 
1965). We included two items to assess self-reported cognitive biases in an attempt to capture a 
tendency to make decisions based on insufficient evidence (as measured with experimental paradigms, 
such as the Box Task, see Table 6). The item ‘When I am certain about something then I must be 
correct’ was inspired by the Beck Cognitive Insight Scale (Beck et al., 2004). With the reverse-coded 
item ‘I consider as much information as possible before I make a decision’ we tried to assess Jumping 
to Conclusions. Unfortunately, the items correlated negatively so that we analyzed them separately. 
We assessed quality of sleep with the item ‘The quality of my sleep is good’. The unspecific wording 
enabled us to capture different kinds of sleep problems (Kasanova et al., 2020). The remaining items 
of the intermediate assessments were not relevant for any of the papers of the present thesis. 
Participants rated all items according to how they felt at the current moment (except for sleep). For 
certain analyses of study 2, we calculated a composite score of predictor variables (the sum of worry, 
negative affect, self-esteem, self-reported cognitive biases, and quality of sleep; α = .60). As for study 
1, the rationale of the composite score was to reduce the number of confirmatory tests.  
2.4.2.3 Outcome measures of the EviBaS Mindfulness Study (study 3) 
In the EviBaS Mindfulness Study (study 3) we analyzed a subsample from study 1 to examine effects 
of the mindfulness module of the EviBaS intervention on mindfulness and distressing auditory verbal 
hallucinations. For this purpose, we drew a subset of participants who reported auditory hallucinations 
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(lifetime) and we only considered participants from the immediate access group in the analyses if they 
completed the mindfulness module. We hypothesized that completing the mindfulness module would 
reduce distress associated with auditory hallucinations and that this effect would be mediated by 
increased mindfulness, so our primary outcome was distress by voices. We drew a subset of items 
from the Delusion and Voices Self-Assessment questionnaire (DV-SA; Pinto et al., 2007), in order to 
capture negative feelings associated with auditory verbal hallucinations. The DV-SA is a 15-item self-
report questionnaire that consists of a delusions subscale as well as a voices subscale. For study 3, we 
drew a subset of items from the voices subscale, which measure voice-related distress, obedience, 
control, interference with relationships, and interference with activities (e.g., ‘Last time you heard the 
voices, did the voices make you feel upset or distressed?’). We disregarded other items, for example 
on the frequency of voices, because we hypothesized that a mindful and accepting approach would not 
necessarily reduce the amount of voices but rather the distress that they cause. The original voices 
scale of the DV-SA shows good internal consistency of α = 0.83, with test-retest reliability ranging 
from 0.86 to 0.96 (Pinto et al., 2007) and our newly created subscale on distress and disturbance was 
internally consistent as well (Cronbach’s α = .83). One important issue with our primary outcome was 
that we translated the DV-SA specifically for the EviBaS Project. As we considered it problematic to 
rely on a so far non-validated questionnaire as the primary outcome, we chose to include a second 
outcome capturing hallucinatory experiences, namely the LSHS-R, which was also part of the 
composite outcome in study 1 (Launay & Slade, 1981; Lincoln et al., 2009). The LSHS-R measures a 
broader construct than the distress by voices subscale but it is conceptually similar (one example item 
is ‘I have been troubled by hearing voices in my head’) and its German version is validated and 
established (Lincoln et al., 2009). We examined both outcomes in separated analyses for study 3. The 
underlying question of paper 3 was whether improvements of mindfulness would result in less distress 
by voices, so we included mindfulness as a second outcome. We measured mindfulness using the 
Mindful Attention and Awareness Scale (MAAS; Brown & Ryan, 2003). On 6-point Likert scales, the 
MAAS measures participants’ ability to mindfully experience the current moment. We used the 
German version of the MAAS, which shows good internal consistency (Cronbach’s α = 0.83), good 
test-retest reliability (r = 0.82), and correlations with subjective well-being indicating validity 
(Michalak et al., 2008). 
2.4.2.4 Predictors and outcome measures of the ESM Study (study 4) 
Study 4 had three major goals, namely a) to identify ESM-based predictors of short-term symptom 
fluctuations within the same day, b) to examine whether these short-term predictors also function as 
predictors of long-term (i.e., bi-weekly) symptom fluctuations, and c) to examine whether said 
predictors might even serve as warning signs for full-blown relapses. To answer these research 
questions, we conducted smartphone-based ESM assessments for one week, followed by bi-weekly 
online assessments over the course of one year, including bi-monthly relapse assessments. 
Conceptually, study 4 is very similar to study 2, as both rely on frequent self-report measures. In fact, 
there is considerable overlap between aforementioned intermediate assessments and the ESM 
assessments described below. The major difference between studies 2 and 4 is that one study 
examined predictors of naturally occurring symptom fluctuations (study 4), whereas the other 
examined predictors of symptom fluctuations that are potentially caused by the EviBaS treatment 
(study 2). 
ESM assessments (7 days, 10 times per day): The ESM smartphone assessments consisted of 17 items, 
rated on visual analogue scales. The following section only presents items that are relevant for paper 
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4. Please find the complete list of measured constructs in the Appendix. We assessed emotional 
valence (visual analogue scale ranging from I feel very pleasant to very unpleasant) and arousal 
(ranging from very excited to very unexcited). In addition, single items assessed anxiety (“I feel 
anxious”), self-esteem (“I feel worthless”), worrying (“At the moment, my worries overwhelm me”), 
and sadness (“I feel sad”). We aggregated anxiety, self-esteem, worrying, and sadness to a negative 
affect scale. As can be seen, the scale consists not only of affective states but also cognitions (e.g., a 
worry thinking style; Freeman & Garety, 2014), so it differs slightly from conventional negative affect 
scales. We used the same items as study 2 (EviBaS Intermediate Assessment Study) to capture 
psychotic symptoms, “I feel suspicious” and “I hear voices that no one else can hear”. Unlike study 2, 
we analyzed paranoia and auditory verbal hallucinations as separate outcomes instead of using a 
composite score. We included five out of seven items of the increased significance scale of the 
aberrant salience inventory (Cicero et al., 2010) to measure aberrant salience. We chose a subset of 
items because we wanted to keep the ESM assessments as brief as possible. The items 27, 21, 1, 16, 
and 5 were selected based on their factor loadings (Cicero et al., 2010) and we adapted them slightly 
to capture current aberrant salience rather than general feelings. In addition, we changed the response 
format to the same visual analogue scale that we used throughout. One example item from the aberrant 
salience scale was: Do certain trivial things suddenly seem especially important or significant to you? 
Follow Ups (one year, bi-weekly): The second phase of study 4 began directly after the ESM 
assessment phase and it was designed to capture long-term fluctuations of the same variables that were 
part of the one-week smartphone assessments. In addition, we amended the assessments slightly to 
capture a few extra constructs because Follow Ups occurred less frequently and were thus less 
demanding for participants. We assessed quality of sleep (“I would describe the quality of my sleep as 
good”) and medication adherence, (“How much of the prescribed medication did you take in the past 
two weeks?”), the latter rated on a visual analogue scale ranging from 0% to 100%. We used the self-
generated item “Do you think that you might experience a relapse in the near future?” to examine 
participants’ relapse expectations at each Follow Up assessment. We included this item because we 
were interested in whether participants could anticipate a possible relapse, and if so, what criteria they 
used to make this prediction. The remaining items on drug abuse and alcohol abuse were not relevant 
for the present analyses.  
Relapse assessments (one year, bi-monthly): We treated relapse as a binary variable meaning that it 
could either be absent (none of the criteria fulfilled) or present (at least one criterion fulfilled). Relapse 
criteria (based on Csernansky et al., 2002) are described in the following. The first criterion was 
hospitalization: Participants reported hospital admissions over a period of the previous two months 
preceding the current assessment. We also asked for the exact dates and the reasons for 
hospitalization, which we inspected manually afterwards. The second criterion was increased 
psychiatric care and a 25% symptom increase: We asked participants “Compared to the start of the 
study, did the psychiatric or psychological care that you received increase within the last 2 months?” 
and we explained what increased psychiatric or psychological care means. Additionally, we computed 
the difference of the Community Assessment of Psychic Experiences (CAPE; Stefanis et al., 2002) 
score compared to baseline to detect symptom increases of at least 25%. The CAPE was developed 
based on the Peters Delusion Inventory (Peters et al., 1999) to capture positive, negative, and 
depressive symptoms in general population samples. The third criterion was deliberate self-injury, 
which we assessed using the item “Please state if you deliberately injured yourself in the past week; if 
yes how often” from the Borderline Symptom List (BSL-23; Bohus et al., 2009). The fourth criterion 
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was suicidal ideation, which we assessed with the suicide item from the Beck Depression Inventory-II 
(BDI-II; Beck et al., 1996). We assessed the fifth criterion, violence towards others or property 
damage, using the item “Has there been a situation in the past 2 weeks where you physically attacked 
another person or where you destroyed the property of others?” which was self-generated. The sixth 
criterion was clinical deterioration, which we defined as a 50% symptom increase compared to 
baseline on the Brief Symptom Rating Scale (BSI-18; Derogatis & Fitzpatrick, 2004b). The reliable 
and valid German version of the BSI-18 measures symptoms of somatization, depression, and anxiety 
(Spitzer et al., 2011). 
2.5 Data analysis  
The studies of the present thesis can be separated into two groups in terms of statistical analyses. 
Studies 1 and 3 focused on the effect of an intervention (EviBaS) on a specific outcome, namely 
positive symptoms in study 1 and distress by voices as well as mindfulness in study 2. Therefore, these 
studies examined differences of a certain variable between a treatment group and a control group. For 
study 1, we used a mixed ANOVA, while study 3 relied on an ANCOVA. Time x group ANOVAs 
and ANCOVAs with baseline values as covariates are comparable methods when it comes to the 
examination of treatment effects. Studies 2 and 4, on the other hand, focused on frequent repeated 
measures, analyzed using lagged regression analyses of predictor-outcome associations within 
participants, a method typical for ESM studies. Hence, two papers focused on identifying group 
differences due to an experimental manipulation (allocation to EviBaS vs. waitlist), while the 
remaining two papers focused on observational regression-based analyses. In all studies, we conducted 
two-sided tests with conventional p-values of .05. All computations were conducted with SPSS (SPSS 
Inc., Chicago, Illinois), version 25 (study 3) and version 26 (all remaining studies).  
2.5.1 Power calculations 
ESM Study (study 4): Rather than conducting a power calculation for the ESM Study, we used 
previous ESM studies as a guide to gauge the necessary sample size. In a previous ESM study of our 
group (Luedtke et al., 2017), we successfully analyzed n = 35 participants who provided up to 8 ESM 
measures each. Other ESM studies found significant effects in similar sample sizes (e.g., n = 41 in 
Udachina et al., 2014), so we aimed for n = 40 participants for study 4.  
EviBaS Project (studies 1-3): We conducted the power calculation for the EviBaS Project using 
G*Power 3 (Faul et al., 2007). The power calculation only applied to study 1 (the EviBaS Efficacy 
Study) and not to the secondary analyses of paper 2 and 3. We based our calculation on the clinical 
significance of expected effects (i.e., the practical or applied value or importance of the effect of an 
intervention; Kazdin, 1999) rather than estimating arbitrary effect sizes. We deemed a medium-sized 
or larger effect (f ≥ 0.25) as clinically significant, so we aimed for a sample size sufficiently large to 
reveal such an effect. The power calculation resulted in a target sample size of 128 to detect a 
medium-sized effect using an ANCOVA with one covariate assuming a power of 80% and a 
conventional α-level of 5%. To compensate for an expected dropout rate of 10%, we increased the 
target sample size to 140.  
2.5.2 Analyses in the EviBaS Efficacy Study (study 1) 
To examine the effect of EviBaS on the composite score of positive symptoms, we conducted a mixed 
model ANOVA with the between-person factor condition (immediate access to the EviBaS 
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intervention vs. waitlist group) and the within-person factor time (baseline vs. post assessment). The 
model included the effect of time, group and the time x group interaction. A significant interaction 
indicates that the change of symptoms over time differs between groups. As mentioned before, the 
composite score of positive symptoms served as the primary outcome, so the interaction term indicates 
whether composite positive symptoms improve more in one group compared to the other. 
Subsequently, we conducted several secondary analyses on the components of the composite outcome 
(PANSS-PF, Paranoia-CL, and LSHS-R), as well as secondary outcomes (see Table 6).  
First, we conducted intention to treat analyses, meaning that we considered all participants in the 
analyses irrespective of whether they provided data at the post assessment or not and irrespective of 
whether immediate access participants used EviBaS or not. Intention to treat analyses are 
recommended for clinical trials because they – inter alia – maintain the randomization of group 
allocation and provide a more realistic estimation of the treatment effect under real world conditions 
(Ranganathan et al., 2016). In addition to the intention to treat analyses, we conducted per protocol 
analyses, which only considered participants who completed at least four of the optimal number of 
eight modules of the EviBaS intervention. We computed effect sizes based on the estimated means 
and standard errors of the mixed effect model analyses.  
2.5.3 Analyses in the EviBaS Mindfulness Study (study 3) 
Study 3 was a secondary analysis based on study 1, in which we only analyzed people who reported 
lifetime auditory verbal hallucinations. Our hypothesis was that the mindfulness module of the EviBaS 
intervention would improve distress caused by auditory hallucinations and that this improvement 
would be mediated by improved mindfulness. Because we were only interested in people who used the 
mindfulness module, we excluded immediate access participants from the analyses if they did not 
complete the mindfulness module. Selecting subsamples from the EviBaS efficacy trial introduced 
several biases, which are discussed in section 0, but it enabled us to examine a possible mechanism of 
change (i.e., mindfulness) of the intervention on a specific outcome (i.e., distressing auditory verbal 
hallucinations) in an exploratory manner. Unlike study 1, study 3 relied on Analyses of Covariance 
(ANCOVAs) rather than mixed effects ANOVAs. The ANCOVA approach differs slightly from the 
ANOVA approach in that it compares the outcome between two groups (comparable to a t-test), while 
controlling for baseline values of the respective outcome. The resulting conclusions are the same in 
both cases (i.e., whether there are group differences in the outcome). We conducted ANCOVAs to 
examine baseline-corrected group differences of mindfulness (MAAS), distress by voices (self-
generated scale based on the DV-SA), and hallucinations (LSHS-R) at post assessment. Apart from 
baseline scores, the ANCOVA models did not include additional covariates. We then conducted a 
mediation analysis to examine whether improved mindfulness accounted for group differences of 
distress by voices or hallucinations. We conducted the mediation analysis with group allocation as the 
independent variable, distress by voices as the outcome, pre-post change scores of mindfulness as the 
mediator, and baseline distress by voices as a covariate, using the PROCESS® macro for SPSS 
provided by Andrew Hayes (Hayes, 2017). The PROCESS® macro enables the reporting of robust 
bootstrap confidence intervals based on a resampling procedure with 5,000 samples in our study 
(LLCI = lower level confidence interval, ULCI = upper level confidence interval). We repeated the 
analysis with LSHS-R scores instead of distress by voices (see section 3.1).  
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In sum, papers 1 and 3 both report group differences of a specific outcome after treatment. Whereas 
study 1 modeled time as a within-person factor (repeated measures ANOVA), study 3 controlled for 
baseline scores using a covariate-approach (ANCOVA).  
2.5.4 Analyses in the EviBaS Intermediate Assessment Study (study 2) 
All papers incorporated in this thesis are longitudinal studies, meaning that participants were assessed 
repeatedly over time. Studies 2 and 4, however, differed from studies 1 and 3 in that they included 
much more frequent measurements, similar to the procedure known from ESM-designs (i.e., short 
repeated assessments on momentary symptoms, enabling a fine-grained view on temporal variability). 
In study 2, these ESM-like assessments were called intermediate assessments and we included them in 
the EviBaS trial in order to monitor psychotic symptoms and predictor variables (e.g., negative 
affective states) over time. Given this “nested” data structure (measurements clustered within 
participants), we used linear mixed models to account for the dependency of measurements within the 
same participant. Mixed models are flexible in handling missing data (Twisk, 2019, p. 150) so that we 
did not need to impute missing values. For hypothesis 1 of study 2, we tested whether a composite 
score of repeatedly measured predictor variables (worry, negative affect, self-esteem, self-reported 
cognitive biases, and quality of sleep) improved more in the immediate access group compared to the 
waitlist group. This analysis resembles the analysis in study 1 (EviBaS Efficacy Study) because it was 
designed to detect group differences regarding a specific outcome. The analysis relied on intermediate 
assessment data obtained between baseline and post-assessment. The statistical model included time, 
group (immediate vs. delayed access), and the time x group interaction. The composite score of 
predictor variables served as the outcome. Unlike the baseline and post assessments in study 1 that 
occurred at fixed time points, intermediate assessments took place at different points in time during 
the intervention compared to the waiting period (upon EviBaS login vs. once per week, see section 
2.2.1). To obtain a comparable number of assessments in both groups for hypothesis 1, we aggregated 
the assessments, resulting in one value per week per participant. For hypothesis 2, we conducted 
lagged regression analyses (i.e., the predictor variable is measured at a previous point in time; t-1) to 
examined if the composite score of predictors (t-1) predicted subsequent psychotic symptoms (t0) 
differently in the two groups (immediate vs. delayed access). The model included momentary 
psychotic symptoms (t0) as the outcome, the composite score of precursors (t-1), group (immediate vs. 
delayed access), and the group x composite score (t-1) interaction as predictors, controlling for 
psychotic symptoms at t-1. Hypothesis 3 was at the core of study 2. We examined whether each 
individual predictor variable predicted subsequent psychotic symptoms during the EviBaS 
intervention. This procedure is virtually identical to the procedure used in ordinary ESM-studies (e.g., 
Luedtke et al., 2017), the main difference being that we analyzed data from people who participated in 
an intervention. We conducted separate analyses with each predictor at t-1 (e.g., worry) and 
momentary psychotic symptoms as the outcome (t0), while controlling for previous psychotic 
symptoms (t-1). We analyzed data from all participants taking part in the intervention, both immediate 
access participants and delayed access participants. 
2.5.5  Analyses in the ESM Study (study 4) 
Conceptually, the analyses of study 4 resembled the analyses in study 2. We conducted linear (for 
continuous outcomes) and logistic (for binary relapse analyses) lagged mixed model analyses. For 
hypothesis 1, we examined whether short-term ESM effects (within the same day) and long-term 
effects (across bi-weekly Follow Ups) were comparable. To do so, we assessed the effect of negative 
 
38 
affect (t-1) as well as aberrant salience (t-1) on subsequent momentary psychotic symptoms (t0), 
controlling for preceding psychotic symptoms (t-1) and subsequently added the assessment type (ESM 
vs. Follow Up) as well as the interaction of precursor and assessment type to the model. The 
interaction term indicated whether the effect of the respective precursor on subsequent symptoms 
differed between ESM and Follow Up assessments. Hypothesis 2 stated that we could use negative 
affect and aberrant salience to predict relapses in lagged mixed model analyses. As relapse was a 
binary variable, the statistical models were variants of logistic mixed models with relapse (yes/no) as 
the outcome and different predictor variables (adherence to medication, quality of sleep, negative 
affect, and aberrant salience) measured prior to the outcome.  
The lagged mixed model analyses in studies 2 and 4 were similar. For example, all models included a 
random intercept but no random slopes and all participant-level predictor variables (e.g., negative 
affect or aberrant salience) were person-mean centered. In order to obtain centered variables, we 
calculated the within-participant mean and subtracted it from each value. Person-mean centering was 
crucial because we aimed at identifying processes occurring within participants, not between 
participants (for a discussion of this topic, see section 4.3). When predictors are not centered, the 
overall effect of a predictor is comprised of the difference between the mean values of two persons 
and between two time points within the same person. Person-mean centering eliminates between 
person variability and leaves only the variance within persons, which we were interested in. Another 
similarity between studies 2 and 4 was that we applied the Benjamini and Hochberg correction to 
control for the false discovery rate due to multiple tests (Benjamini & Hochberg, 1995). 
3 Summary of results 
ESM-based studies have shed light on the processes that occur prior to the emergence of psychotic 
symptoms in the daily life of people with psychosis. The overarching goal of the present thesis was to 
apply this knowledge to new contexts, namely the treatment of psychosis and the prediction of relapse. 
In addition, the thesis aimed at applying the assessment strategies (multiple repeated measures within 
participants) and statistical methods (lagged regression analyses) from ESM studies to much larger 
periods of time in order to find meaningful long-term warning signs of symptoms and possibly 
relapses. The following section will briefly summarize the main results of the four included studies. 
More detailed information, for example on baseline characteristics, secondary outcomes, or additional 
per-protocol analyses, can be found in the attached papers (papers are included at the end of the 
thesis).  
3.1 Results of the EviBaS Project (studies 1 to 3) 
The EviBaS Internet intervention (for a description, see section 2.3) targets feelings of persecution, 
hallucinations, as well as a variety of predictors of psychotic symptoms that have been identified in 
ESM studies, for example worrying and sleep problems. The first paper of this thesis, the EviBaS 
Efficacy Study, examined whether the intervention’s approach of treating ESM-based predictors of 
psychosis was successful (6 out of 11 modules targeted ESM-based predictors of psychotic 
symptoms). In line with our hypothesis, the EviBaS intervention improved the primary outcome, 
which consisted of a composite score of 3 positive symptom measures (see section 2.4.2.1), as 
indicated by a significant interaction of time (baseline vs. post assessment) and condition (immediate 
access to EviBaS vs. delayed access); F(1, 87.28) = 4.04, p = .047. The size of the effect was small to 
medium d = -0.37, 95% CI [-0.67, -0.07]. Following up the significant effect on the composite score, 
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we examined effects on each of the outcome’s components separately. We repeated the analysis with 
LSHS-R scores as the outcome to assess the intervention’s effect on hallucinations specifically. The 
interaction of time x group reached significance, indicating that the overall effect was driven by an 
effect on hallucinations; F(1, 88.22) = 7.15, p = .009. The corresponding p-value withstood a 
Bonferroni Holm correction (the p-value of p = .009 was below the corrected value of .017). In 
contrast, there were no effects on the remaining individual outcomes (Paranoia Checklist: F(1, 87.85) 
= 3.07, p = .083; PANSS-PF: F(1, 88.38) = 0.16, p = .686).  
Traditionally, effects on observer-rated outcomes such as the PANSS are considered to be more 
reliable than self-report measures in psychosis research (as reviewed in Lincoln et al., 2010b), but the 
results of study 1 were nonetheless very encouraging because they demonstrated that an Internet 
intervention which mainly targets predictors of psychotic symptoms efficaciously reduces symptoms 
of psychosis. Furthermore, the EviBaS intervention was safe as the number of adverse events was low 
(0.02 events per participant) compared to CBTp in outpatient settings (e.g., 0.18 in Lincoln et al., 
2012) and the satisfaction with EviBaS was high (89% were satisfied with the program’s quality). In 
per protocol analyses of participants who used the program regularly, the intervention had a significant 
effect on mindfulness, self-esteem, social skills, and psychological quality of life, although these 
effects did not withstand a conservative alpha correction. 
The EviBaS intervention aimed at helping people with psychosis through various pathways. It 
combined methods of CBT and mindfulness-based techniques, it addressed several putative causal 
factors of psychosis ranging from sleep problems to depression, and it granted a lot of autonomy to the 
participants (e.g., participants could choose which modules they wished to complete). This 
comprehensive approach came with the limitation that it was difficult to identify the processes through 
which EviBaS was efficacious. Study 2, the EviBaS Intermediate Assessment Study, attempted to 
answer this question using an approach that resembles a typical ESM study design. Throughout the 
EviBaS study, we asked participants to complete short intermediate assessments on their personal 
computers. These short assessments captured momentary psychotic symptoms as well as a variety of 
potential predictors that are targeted in the EviBaS intervention (i.e., worrying, negative affect, self-
esteem, self-reported cognitive biases, and quality of sleep, all of which represent predictors in ESM 
studies). Both immediate access participants as well as delayed access participants from the EviBaS 
Project completed these short assessments while using EviBas and while waiting, respectively. In 
addition to the participants from study 1, we incorporated participants in the analyses who failed to 
reach the symptom severity threshold of study 1, so that we were able to analyze data from n = 124 
participants who provided M = 10.32 intermediate assessments each. Within study 2, we first 
examined whether a composite score of predictor variables (worrying, negative affect, self-esteem, 
self-reported cognitive biases, and quality of sleep) improved more in participants using EviBaS 
compared to waiting participants. Contrary to our hypothesis, the group x time interaction was non-
significant, indicating that the course of composite predictor variables did not differ between groups (b 
= -0.043, SE = .096, t = 0.449, p = .653). Although this finding is subject to the important limitation 
that providing intermediate assessments was tied to the adherence to the intervention, it indicates that 
EviBaS intervention was not efficacious by improving worrying, negative affect, self-esteem, and so 
forth, but rather by improving psychotic symptoms directly. Subsequently, we examined if the 
composite score of predictor variables predicted momentary psychotic symptoms differently in the 
immediate access group compared to the delayed access group. We expected that an intervention that 
targets worrying, depression, and so forth would have an effect on how these variables interact with 
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psychotic symptoms. Contrary to our hypothesis, we again found no significant effect, indicating that 
the composite score of precursors did not predict subsequent momentary psychotic symptoms 
differently in the two groups (b = 0.031, SE = .032, t = 0.945, p = .345). This finding further 
substantiated the assumption that the efficacy of EviBaS was independent from its capacity to improve 
predictors of psychotic symptoms. Neither did the intervention improve composite predictors, nor did 
it affect the association of predictors and psychotic symptoms. Interestingly, however, we found that 
within the EviBaS intervention (i.e., without considering group differences), momentary worrying (b = 
0.156, SE = 0.064, t = 2.438, pcorrected = .030) and quality of sleep (b = -0.198, SE = 0.059, t = 3.359, 
pcorrected = .003) predicted subsequent psychotic symptoms several days later. This effect means is that 
when participants experienced more worry or worse sleep than usual while using the EviBaS 
intervention, they reported more severe psychotic symptoms upon the next assessment. So, although 
EviBaS did not consistently improve worrying and quality of sleep over time, our analyses indicate 
that when these variables improved, they preceded (on average) an improvement of subsequent 
psychotic symptoms. Worrying and quality of sleep are therefore very worthwhile treatment targets 
and mechanisms of change during an intervention such as EviBaS. In sum, study 2 provided 
interesting insights into the variability of symptoms during an online intervention for people with 
psychosis. The results indicate that worrying and sleep are, in fact, important treatment targets but the 
efficacy of EviBaS was apparently not dependent on its ability to alter these variables.  
In study 3, the EviBaS Mindfulness Study, we investigated another potential pathway that could 
explain the intervention’s efficacy, namely mindfulness. We did not include mindfulness (or its 
counterpart experiential avoidance) in study 2 because we expected it to be associated with the distress 
elicited by psychotic symptoms – not the frequency or intensity of symptoms. We hypothesized that 
mindfulness would enable participants to experience psychotic symptoms (particularly hallucinations) 
in a nonjudgmental and thus less distressing way as suggested by the definition of mindfulness by 
Kabat-Zinn (2015) who describes mindfulness as “paying attention in a particular way: on purpose, in 
the present moment, and nonjudgmentally” (p. 4). Unlike study 2, study 3 used a mediation approach 
rather than EMS-based analyses: We drew a subset of participants from the EviBaS Efficacy Study 
(study 1) of people who reported lifetime auditory verbal hallucinations and within this subgroup of 
participants, we compared the immediate access group (using EviBaS) to the delayed access group 
(waitlist). As our focus lied on the mindfulness components of EviBaS, we only considered 
participants from the immediate intervention group who used the mindfulness module. The resulting 
sample (n = 55) was considerably smaller than the one from the EviBaS Efficacy Study, with only n = 
16 users of the mindfulness module and n = 39 delayed access participants (i.e., waitlist). Contrary to 
our hypothesis, the group who used the mindfulness module did not show lower distress by auditory 
verbal hallucinations at post assessment when compared to the delayed access group (F(1, 49) = 
0.281, p = .598, ηp2 = 0.006), although there was an effect on mindfulness (F(1, 49) = 6.346, p = 
0.015, ηp2 = 0.115). When we examined general hallucinations (LSHS-R) as the outcome, however, 
the intervention led to a significant improvement (F(1, 49) = 13.360, p = 0.001, ηp2 = 0.214). 
Interestingly, the effect on hallucinations (LSHS-R) was mediated by improved mindfulness: Adding 
mindfulness change scores as a mediator reduced the group difference of hallucinations and the 
bootstrap confidence interval of the indirect effect confirmed a significant mediation (indirect effect: b 
= -1.618, CI [-3.747, -0.054]). There are several important limitations to study 3, which will be 
discussed in detail in section 0. In short, the subgroup analyses introduced biases and extinguished the 
positive features of randomized group allocation. Nonetheless, our findings provide a very promising 
starting point in understanding the efficacy of the EviBaS intervention. It is possible that the 
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intervention’s effect on LSHS-R scores, which primarily brought about the intervention’s overall 
efficacy, was partly due to effects on mindfulness. Although the analyses presented in paper 3 must be 
interpreted with caution due to their exploratory nature, they do suggest that improving mindfulness 
could be a mechanism of change, which coincides with findings from ESM trials (Udachina et al., 
2014).  
3.2 Results of the ESM Study (study 4) 
Usually, ESM studies examine processes on a micro level (Myin-Germeys et al., 2018). They reveal 
small symptom fluctuations and their predictors that occur within very short periods of time, such as 
two to three hours in advance. Research on micro level processes helped us to better understand 
underlying pathways of symptom formation, but one might argue that we could improve the lives of 
people with psychosis more effectively if we were able to predict symptom fluctuations that lie further 
ahead – days or even weeks. Knowledge about more far reaching associations would enable patients, 
but also caregivers, family or friends to intervene before symptoms become so severe that they require 
intensive treatment. The crucial question is therefore whether within-day ESM associations generalize 
to less frequent assessments with longer time intervals between them. Study 2 provided first evidence 
that certain ESM-based predictor variables (i.e., worrying and poor sleep) could in fact be suited as 
predictors of symptom fluctuations that occur several days later during treatment. In study 4 we took 
this idea one step further. The underlying rationale was as follows. If micro fluctuations of negative 
affect, aberrant salience and other ESM-based predictors forecast micro fluctuations of psychotic 
symptoms shortly after, larger-scaled fluctuations of the same variables can potentially predict larger-
scaled psychotic symptoms and potentially even full-blown relapses in assessments lying further apart. 
As reviewed in section 1.4, the risk of relapse is high in psychotic disorders and findings from ESM-
studies could help to provide new candidate warning signs that would help people with psychosis and 
caregivers to mitigate or prevent upcoming symptom exacerbations.  
To examine whether micro level effects of ESM studies generalize to long-term fluctuations of 
symptoms, we conducted a one-week ESM assessment period (10 assessments per day) followed by a 
one-year Follow Up period (bi-weekly online assessments) to measure short- and long-term 
fluctuations of negative affect (i.e., anxiety, sadness, worry, and self-esteem), aberrant salience, 
paranoia, and auditory verbal hallucinations. Apart from the devices used for sampling (smartphone 
vs. personal computer), ESM- and Follow Up assessments were virtually identical. We assessed 
occurrences of relapse in bi-monthly online assessments (using criteria, such as hospitalization, 
symptom deterioration or suicidal tendencies; Csernansky et al., 2002). Using linear and logistic 
mixed models, we examined predictors of psychotic symptoms and relapse. Thirty participants with 
verified psychotic disorders provided a total of 1194 ESM- and 416 Follow Up assessments. Negative 
affect (b = 0.184, pcorrected = .003) and aberrant salience (b = 0.187, pcorrected < .001) predicted 
subsequent paranoia in ESM assessments, substantiating established ESM findings. However, only 
aberrant salience remained a significant predictor of bi-weekly symptom fluctuations during the one-
year Follow Up assessments (b = 0.366, pcorrected < .001). When we compared effects between the 
ESM- and the Follow Up phase using an interaction term of assessment type (ESM vs. Follow Up) 
and the respective predictor variable (aberrant salience, negative affect), a non-significant interaction 
confirmed that the association of aberrant salience and paranoia was not significantly different (b = 
0.103, SE = 0.077, t = 1.340, p = .181). Unfortunately, none of the examined variables predicted 
relapse, likely due to the low number of people who relapsed overall (n = 13, 43%). Nonetheless, 
people with psychosis could benefit from our findings by monitoring feelings of aberrant salience 
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regularly to be able to anticipate an upcoming paranoid symptom deterioration. It is possible that the 
predictive value of aberrant salience relies on its associations with underlying dopaminergic processes 
as exploratory analyses indicated that antipsychotic medication served as both a moderator (the effect 
was significantly weaker in medicated participants; b = -0.763, p < .001) and confounder of aberrant 
salience’s effect on paranoia (adding adherence to medication increased the effect by 42%). 
4 Discussion 
Psychotic symptoms are associated with anxiety, depressed mood, compromised sleep, or excessive 
worrying (Freeman & Garety, 2014). Interestingly, these comorbid symptoms are not only 
consequences of psychosis (e.g., not being able to sleep because voices keep you awake) but also 
warning signs of upcoming symptoms (e.g., experiencing paranoia due to compromised sleep; 
Kasanova et al., 2020). Studies using the Experience Sampling Method (ESM) studies have greatly 
enhanced our understanding of how symptoms unfold in the daily lives of people with psychosis by 
shedding light on mechanisms of moment-to-moment symptom variation. In combination with 
experimental (e.g., Reeve et al., 2018) and theoretical considerations (Freeman & Garety, 2014), ESM 
studies have contributed to the development of a branch of interventions for people with psychosis, 
which focus on putative causal factors of psychotic symptoms to reduce psychotic symptoms 
indirectly (e.g., Freeman et al., 2015a). Following this approach, we have developed EviBaS, an 
Internet intervention for people with psychosis targeting not only psychotic symptoms but a plethora 
of ESM-based putative causal factors, such as worrying, sleep, self-esteem and so forth. In studies 1 to 
3, we evaluated EviBaS and examined its potential modes of action to learn about whether targeting 
ESM-derived predictors can lead to an improvement of psychotic symptoms. Study 4 likewise aimed 
at applying knowledge from ESM studies to real world problems of people with psychosis but it used 
a different approach. Rather than treating predictor variables, study 4 used these variables as 
predictors of large-scaled symptom fluctuations and relapses in bi-weekly assessments. 
4.1 Discussion of main findings 
Across all papers, the present thesis aimed at improving the lives of people with psychosis using 
insights from ESM studies. Hence, one might argue that study 1 provided the most important finding 
of this thesis, namely that the EviBaS intervention is safe and efficacious. Interestingly, the size of the 
intervention’s effect (d = 0.37) is comparable to face-to-face therapies in psychosis (d = 0.36), see 
Bighelli et al. (2018) for a review, although this effect must be interpreted in the light of important 
limitations (see section 0). So far, Internet interventions for people with psychosis are very rare so that 
it is difficult to compare our finding to similar trials. Nonetheless, there are a few trials that examined 
Internet- or computer-delivered interventions for people with psychosis: In a randomized controlled 
trial conducted by Gottlieb et al. (2017), the computer-delivered program “coping with voices” 
resulted in significantly greater increases of social functioning compared to usual care but there was 
no effect on the severity of auditory hallucinations. As the name suggests, the intervention targeted 
voices specifically rather than overall psychosis. Another difference to the EviBaS program was that 
participants completed “coping with voices” at a clinic rather than at home. Apart from these 
differences, the approaches were comparable (modular intervention, web-based, CBT-focused). At 
first sight, it might therefore be surprising that EviBaS improved hallucinations while “coping with 
voices” did not. However, this result might be due to the fact that Gottlieb et al. (2017) used a 
clinician rated interview to assess hallucination severity. In the EviBaS trial, the clinician-rated 
measure likewise showed no improvements, only self-report measures did. Moritz et al. (2016) 
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conducted a trial that used similar methods as the EviBaS Project, namely a randomized controlled 
design evaluating an intervention, which participants completed independently on their own personal 
computers. However, the treatment approach was very different in that the intervention called 
“HelpID” targeted depressive symptoms exclusively rather than symptoms of psychosis. The 
intervention resulted in medium to large effects on reduced depressive symptoms, but psychotic 
symptoms remained unchanged (Moritz et al., 2016). To our knowledge, there is only one Internet 
intervention study besides the EviBaS Efficacy Study that could demonstrate reductions of positive 
symptoms: Rotondi et al. developed and evaluated a telehealth website, which provided 
psychoeducational information and different therapy forums, accompanied by a four-hour workshop 
focused on psychoeducation (SOAR; Rotondi et al., 2005). The SOAR website followed a very 
interesting approach in that it incorporated family psychoeducation to help family members better 
cope with their relative’s disorder. The trial resulted in a significant effect on positive symptoms in 
clinician rated interviews (Rotondi et al., 2010). The concept of the SOAR intervention was very 
different from the EviBaS Project in that it was not a conventional self-help application but rather a 
comprehensive intervention for families of people with psychosis – even including an extensive face-
to-face component. Given the different scopes, it is difficult to compare the results directly. 
Nonetheless, one must acknowledge that an approach that incorporates the families of patients is very 
likely to be more efficacious in heavily impaired patients (see section 4.5 for future directions).  
4.1.1 The complexity of EviBaS, curse and blessing 
Comparing EviBaS to the few previous Internet interventions for psychosis (or related disorders) 
highlights several unique characteristics of our intervention, particularly in comparison to the 
efficacious web-based family intervention approach by Rotondi et al. (2010). 
The complexity of the self-help format: Although EviBaS is a guided intervention, it delivers self-help 
materials in an online format, meaning that participants have to work through materials independently 
(apart from reminders and feedback by the guides) and with a high degree of autonomy. This format 
places high demands on participants in terms of motivation but also executive functions, such as 
attention, planning, or memory capacity. Overall, 32% of participants did not complete a single 
module and 14% of participants from the immediate access group dropped out of the study. 
Importantly, participants who dropped out had higher positive symptom severity at baseline, 
indicating that EviBaS might be too demanding for severely affected individuals (Rotondi et al., 
2015). At the same time, it is one of EviBaS’ biggest strengths to provide autonomy and control to 
patients. EviBaS perceives patients as competent and motivated, and it is oriented towards the 
treatment wishes of patients (Freeman et al., 2019; Moritz et al., 2017; Westermann et al., 2015). 
Possibly, neither SOAR nor EviBaS are suited for all people with psychosis. Rather, selecting a 
suitable approach based on participants’ needs and wishes would be most appropriate. If a person is 
severely psychotic, they might benefit more from SOAR; if they are mildly psychotic and cognitively 
capable of completing self-help exercises, they might prefer EviBaS; and if they are currently in 
remission, they might strongly prefer EviBaS as it does not give the feeling of being “in need” of help 
by others. 
The complexity of the intervention’s contents: Not only was EviBaS complex in terms of requiring 
autonomy and motivation, it was also complex in terms of contents. EviBaS encompasses eleven 
modules, numerous work sheets, and it addresses a plethora of putative causal factors, ranging from 
sleep problems to depression. This excess of supply can cause confusion, especially when 
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conventional treatments (e.g., in inpatient care) provide few degrees of freedom. Instead of reducing 
the complexity for all participants, a promising approach might be to tailor interventions to the 
requirements and expectations of individuals or subgroups, meaning that those with high cognitive 
capacities can benefit from a demanding intervention but those with impairments can receive fewer or 
simpler modules.  
4.1.2 Potential modes of action of EviBaS 
As reviewed in section 4.1.1, EviBaS was extensive in terms of modules and contents, so a question 
which inevitably comes to mind is how EviBaS was efficacious. Were all of these modules necessary 
or would a trimmed down version work just as well? In view of theoretical considerations (Freeman & 
Garety, 2014) and ESM studies (Hartley et al., 2014; Kasanova et al., 2020), we hypothesized that the 
intervention’s efficacy would be dependent on its capacity to improve causal factors (e.g., worrying, 
depression or sleep), which in turn lead to reduced psychotic symptoms. However, as reviewed in the 
following section, the potential modes of action appear to be different than expected. 
Mindfulness might have played a very important part in the intervention’s efficacy. Although the 
effect would not withstand a conservative Bonferroni correction, mindfulness improved consistently in 
intention to treat and per protocol analyses (the effect on mindfulness was confirmed in voice hearers 
in paper 3), indicating that increased mindfulness could be one mechanism of change through which 
EviBaS was efficacious. No other secondary outcome reached significance in intention to treat 
analyses (self-esteem, social skills, and psychological quality of life reached uncorrected significance 
in exploratory per protocol analyses, though). Based on the pioneering trials by Philippa Garety, 
Daniel Freeman and colleagues (Freeman et al., 2015a; Freeman et al., 2017; Freeman et al., 2015b) 
which made use of the so-called interventionist causal model approach, we would have expected that 
worrying and improvements of sleep problems would be particularly promising mechanisms of change 
but neither the ISI (measuring insomnia; Bastien, 2001) nor the PSWQ (measuring worrying; Hopko 
et al., 2003) reached significance.  
In study 2, we approached the research question of potential mechanisms of change differently (using 
more frequent intermediate assessment data) but the conclusion remained the same. A composite score 
of worry, negative affect, self-esteem, self-reported cognitive biases, and quality of sleep did not 
improve more in the EviBaS immediate access group compared to the delayed access group. At first 
sight, this finding might seem surprising because worrying and sleep problems play such an important 
role in the formation of psychotic symptoms. On closer inspection, however, the results fit the 
literature. Although EviBaS originally aimed at improving both paranoia and hallucinations (as well as 
a variety of other symptoms), the data suggest that the efficacy of EviBaS (i.e., in intention to treat 
analyses) eventually relied mainly on reducing hallucinations rather than paranoia. As worry and 
quality of sleep are associated with the paranoia specifically (Freeman et al., 2015a; Freeman & 
Garety, 2014; Hartley et al., 2014; Kasanova et al., 2020), it is not surprising that the intervention’s 
effect on hallucinations was not accompanied by an effect on worrying and insomnia. Albeit 
speculative, it is possible that the intervention’s effect on paranoia could be enhanced by improving its 
capacity to reduce worrying and sleep problems. In line with this view, paper 2 showed that 
momentary worrying and quality of sleep predicted subsequent paranoia in users of EviBaS, although 
the intervention did not successfully improve these variables.  
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Whereas our data suggest that worrying and sleep problems were not responsible for the efficacy of 
EviBaS, improved mindfulness could be an important mechanism of change. Before discussing 
mindfulness as a potential mediator, it is crucial to acknowledge that mindfulness as a secondary 
outcome did not meet the conservative Bonferroni correction for multiple tests. Nonetheless, the effect 
occurred consistently in intention to treat, per protocol, and also in the subgroup analyses in paper 3, 
so that it will be discussed despite this caveat.  
Mindfulness can be defined as “moment-to-moment, nonjudgmental awareness” (Kabat-Zinn, 2015) . 
The term moment-to-moment implies that mindfulness allows us to experience the present moment 
attentively rather than ruminating about the past or worrying about future events. Most importantly in 
the context of the EviBaS trial, however, is the term nonjudgmental, which means that a mindful 
perception of current experiences is detached from negative emotions or dissatisfaction with the 
current state. To illustrate, being mindful means to notice one’s own bodily but also mental states 
attentively and to accept them as they are, without wishing they were different. In the context of ESM 
research, studies have focused on experiential avoidance (i.e., attempts to avoid unpleasant thoughts, 
feelings, or sensations; Udachina et al., 2014), which can be described as the opposite of a mindful and 
accepting way of dealing with negative emotions. From a theoretical point of view, we expected that 
learning mindfulness skills would help a person to experience uncontrollable negative states as less 
distressing and disrupting because of the ability to accept current experiences non-judgmentally. 
Therefore, we hypothesized that mindfulness would be particularly helpful when experiencing 
hallucinations, which are characterized as uncontrollable (Baumeister et al., 2017). We examined this 
hypothesis in paper 3. In a subgroup analysis of voice hearers, we found that EviBaS participants who 
completed the mindfulness module reported more mindfulness and reduced hallucinations (measured 
with the LSHS-R) at the post assessment. An additional mediation analysis revealed that mindfulness 
improvements (measured with the MAAS) accounted for 1.6 points of the 7.2 point-difference in 
LSHS-R scores between groups. This analysis indicated that the intervention’s effect on hallucinations 
could be explained partly through its positive effect on mindfulness. Contrary to our hypothesis, we 
did not find an effect on distress and disruption caused by voices though. Initially, this pattern of 
results was surprising but a closer look at the content of the LSHS-R, our measure of hallucinations, 
provided possible explanations. The LSHS-R is a measure of hallucinatory experiences that is widely 
used in non-clinical populations. According to Waters et al. (2003), only a subset of the scale’s items 
assesses distinct hallucinatory experiences, whereas half of the items tap on “vivid mental events”. 
Vivid mental events are related to hallucinations but they are recognized by individuals as their own 
mental experiences rather than coming from the outside. One can describe these experiences as 
daydreams or uncontrollable thoughts (Waters et al., 2003). Several items from the “vivid mental 
events” factor of the LSHS-R measure experiences, which show overlap with mindfulness-related 
processes. For example, the first item captures difficulties in concentrating, which can be interpreted 
as the opposite of attentive mindfulness: “No matter how hard I try to concentrate, unrelated thoughts 
always creep into my mind”. Other items refer to daydreams, which are conceptually and empirically 
opposed to mindful perceptions of the present moment (Mrazek et al., 2012). It is possible that the 
partial overlap of mindfulness and subclinical hallucinatory experiences (mind wandering or 
daydreams) was responsible for the partial mediation observed in study 3. Thus, mindfulness was an 
important mechanism of change but apparently in a different way than initially expected: Mindfulness 
was not related to the distress or disruptiveness component by hallucinations but it was probably rather 
related to the non-attentive component of subclinical hallucinations.  
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To sum up, the rationale of EviBaS was (a) to directly target psychotic symptoms and (b) to target 
putative causal factors contributing to these symptoms, many of which were derived from ESM 
studies. Results indicate that the intervention reduced psychotic symptoms – mainly driven by 
improvements of self-reported hallucinations rather than paranoia (in intention to treat analyses). 
Studies 1 to 3 paint a clear picture in terms of how this efficacy came about. The intervention’s 
efficacy was unrelated to improvements of most putative causal factors, such as poor sleep, worrying, 
or negative affect. As these factors are associated with paranoia specifically (Freeman & Garety, 
2014), this finding makes a lot of sense in the light of the intervention’s inability to improve paranoia 
consistently. In contrast, improvements of mindfulness could explain the efficacy of EviBaS at least 
partly. Given the overlap of mindfulness and parts of the hallucination questionnaire, it is possible that 
EviBaS reduced daydreaming as well as intrusive thoughts, which are likewise components of 
(subclinical) hallucinatory experiences. Our findings substantiate that worrying and sleep problems 
represent important treatment targets in psychosis (study 2), although EviBaS did not successfully 
address them.  
4.1.3 ESM can improve the prediction of long-term symptom fluctuations 
The knowledge base about ESM predictors of psychotic symptoms significantly influenced the 
development of the EviBaS intervention although the intervention’s efficacy was only marginally 
attributable to improvements of these predictors. Nevertheless, studies 1 to 3 showed that basic 
research findings from ESM studies can be of practical use for people with psychosis. In study 4, we 
found that ESM findings can be of practical use in an additional way by providing candidate 
predictors of long-term symptom fluctuations in bi-weekly online assessments. As reviewed in section 
1.2.3, ESM studies have identified numerous short-term predictors of psychotic symptom fluctuations 
in assessment periods of few days. As these short-term predictors resemble long-term warning signs of 
psychotic relapse (e.g., depressed mood or compromised sleep), we hypothesized that one can draw on 
ESM-based predictors to predict long-term symptom fluctuations and potentially relapse. We 
compared predictor-symptom associations between an ordinary one-week ESM assessment phase and 
a subsequent Follow Up period lasting one year. Aberrant salience was a significant predictor of 
subsequent paranoia consistently in ESM and in bi-weekly Follow Up assessments but there was no 
effect on relapse. The results of study 4 imply that it is promising for people with psychosis to monitor 
aberrant salience in bi-weekly intervals because it can signal subsequent increases of paranoia several 
weeks in advance. Medication influenced aberrant salience’s effect on paranoia as a moderator and 
confounder. Possibly, aberrant salience is most predictive in unmedicated participants because it is not 
dampened by antipsychotic medication (Kapur, 2003). One of the most important findings from study 
4 was that ESM findings can provide information about predictor-symptom associations in much 
larger time frames. The following section provides a discussion of this finding.  
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4.2 ESM designs in new time frames 
An overarching theme of study 2, the EviBaS Intermediate Assessment Study, and study 4, the ESM 
Study, was the application of assessment strategies from ESM research (i.e., repeated self-report 
assessments of momentary psychotic symptoms and putative predictor variables) as well as data 
analytical methods (i.e., time-lagged mixed model analyses) to a new setting and time frame. Usually 
ESM studies are conducted in a naturalistic setting of participants’ everyday lives, encompassing 
smartphone-based assessments over a period of approximately one week (Myin-Germeys et al., 2018). 
In the present thesis, we applied many of the aforementioned ESM principles to the context of a 
psychological online intervention (study 2) as well as bi-weekly online assessments over a one-year 
Follow Up period. In both studies, we increased the distance between two consecutive assessments 
considerably when compared to conventional ESM studies, while using the same or very similar 
predictor variables of psychotic symptoms, such as negative affect or aberrant salience. This approach 
might seem counterintuitive at first glance because ESM studies deliberately try to uncover processes 
that are short-lived. For example, Kramer et al. (2014) examined associations of negative affect and 
paranoia in a general population sample and found that moments of negative affect resulted in an 
increase of paranoia over 180 subsequent minutes. Poor quality of sleep was likewise examined only 
as a short-term predictor of paranoia (i.e., immediately at the next morning; Kasanova et al., 2020). 
Given this background, one might argue that it is both a pointless and hopeless endeavor to change the 
distance between ESM assessments because momentary expressions of predictor variables, such as 
negative affect, should not have any effect on paranoia several days later (study 2), let alone two 
weeks later (study 4). We nonetheless held on to the idea that ESM based predictor-outcome 
associations could also apply to longer-distanced assessments because we assumed that short-term 
fluctuations of mood, worrying, aberrant salience, or paranoia occur around slower fluctuations (i.e., 
trends) of the same variables. This would imply that, for example, paranoia fluctuates rapidly from 
moment to moment during the day, but the average value of paranoia for each day changes at a slower 
Figure 6 – Exemplary course of paranoia across one week of ESM. Y-axis displays raw scores from a visual 
analogue scale for paranoia (0 – 100), X-axis displays days. 
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rate across days or even weeks. Figure 6, which is based on 8 days of ESM data from one of our 
participants in study 4, illustrates this idea.  
As the exemplary data in  Figure 6 show, the paranoia scores for participant 6 fluctuate heavily within 
the same day. At the same time, a trend of slowly changing mean levels of paranoia becomes visible 
only when observing data points across several days. Please note that Figure 6 was created for purely 
descriptive purposes using 2 Loess-curves with different degrees of smoothing in an exploratory way. 
It is only meant to illustrate a theoretical point and should not be misunderstood as “proof”. If we 
assume that ESM variables behave as depicted in Figure 6, it seems plausible that ESM assessments 
capture associations between rapid fluctuations of variables, whereas infrequent Follow Ups capture 
associations between slower trends of the same variables. Overall it was not free of risk to expect that 
ESM findings generalize to longer-distanced assessments but the potential benefit outweighed the risk 
because knowledge about symptom fluctuations that occur several days in advance would come with 
possibilities such as the prediction of treatment response or even relapses.  
Eventually, the data suggested that not all but some findings from ESM studies hold in longer 
assessment periods. In intermediate assessments during the EviBaS intervention, we found that 
momentary quality of sleep predicted subsequent paranoia and auditory verbal hallucinations several 
days later, whereas momentary levels of worrying predicted subsequent paranoia. We only considered 
data points in the analyses if they were at least one day and up to 1.5 weeks apart. Hence, the distance 
between predictors and outcomes was much greater than in conventional ESM studies and effects 
were nonetheless observable. Momentary negative affect and self-esteem, on the other hand, did not 
predict subsequent psychotic symptoms several days later. This distinction is very interesting because 
all four variables are well-established in ESM trials, particularly negative affect (as reviewed in 
section 1.2.3). In study 4, we directly compared a 1-week ESM phase to a one-year Follow Up phase 
to examine the congruence of predictor-outcome associations across short- and long-term assessment 
periods. In accordance with study 2, we found that the effects of negative affect on paranoia were only 
short-term and not observable in bi-weekly online assessments. In contrast, aberrant salience, which 
was not assessed in study 2, predicted subsequent paranoia consistently in ESM and Follow Up 
assessments. Worrying, which we assessed as a stand-alone predictor in study 2, was part of the 
negative affect scale in study 4. We examined it separately in exploratory analyses of study 4, though, 
and found that worrying served both as a short-term (within the same day) and a long-term (across 
weeks) predictor of paranoia, further substantiating the results from study 2.  
Post hoc, the pattern of results from studies 2 and 4 can be explained in the light of conceptual 
differences between negative affect as well as self-esteem on the one hand and sleep, worrying, or 
aberrant salience on the other hand. Affect is highly unstable in people with psychosis (Myin-Germeys 
et al., 2000) and stressful events are followed by higher levels of negative affect compared to controls 
(Myin-Germeys & van Os, 2007). These findings indicate that momentary negative affect does not 
follow long-term trends in people with psychosis but rather occurs randomly in response stressful 
events. This would explain why negative affect is a powerful predictor of short-term paranoia but not 
of long-term symptom fluctuations. Self-esteem likewise failed to predict psychotic symptoms several 
days later although it is predictive in short-term ESM studies (Udachina et al., 2014). Post hoc, the 
absence of long-term effects actually fits the literature well because momentary self-esteem appears to 
be highly unstable in people with psychosis, comparable to negative affect. The influential paranoia 
as defense model of persecutory delusions (Bentall et al., 1994) initially proposed that persecutory 
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delusions emerge in an attempt to restore low self-esteem. The rationale being that one regains high 
self-esteem if others are to blame for negative events rather than one-self (i.e., externalizing 
attributions). Based on empirical findings, the model had to be revised, however. Instead of restored 
self-esteem, participants with paranoia show highly unstable self-esteem, which fluctuates rapidly over 
time (for a review, see Murphy et al., 2018). Consistent with the model’s predictions, the moment-to-
moment variability of self-esteem predicts trait paranoia better than the overall level of self-esteem 
(Thewissen et al., 2008). Just as for negative affect, the randomness and strong variability of self-
esteem could explain why it is not suited as long-term predictors of psychotic symptoms.  
In contrast to negative affect and self-esteem, theoretical models describe worrying as both a 
momentary action as well as a more stable thinking style (i.e., a ‘worry thinking style’; Freeman & 
Garety, 2014). Hence, conceptually it makes sense to assume that the action of worrying about future 
events occurs momentarily throughout the day, while the tendency to worry (the worry thinking style) 
changes at a slower rate, making it a suitable predictor of both short- and long-term symptom 
fluctuations. Quality of sleep naturally changes at a slow rate than negative affect or self-esteem so 
that it comes as no surprise that it served as a predictor of long-term symptom fluctuations in study 2 
as well. It was nonetheless interesting to see that effects do not appear to be restricted to next-day 
paranoia. Lastly, aberrant salience predicted paranoia consistently in short- and long-term 
assessments, indicating that it is a predictor of both short- and long-term fluctuations of paranoia. 
Conceptually, aberrant salience has been described as part of the prodromal phase of psychosis, 
meaning that experiences of aberrant salience accumulate over periods ranging from days to years 
before illness onset (Kapur, 2003), so it is not surprising that aberrant salience served as an indicator 
of paranoia two weeks later in our study.  
In hindsight, it was naïve to expect that all ESM findings generalize to longer assessment periods. Our 
findings suggest that momentary affective processes in particular are too transient to predict symptoms 
that occur days or even weeks later. Other predictors, such as aberrant salience, have the potential to 
serve as very early warning signs of symptom deterioration. A unique feature of aberrant salience is its 
specific association with psychosis. Worrying, depressed mood, or sleep problems occur across a 
variety of disorders (e.g., for worrying in generalized anxiety disorder see Goodwin et al., 2017) and 
are therefore not specific warning signs for psychotic symptom deterioration. Aberrant salience, on the 
other hand, is an experience that is linked to psychosis particularly – first and foremost through its 
implications with the dopamine hypothesis of psychosis (Kapur, 2003; Miyata, 2019). Therefore, our 
findings show that it is indeed worthwhile to draw on ESM research to identify candidate predictors of 
larger scaled symptom fluctuations. Certain predictors (highly variable negative affective states in 
particular) appear to be predictive only in conventional ESM settings. 
4.3 ESM in psychotherapy research 
Studies 2 and 4 demonstrated that it can be worthwhile to apply the Experience Sampling 
methodology to a new time frame. At the same time, study 2 also showed that it can be promising to 
apply ESM methods to the context of psychosis treatment. Whereas ESM studies usually observe the 
natural ebb and flow of symptoms in participants’ daily lives, study 2 used ESM-like repeated 
assessments in participants undergoing treatment. As EviBaS aims at ameliorating the variables, 
which serve as predictors of psychotic symptoms in ESM studies, it was interesting to see how 




4.3.1 Worrying and quality of sleep as predictors of psychotic symptoms 
during treatment 
In study 2, we were able to identify worrying and quality of sleep as predictors of subsequent 
psychotic symptoms in participants who used the EviBaS intervention. These effects tell us that when 
a participant slept better or worried less than usual, they reported less symptoms at the next login. On 
a group level, however, worrying and sleep did not improve during treatment as indicated by null 
effects on respective secondary outcomes in the main trial. This pattern of results illustrates that the 
ESM-derived variables worrying and sleep problems represent important treatment targets, even 
though the EviBaS intervention was unsuccessful in treating them. We can conclude that whenever 
worrying or quality of sleep changed within participants, this was associated with subsequent 
symptoms, but the interventions efficacy did not rely on its ability to improve worrying and sleep. 
Albeit speculative, one would expect that the efficacy of EviBaS could be improved considerably if 
the intervention would consistently improve these variables.  
The findings of study 2 coincide well with the literature. Worry and rumination are associated with 
paranoia in experimental (Martinelli et al., 2013) and ESM trials (Hartley et al., 2014), but most 
importantly, treating worry leads to improved persecutory delusions in people with psychosis 
(Freeman et al., 2015a), mediated by change in worrying. The influential model by Freeman and 
Garety (2014) assumes a causal relationship of worry with paranoia in particular. Our results from 
study 2 support this notion inasmuch as we found associations of worry with subsequent paranoia but 
not auditory verbal hallucinations. Conceptually, worrying is very similar to paranoia, although its 
connotation is much less pathological. As Freeman and Garety phrased it ‘worry brings implausible 
ideas to mind, keeps them there, and increases the distress that they cause’ (Freeman & Garety, 2014, 
p. 1180). As for worry, the effects of quality of sleep on subsequent symptoms during the EviBaS 
intervention were not surprising in the light of a large body of literature. Our findings coincide with 
cross-sectional (Koyanagi & Stickley, 2015), experimental (Petrovsky et al., 2014; Reeve et al., 2018), 
ESM- (Kasanova et al., 2020; Mulligan et al., 2016), and interventional trials in healthy participants 
(Freeman et al., 2017). So far, preliminary clinical trials in people with persecutory delusions did not 
show effects of sleep interventions on psychotic symptoms as a secondary outcome (Freeman et al., 
2015b; Hwang et al., 2019) but as these trials did not examine psychotic symptoms as primary 
outcomes, future studies are necessary to make valid conclusions. To date, it is not entirely clear how 
sleep contributes to psychotic symptoms. Possibly, there is a mediating effect of negative affect of 
sleep quality (Kasanova et al., 2020; Rehman et al., 2018) or induced sleep loss (Reeve et al., 2018) on 
paranoia, meaning that poor sleep leads to increased negative affect, which in turn leads to paranoia. 
Further, sleep influences quality of life, emotion regulation, and cognitive functioning (Faiola et al., 
2018; Grezellschak et al., 2017; Harvey, 2009), especially the regularity of sleep patterns (Sano et al., 
2017).  
4.3.2 Methodological considerations on using ESM in psychotherapy 
research 
The idea of conducting ESM-like consecutive repeated measurements to identify underlying 
mechanisms of change during psychological treatment is not new. For example, Rubel et al. (2017) 
analyzed data from participants with various disorders who underwent psychotherapeutic outpatient 
treatment. At the end of each session, participants reported their experiences of the therapy session 
they had just completed (unlike at the beginning of each session in study 2 of this thesis). Participants 
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rated interpersonal experiences (i.e., the therapeutic relationship), problem coping experiences, and 
affective experiences (e.g., a deeper understanding of one’s own emotions). All of these variables 
were associated with subsequent symptom improvements on a within-person level. In their paper, 
Rubel et al. (2017) highlight the importance of separating within- from between-participant variance 
in such analyses. In mixed models, effects contain both a within- and a between-subject component. 
To illustrate, if negative affect predicts subsequent psychotic symptoms, then this effect is comprised 
of two components. First, if a person has higher mean levels of negative affect than another person, 
they show higher momentary psychotic symptoms. Second, if a person reports higher negative affect 
than the same person usually does, they report more momentary psychotic symptoms (i.e., the 
simultaneous examination of person-level and within-person time-varying relationships, Ben-Zeev et 
al., 2012). The theoretical considerations by Rubel et al. (2017) therefore illustrate an important point. 
Intermediate assessments can be a useful tool to uncover processes that occur during treatment only if 
analyses focus on within- rather than between-person processes. However, even if one takes within-
person centering into account, the conclusions that can be drawn from purely observational 
intermediate assessments are limited. For example, from paper 2, we cannot draw the conclusions that 
the EviBaS intervention was efficacious because of improved worry or sleep. Further, we cannot 
conclude that worry or sleep caused subsequent symptoms due to the regression-based design. We can 
only conclude that when these variables improved, this was associated with an improvement of 
psychotic symptoms shortly after. 
The aforementioned constraints of ESM-like assessments in therapy research illustrate that it is 
difficult to interpret them independently from additional analyses. As studies 1 and 2 show, 
randomized controlled designs and ESM-like intermediate assessments can complement each other 
very well. Study 1 (and also group-based analyses of study 2) showed that EviBaS did not improve 
worrying or insomnia. This information is crucial to correctly interpret the intermediate assessment 
analyses (i.e., changes of worry and sleep are probably not due to the intervention). At the same time, 
the intermediate assessment analyses help to correctly interpret the findings from the EviBaS Efficacy 
Study in that worrying and sleep problems should have been addressed more efficiently to improve the 
interventions effect on psychotic symptoms. Consequently, a combination of a randomized controlled 
trial with additional intermediate assessments – as demonstrated in the EviBaS Project – is a very 
powerful design.  
4.4 Limitations  
Out of the four included studies, study 1 (the EviBaS Efficacy Study) was the most elaborate for 
various reasons. Only study 1 allowed drawing causal conclusions due to its randomized controlled 
research design. Further, it relied on clinician-rated interviews (in addition to self-report), which are 
considered the gold standard in psychosis research (e.g., PANSS interview), and it was the most 
innovative study of the thesis because it examined a newly developed Internet intervention in a so far 
underexplored population. Despite these positive features, there are constraints to the trial that limit its 
interpretability. First, we compared EviBaS to a waitlist control condition rather than an active control 
condition. Strictly speaking, the control condition was not a purely “waiting” condition because all 
participants were required to receive simultaneous pharmacological and/or regular psychiatric or 
psychological treatment, which one might consider sufficient to name the control condition “treatment 
as usual”. However, as most participants were outpatients and we had little information about their 
treatment outside of the study, the wording seemed more appropriate. Waitlist control conditions are at 
risk of overestimating effect sizes but they can be useful for evaluating novel interventions (Mohr et 
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al., 2009). In a possible follow up study, a stronger control condition might be the better choice as it 
would control not only the natural course of symptoms but also non-specific effects of the intervention 
(e.g., interpersonal contact with a moderator). A second limitation was that the effect of the EviBaS 
intervention on composite psychotic symptoms was driven by improvements of only one of the three 
outcomes (a self-report hallucination measure), whereas the putatively more reliable PANSS interview 
showed no group differences. Due to the study’s online design, we had to conduct the PANSS via the 
telephone, which might have resulted in ratings that are less sensitive to change. Finally, the 
immediate access group (i.e., the group that received EviBaS immediately) reported fewer years of the 
duration of their disorder compared to the control condition. This group difference at baseline 
occurred despite randomization, a process designed to eliminate differences through chance. It is 
possible that the difference in illness duration explained the effect of the EviBaS intervention. This 
explanation is unlikely, though, because groups did not differ regarding any other baseline variables 
(e.g., the number of hospitalizations) and adding illness duration as a covariate did not change the 
effect.  
Whereas the issue of baseline differences was purely due to chance in study 1, the problem was much 
more pronounced in study 3. In study 3, we drew a subset of participants from the EviBaS Efficacy 
Study in order to compare people who used the mindfulness module to delayed access participants (in 
addition to selecting people who reported lifetime auditory hallucinations, see section 2.2.1). This 
resulted in groups that were no longer determined by randomization and hence likely affected by 
confounders. Only about 50% of participants from the voice-hearing sample of study 3 used the 
mindfulness module (usage of most modules was not mandatory, see section 1.3.2). It is very likely 
that this selection process resulted in a biased sample of people who were highly motivated and 
possibly even at risk to give socially desirable answers. In fact, there was a significantly higher 
proportion of female participants in the group of people who completed the mindfulness module. As 
female gender is associated with higher adherence in Internet interventions (Beatty & Binnion, 2016), 
the selection of mindfulness-module users is likely confounded by general adherence to the EviBaS 
intervention. Further, the analyses of paper 3 do not allow drawing the conclusion that the mindfulness 
module resulted in the observed effects on mindfulness. We did not evaluate a purely mindfulness-
based intervention but a comprehensive Internet intervention, which targets mindfulness among other 
factors. As participants in study 3 did not use the mindfulness module exclusively but in combination 
with other EviBaS modules, it cannot be ruled out that other contents of the intervention were 
responsible for improved mindfulness. Administering the mindfulness module as a stand-alone 
intervention would probably not have yielded the same improvements of mindfulness or 
hallucinations. Unlike study 1, study 3 relied purely on self-report measures. In mindfulness research 
particularly, self-report measures have faced severe criticism (Grossman, 2008). Finally, the mediation 
approach does not allow drawing causal conclusions. Although a mediation analysis usually relies on 
the assumption that the mediator is causally related, the procedure itself is regression-based. It is 
important to acknowledge that this limitation (i.e., the lack of causal inferences) refers to all studies 
but study 1. Studies 2 and 4 relied on regression-based analyses as well. We cannot conclude that 
fluctuations of, for example, worrying caused subsequent paranoia despite their temporal ordering.  
The EviBaS Project (studies 1 and 3) as well as the ESM Study (study 4) suffered from insufficient 
sample sizes. The sample size of n = 101 in the EviBaS Efficacy Study was below the target sample 
size of n = 140. Although a post hoc power analysis revealed that the final sample size was large 
enough to detect small to medium-sized effects, subtler effects were not detectable due to insufficient 
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power. The sample size problem became even more apparent when we drew a subset of participants 
for the EviBaS Mindfulness Study (study 3), in which the treatment group only consisted of n = 16 
participants. In study 4, we aimed for n = 40 participants but only reached n = 30. This shortcoming 
affected relapse analyses specifically, as only n = 13 participants with relapses did not allow drawing 
sound conclusions. Another limitation that affected all studies was an unusually high proportion of 
female participants. Usually, samples of people with psychosis are predominantly male (e.g., 62% 
male in Lincoln et al., 2012). In the EviBaS Project, the high proportion of female participants (e.g., 
58% in study 1) could be explained by the fact that the project evaluated an Internet intervention rather 
than a face-to-face treatment. High proportions of female participants are common in studies on 
Internet interventions for other disorders (e.g., 67% in trials on depression; Karyotaki et al., 2018). In 
study 4, the proportion of female participants was likewise high (53%).  
Although each individual papers’ methods must be interpreted with caution due to the aforementioned 
methodological constraints, one might argue that the conclusions drawn from the thesis as a whole are 
relatively robust. To illustrate, the results of study 2 indicate that worrying and sleep problems are 
important mechanisms of change during the EviBaS intervention. In itself, this finding is hard to 
interpret due to the regression-based design. However, in combination with the EviBaS efficacy trial, 
one can conclude that EviBaS was not efficacious through these processes (because it did not affect 
respective secondary outcomes) but that worrying and sleep are important treatment targets that 
EviBaS should have treated better. Study 3 was the least rigorous out of all studies given the post hoc 
subsample selection. Nonetheless, it plays a part in understanding the efficacy of the EviBaS 
intervention by providing a fine-grained examination of mindfulness. Paper 3 highlighted the overlap 
of the mindfulness outcome (MAAS; Brown & Ryan, 2003) and the hallucinations outcome (LSHS-R; 
Launay & Slade, 1981; Lincoln et al., 2009), which is important to understand how mindfulness might 
have served as a mediator of the intervention’s efficacy. Finally, studies 2 and 4 demonstrated in 
independent samples that certain ESM-based predictor variables (i.e., worrying) can be promising 
predictors of larger scaled symptom fluctuations, while others are not (i.e., negative affect). This 
accordance of results strengthens each individual finding despite aforementioned limitations.  
4.5 Future directions  
The EviBaS Efficacy Study was a success. The trial was the first to develop and evaluate a 
psychological Internet intervention delivering self-help materials for people with psychosis in a 
relatively large randomized-controlled trial. EviBaS proved to be safe, mostly accepted by 
participants, and efficacious. At the same time, the EviBaS Project was only a first step in the young 
field of Internet delivered self-help for psychosis, offering starting points for several future directions. 
It goes without saying that one important goal will be the independent replication of EviBaS’ efficacy 
in future studies. Irrespective of the methodological rigor of the EviBaS Project (e.g., the analysis plan 
was published; Ruegg et al., 2018), a replication will be necessary to validate findings – particularly in 
times of the replication crisis in psychology (Aarts et al., 2015). Preferably, a replication study should 
encompass a larger sample size to obtain more reliable estimates of effect sizes. However, future 
studies should not only replicate the efficacy of the intervention as it exists today. Rather, the 
intervention offers room for improvement. Despite the intervention’s complexity (i.e., 11 modules 
targeting multiple psychosis-related problems), its efficacy appears to be limited to hallucinations 
whereas many secondary outcomes, such as worrying, sleep, or depression showed no significant 
improvements. Hence, it might be worthwhile to rework these modules. The intervention’s inability to 
improve worrying is particularly critical because interventionist causal evidence (Freeman et al., 
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2015a) suggests that a successful reduction of worrying leads to reduced persecutory delusions. If 
EviBaS would shift its focus more towards a reduction of worrying (e.g., add a second module or 
rework exercises), it is likely that the intervention would become more successful in reducing 
paranoia. In addition, future evaluations of EviBaS (or an improved version of it) should incorporate 
intermediate assessments, comparable to the ones from study 2. The EviBaS Intermediate Assessment 
Study has shown that incorporating brief intermediate assessments can be beneficial in a randomized 
controlled trial by enabling researchers to obtain a fine-grained comparison of symptom change as 
well as predictors of such improvements. However, in future studies, the focus of intermediate 
assessments should be defined clearer than it was in study 2. The problem with intermediate 
assessments in study 2 was that the sampling plan was different for the immediate access group and 
the delayed access group. Whereas we assessed symptoms and predictors upon login in the immediate 
access group, we assessed them in equidistant weekly assessments in the delayed access group (see 
section 2.2.1). This was problematic because the unmatched time points of measurements resulted in 
difficulties comparing the course of symptoms over time. If the focus is on treatment progression, the 
assessments should take place at the same time points, for example every seven days. If the focus is on 
mechanisms of change, however, assessments should take place at the end of a module, as proposed 
by Rubel et al. (2017), to examine what processes took place during the preceding session that might 
explain subsequent symptom improvements. The latter version would not require intermediate 
assessments in the control group.  
Following up on the results of paper 3, it would be a very promising endeavor to assess the 
contribution of mindfulness on voice hearing in a methodologically more rigorous way. So far, the 
literature on mindfulness in psychosis is diverse, reporting various positive effects but no clear picture 
regarding specific effects on certain symptoms (Cramer et al., 2016; Jansen et al., 2020; Khoury et al., 
2013). Based on this thesis, one would expect that mindfulness would improve hallucinations 
specifically rather than psychotic symptoms in general. It is still open to question which component of 
mindfulness affects hallucinations. Initially, we hypothesized that the acceptance component of 
mindfulness would be crucial to reduce the distress caused by hallucinations. Study 3, however, rather 
indicates that a reduction of daydreaming or mind wandering could represent a potential mechanism of 
change. A randomized controlled dismantling trial, as proposed by the interventionist causal model 
approach by Freeman and colleagues (Freeman et al., 2015a; Freeman et al., 2017), would be 
necessary to examine this question.  
Study 4 offers several starting points for future studies as well. Study 4 brought attention to aberrant 
salience as a predictor of both short- and long-term paranoia. Although the study was insufficiently 
powered to detect predictors of relapse, it nonetheless seems very promising to follow up on the idea 
that self-reported aberrant salience represents a candidate relapse predictor. Aberrant salience stands 
out from the available candidate relapse predictors in many ways. First, it is a processes specifically 
linked to psychosis. Compromised sleep, worrying, or depressed mood are all related to a plethora of 
disorders (e.g., Goodwin et al., 2017; Harvey, 2009), whereas aberrant salience is theoretically 
grounded in a model on psychosis (Kapur, 2003). Further, predictors, such as compromised sleep, 
depression, anxiety, and others can be considered both precursors and outcomes of psychotic 
symptoms. From a theoretical perspective, it is equally plausible that paranoid thoughts keep a person 
awake as it is that compromised sleep causes later paranoia. Aberrant salience, in contrast, belongs to 
the prodromal phase of psychosis specifically (Kapur, 2003) and it appears unlikely that psychotic 
symptoms occur before feelings of aberrant salience. To arrive at more durable conclusions regarding 
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the prediction of relapse in a future trial, it would be worthwhile to include short diagnostic interviews 
to verify psychotic relapses in a more valid and reliable way. In study 4, we assessed relapses mostly 
on the basis of self-report, which is not ideal given that acute psychotic symptoms lack insight 
(Arciniegas, 2015). At the same time, frequent interviews can be off-putting for participants. A 
possible trade-off could be a combination of self-report and additional interviews when symptom 
thresholds are surpassed in self-reports. Most importantly, a future relapse prediction trial would 
require a much larger sample size, which will be difficult to acquire given the effort that is required 
from participants.  
As reviewed above, there are many worthwhile future directions which arise from the EviBaS Project 
and the ESM Study. However, all of these ideas face the same problem: Even if we manage to 
improve assessment methods, intervention contents, or technical components, follow up projects based 
on the EviBaS Project or the ESM Study will always require participants who show a lot of insight, a 
high degree of motivation, and relatively good cognitive abilities. In clinical practice – particularly in 
inpatient treatment or assisted living facilities – such patients are the exception rather than the rule. 
One must acknowledge that complex self-help interventions or the autonomous monitoring of internal 
mental states to prevent relapses will only benefit a certain proportion of patients and that others will 
require alternative approaches. Family interventions appear to be effective in reducing the number of 
relapses and hospitalizations (Pharoah et al., 2010), so a final worthwhile future direction would be to 
use what we have learned from studies 1 to 4 and to combine it with family psychoeducation. To 
illustrate, EviBaS can be effective for functional patients with psychosis but if patients have too severe 
symptoms, EviBaS could be adapted to provide valuable information for family members (e.g., family 
members could take care of certain environmental factors that impair sleep of their relative with 
psychosis). The SOAR intervention has shown that such an approach can be efficacious (Rotondi et 
al., 2010). The same is true for the ESM Study: While highly functional patients will be able to 
monitor bursts of aberrant salience independently, others cannot. In cases of limited cognitive 
capacities, we should rather educate family members to pay attention to potential warning signs 
instead of relying on the patient’s ability to monitor them.  
From a methodological perspective, the present thesis has highlighted the advantages of symptom- 
rather than diagnosis-focused research. The EviBaS intervention reduced psychotic symptoms 
(composite outcome) but a closer look revealed that this effect only applied to hallucinatory 
experiences. Worrying and sleep problems predicted subsequent psychotic symptoms during the 
intervention, but eventually, the effect of worry was limited to paranoia (which coincides with 
theoretical considerations), and in the ESM Study, predictive effects of aberrant salience likewise only 
occurred for paranoia, not auditory hallucinations. The symptom focused approach of the present 
thesis was influenced by ESM research findings, which mainly focus on single symptoms rather than 
composite scores (e.g., Ben-Zeev et al., 2012; Luedtke et al., 2017; So et al., 2018). Future studies, 
both treatment as well as relapse prediction trials, could benefit from adapting this approach. For 
example, study 4 demonstrated that it can be a fruitful endeavor to predict bi-weekly fluctuations of 
paranoia rather than relapses. Relapses are complex events with different underlying symptom 
exacerbations (Csernansky et al., 2002). Possibly, the predictive value of previously examined 
predictors was limited because of the diversity of the outcome. Future studies should consider 
adopting the ESM-based approach of predicting exacerbations of certain symptoms rather than 
complex events in order to end up with more potent models.  
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Lastly, an important methodological future direction will be to move forward to “real” idiographic 
research. Idiographic research refers to the study of the individual – an individual’s behavior, their 
cognitive processes, and personality (as reviewed in Piccirillo & Rodebaugh, 2019). In the context of 
ESM, idiographic research refers to examinations of individual symptom trajectories of participants 
rather than relying on group-level statistics. The ESM-based procedures used in this thesis give the 
impression of idiographic research because we examined repeated measures clustered within 
participants using person-mean centered predictors (studies 2 and 4 of the present thesis). In the end, 
however, all analyses were nomothetic (i.e., group-level based) because they relied on fixed effects 
that were estimated across the whole sample. It would be a very interesting approach to use ESM data 
in order to identify relevant symptom predictors for individuals rather than groups of people. Whereas 
sleep problems might be a symptom trigger for person “A”, they might be irrelevant for person “B” 
who mainly experiences symptom exacerbations after excessive worrying. Particularly in the context 
of relapse prevention, individualized ESM assessments could provide a tool to identify idiographic 
risk factors. Such individualized approaches could not only improve the prediction of relapse, they 
would also give a person the impression that a treatment- or prevention program is truly tailored to 
their needs, which would eventually increase compliance and motivation.  
4.6 Conclusions 
The present thesis granted several insights into the variability of psychotic symptoms and their 
treatment. First and foremost, the Internet-based EviBaS intervention proved to be safe, accepted, and 
efficacious. Secondly, the intermediate assessment study indicated that worrying and sleep problems 
represent important treatment targets, which were not sufficiently addressed by EviBaS. Rather, the 
efficacy of EviBaS potentially relied on effects on mindfulness (study 3). Finally, study 4 showed that 
it is possible to predict bi-weekly symptom fluctuations of paranoia using self-reported aberrant 
salience, potentially paving the way for future studies of aberrant salience as a promising relapse 
warning sign. A closer look at these results, which at first appear convincing, reveals that much work 
still needs to be done. EviBaS appears to be efficacious through a very specific pathway of reducing 
hallucinatory experiences and increasing mindfulness. Other outcomes – particularly observer-rated 
interviews but also worrying, sleep problems, or depression – remained unaffected. Further, the 
intervention appears to be too demanding for heavily impaired participants. In short, there is much 
room for improvement. In addition, the ESM Study only represents a very first step in the endeavor of 
improving the prediction of relapse in psychosis. The underlying goal – predicting relapses – was not 
achieved and will require much larger samples in future studies.  
The Experience Sampling Method was at the core of this thesis. Findings from ESM studies 
influenced the development of EviBaS, the selection of relapse predictors, and the intermediate 
assessment analyses. Grounding the thesis on ESM research shifted its focus towards individual 
symptoms and warning signs and away from overarching syndromes or diagnoses. Being at the 
intersection of nomothetic and idiographic research, this approach greatly benefited the present studies 
and I believe that it has the potential to exert positive influence on clinical research in general. So far, 
we have certainly not exhausted the potential of the Experience Sampling Method, and we should 
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Identifying novel and reliable early warning signs could help to reduce the high risk of relapse 
in psychosis. Here, we examined whether short-term symptom predictors from Experience 
Sampling Method (ESM) studies represent worthwhile candidate relapse predictors. We 
conducted a one-week ESM assessment period (10 assessments per day) followed by a one-
year Follow Up period (bi-weekly online assessments) to measure short- and long-term 
fluctuations of negative affect (i.e., anxiety, sadness, worry, and self-esteem), aberrant 
salience, paranoia, and auditory verbal hallucinations. In addition, we assessed relapse in bi-
monthly online assessments (e.g., hospitalization, symptom deterioration, suicidal 
tendencies). Using linear and logistic mixed models, we examined predictors of psychotic 
symptoms and relapse. Thirty participants with verified psychotic disorders provided 1194 
ESM- and 416 Follow Up assessments. Negative affect (b = 0.184, pcorr. = .003) and aberrant 
salience (b = 0.187, pcorr < .001) predicted subsequent paranoia in ESM assessments, but only 
aberrant salience remained a significant predictor in bi-weekly Follow Up assessments (b = 
0.366, pcorr < .001). None of the examined variables predicted relapse, possibly due to the low 
number of people who relapsed (n = 13, 43%). To our knowledge, this is the first study to 
compare ESM and Follow Up assessment periods directly in order to identify novel relapse 
predictors, such as aberrant salience. Our results suggest that patients should monitor changes 
of aberrant salience as a warning sign of long-term fluctuations of paranoia, presumably 
reflecting underlying dopaminergic processes.  
Keywords: schizophrenia, psychotic symptoms, Ecological Momentary Assessment, 
auditory verbal hallucinations, negative affect  
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General Scientific Summary 
We examined whether negative emotions (e.g., sadness, anxiety), as well as the 
unusual feeling that something unimportant suddenly catches one’s attention, are warning 
signs of paranoia, voice hearing, and potentially even psychotic relapses over a one-year 
study period. Although no variable predicted relapse, the unusual feeling that unimportant 
things appear significant did predict paranoia two weeks later, indicating that it is promising 
for people with psychosis to monitor this feeling of aberrant salience in order to anticipate 
and potentially prevent the worsening of symptoms before they occur.   
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Aberrant Salience Predicts Fluctuations of Paranoia but not Relapse During a 
One-Year Experience Sampling Study in People With Psychosis 
 
As early as 1919, Kraepelin believed that dementia praecox, as he termed 
schizophrenia, would inevitably deteriorate (for a review on the history of relapse research, 
see Taylor & Jauhar, 2019). Although Kraepelins view appears exaggerated today, relapse 
rates are indisputably high. They range from 49% within 3 years (Pelayo-Teran et al., 2017) to 
82% within 5 years (Robinson et al., 1999). Consequently, it comes as no surprise that there is 
an extensive body of research on predictors of psychotic relapse (e.g., Lecomte et al., 2019). 
Although studies are numerous, only a fraction examined time-variant predictors, such as 
prodromal symptoms that forecast relapse, in prospective repeated-measures studies. Unlike 
stable predictors of relapse (e.g., age of psychosis onset; Pelayo-Teran et al., 2017), time-
variant predictors help people with psychosis and caregivers to gauge the risk of an upcoming 
relapse at any given time. Eisner et al. (2013) reviewed the sensitivity and specificity of 
prodromal symptoms, also referred to as early signs of relapse (e.g., anxiety, dysphoria, or 
insomnia). Sensitivity ranged from 10% to 80% (median = 61%) and specificity ranged from 
38% to 100% (median = 81%). The largest reviewed study incorporated 339 outpatients in up 
to bi-weekly diagnostic meetings over a period of two years (Gaebel & Riesbeck, 2007). 
Trouble sleeping was the most sensitive prodromal symptom (sensitivity = 39%, specificity = 
78%), followed by being tense and nervous (sensitivity = 37%, specificity = 79%), 
exemplifying that the predictive validity of prodromal symptoms is modest at most (Eisner et 
al., 2013). Recently, a new approach emerged, which relies on collecting passive smartphone 
data to detect anomalous behavior to predict relapses (Barnett et al., 2018; Buck et al., 2019). 
For example, the number and duration of outgoing calls and the number of total text messages 
predicted relapse in one study (Buck et al., 2019). These passive approaches are promising 
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but preliminary so far (Buck et al., 2019). In sum, there is room for improvement in the 
prediction of relapse using time-variant predictors. 
One way to improve the prediction of relapse is to identify novel and reliable relapse 
predictors. For the present study, we focused on self-reported predictors rather than passive 
smartphone data because self-report predictors have the advantage that participants can 
monitor them on their own, without having to rely on an algorithm or an external person who 
monitors the data. Hence, self-report predictors promote participants’ autonomy, a concept 
that received increasing attention recently, for example in interventions for psychosis 
(Westermann et al., 2020). In order to identify candidate predictors, we drew on the so-called 
Experience Sampling Method (ESM; Myin-Germeys et al., 2018). ESM studies aim at 
identifying moment-to-moment fluctuations of psychotic symptoms and their predictors while 
relying on frequent ecologically valid assessments conducted mostly via handheld computers 
or smartphones. Usually, ESM studies encompass short assessment periods of up to 10 
measurements per day for approximately one week, meaning that they examine micro 
fluctuations of symptoms. If applied to longer assessment periods, however, predictors 
derived from ESM studies have the potential to add to the prediction of relapse, assuming that 
ESM effects generalize to longer assessment periods. In fact, there is considerable overlap of 
short-term ESM predictors and early signs of relapse. In ESM studies, sleep problems 
(Kasanova et al., 2020), but also negative affective states, such as anxiety or depressed mood 
(Ben-Zeev et al., 2011; Ludtke et al., 2017) predict upcoming micro-fluctuations of 
symptoms. All of these variables likewise serve as warning signs of relapse (e.g., Gaebel & 
Riesbeck, 2007).  
The evident overlap of ESM- and relapse predictors suggests that short-term ESM 
processes represent micro-level equivalents of long-term mechanisms of relapse. Feeling 
anxious, for example, precedes subsequent paranoia few hours later (Ludtke et al., 2017) but 
 
122 
likewise predicts relapse one week later (Gaebel & Riesbeck, 2007). Although relapse and 
paranoia are different outcomes, it is possible that the underlying process is the same, in that 
anxiety predicts subsequent paranoia (which can be part of a psychotic relapse). The isolated 
effect on specific symptoms, such as paranoia, could be one of the reasons why established 
early signs of relapse show only moderate predictive validity. It is possible that certain 
warning signs consistently precede psychotic symptoms but these symptoms do not 
necessarily lead to relapse (Herz & Lamberti, 1995). Thus, we assume that ESM-based 
predictor-symptom associations generalize to long-term assessment periods, explaining the 
overlap of ESM-based predictors and early signs of relapse. In addition, we assume that 
further ESM studies can inform us about future, so far uninvestigated, warning signs of 
relapse. 
In the present study, we tested the aforementioned assumptions by directly comparing 
a one-week ESM assessment period to a one-year Follow Up period in the same sample. This 
procedure enabled us to examine whether short-term ESM effects on paranoia and 
hallucinations generalize to long-term assessment periods, potentially granting insight into 
underlying processes of relapse formation. If ESM-based variables can predict a worsening of 
paranoia two weeks in advance, people with psychosis can target these predictors or seek help 
in order to avert these symptoms. As our overarching goal was to improve the prediction of 
relapse, we examined the same ESM-based variables as predictors of full-blown relapse as 
well.  
To identify candidate precursors for the present study, we drew on established 
symptom predictors from ESM trials. We chose aberrant salience, defined as the attribution of 
novelty and significance to stimuli that are not inherently significant (Kapur, 2003), as well as 
negative affect (i.e., sadness, anxiety, low self-esteem, and worrying), the latter overlapping 
with established warning signs of relapse (e.g., Gaebel & Riesbeck, 2007). Aberrant salience 
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has great potential to improve the prediction of long-term symptom fluctuations and relapse 
as it has a strong theoretical foundation (Kapur, 2003), is introspectively accessible (Cicero et 
al., 2010), and reliably associated with psychotic symptoms in ESM-studies (Reininghaus et 
al., 2016; So et al., 2018). Due to its theoretical (Kapur, 2003) and empirical (for a review see 
Miyata, 2019) associations with dopamine functioning, aberrant salience may signal 
subsequent symptom fluctuations or relapses through underlying changes within the 
dopamine system. Further, aberrant salience could be a psychosis-specific relapse predictor 
rather than an unspecific prodromal symptom, such as sleep problems (Gaebel & Riesbeck, 
2007), as it is a construct specifically tied to psychosis.  
We hypothesized that aberrant salience, as well as negative affect (i.e., sadness, 
anxiety, low self-esteem, and worrying) predicts subsequent psychotic symptoms in a one-
week ESM phase as well as a one-year Follow Up phase. Further, we hypothesized that 
aberrant salience, negative affect, extreme levels of affect, quality of sleep and adherence to 
medication predicts subsequent psychotic relapse (measured bi-monthly), and that participants 
could anticipate an upcoming relapse.  
Method 
Recruitment 
We recruited participants from Hamburg, Germany, and surrounding areas between 
March 2018 and May 2019. We reached out to former participants, who consented to receive 
study invitations, and contacted psychiatric wards of local hospitals, self-help groups, and 
assisted living facilities. In addition, we advertised the study on the internet, via leaflets, 
posters, and within a local newspaper.  
Inclusion criteria were age (18–65 years), sufficient command of the German 
language, a verbal IQ of 85 or higher according to a verbal intelligence test (Schmidt & 
Metzler, 1992), and a non-affective psychotic disorder according to a clinician-administered 
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interview (MINI; Lecrubier et al., 1997). We excluded participants if they reported a 
diagnosis of dementia or a severe neurological disease, and if they fulfilled the diagnostic 
criteria of a severe substance use disorder or high suicidality according to the MINI. Finally, 
we excluded participants who refused to fill in an emergency plan, a document listing contact 
persons whom participants could reach out to in case of suicidal thoughts, psychotic relapse, 
or other crises. 
Trial Design and Procedure 
The ethics committee of the German Psychological Association approved the study 
(ID: SM082017) and all participants provided written informed consent prior to participation. 
We conducted the study in accordance with the Declaration of Helsinki and we prospectively 
registered the analysis plan (osf.io/em6v9, registered September 12, 2018). Participants 




Overview of the trial design. 
1. Baseline  
 
- Face-to-face meeting, ca. 2 hrs. duration 
- Interview: MINI, PANSS 
- Questionnaires: CAPE, BSI-18… 




- 70 scheduled assessments, 10 per day for 
7 days, 98 sec. duration 
- ESM Items: paranoia, verbal 
hallucinations, aberrant salience, negative 
affect… 
Post-ESM assessment took place when participants returned smartphone after ca. 7 days 
3. Post-ESM  
 
- Face-to-face meeting, ca 20 min. duration 
- Questionnaire: Experiences ESM 
- Instructions Follow Ups 
Follow Ups started ca. one week after the Post-ESM assessment 
4. Follow Up 
 
distance 
- 24 scheduled assessments, bi-weekly for 
one year, 13 min. duration 
- ESM items (identical to ESM) 
- Follow Up items: Sleep, adherence, 
relapse-expectation… 
- Bi-monthly, relapse assessment, 43 min. 
duration: 
Hospitalization, increased care & 25% 
CAPE increase, self-injury, suicidal 
ideation, violence, clinical deterioration 
 
Baseline Assessment  
At baseline, we conducted a structured clinical interview (MINI and PANSS; for a 
description, see measures section) to examine the severity of psychotic symptoms as well as 
inclusion and exclusion criteria.  
ESM Assessment Phase  
Participants received a smartphone (Motorola G3, 5-inch screen) and a user manual at 
the end of the baseline assessment. The experimenter explained functions of the smartphone 
and the items. Participants completed as many practice trials as necessary to ensure 
comprehension. We used a password-secured program to lock all functions of the smartphone 
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except for the ESM program movisensXS (movisens GmbH, Karlsruhe, Germany). The alarms 
for the ESM assessments occurred randomly ten times per day between 9:00 a.m. and 9:00 
p.m. with a minimum distance of 30 minutes between them. In addition, participants could 
activate ESM assessments manually when they wanted to catch up on a missed assessment or 
if they currently experienced symptoms. To reduce burden, participants could change the 
loudness of the alarm as long as they notice it. We informed them that they should not answer 
the phone when it would result in safety risks or severe disturbances. After the ESM 
assessment phase, participants returned the smartphone and completed a questionnaire on 
their ESM experience (Post-ESM assessment). Of note, the design and parts of the items were 
based on a previous study (Westermann et al., 2017) but the participants of the current and the 
preceding study were sampled independently.  
Follow Up Phase 
Over the course of one year, participants completed bi-weekly Follow Up assessments 
online (QuestBack Unipark®) on their private computers, using a link that we sent them via 
email. Study personnel sent reminder emails if participants did not respond within two days 
after the invitation. If participants skipped several consecutive assessments, we contacted 
them via telephone. We matched responses from the same participant using an anonymous 




We report participants’ cumulated antipsychotic dosages, defined as the dosage of a 
certain drug divided by its maximum dosage, cumulated across drugs. We chose this index 
because chlorpromazine equivalents have faced criticism (Danivas & Venkatasubramanian, 
2013). We administered the Mini International Neuropsychiatric Interview, Version 7.0.2 
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(MINI; Lecrubier et al., 1997) to confirm relevant disorders, and the Positive and Negative 
Syndrome Scale to assess psychotic symptom severity (PANSS; Kay et al., 1987). Study 
personnel received extensive training for the MINI and the PANSS, including several 
attendances of interviews by the principal investigator, interviews with supervision, and 
continuous debriefings and supervision during the study. We included the Community 
Assessment of Psychic Experiences (CAPE; Stefanis et al., 2017) as a self-report measure of 
psychotic and global symptom deterioration during relapse assessments.  
ESM Assessments (7 Days, 10 Times per Day) 
The ESM smartphone assessments consisted of 17 items, rated on visual analogue 
scales. Here, we only present items that are relevant for the present study. Please find the 
complete list of items in the preregistered report (osf.io/em6v9). We assessed emotional 
valence (I feel very pleasant – very unpleasant) and arousal (very excited – very unexcited). 
In addition, single items assessed anxiety (“I feel anxious” based on Kramer et al., 2014), 
self-esteem (“I feel worthless”, based on Rosenberg, 1965), worrying (“At the moment, my 
worries overwhelm me”, based on Stober & Bittencourt, 1998), and sadness (“I feel sad”, 
self-generated). To reduce the number of confirmatory tests, we aggregated anxiety, self-
esteem, worrying, and sadness to a negative affect scale. In the proper meaning, the scale 
consists of not only affective states but also cognitions (e.g., a worry thinking style; Freeman 
& Garety, 2014) but for the sake of brevity, we refer to it as negative affect throughout. Two 
items captured psychotic symptoms, “I feel suspicious”, adapted from previous ESM trials 
(Kramer et al., 2014; So et al., 2018) and the self-generated item “I hear voices that no one 
else can hear”. We analyzed paranoia and auditory verbal hallucinations as separate outcomes 
instead of using a composite score because we expected differential effects of predictors on 
each outcome based on a recent study (Lüdtke et al., in press). This was a deviation from the 
preregistered analysis plan. We included five out of seven items of the increased significance 
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subscale of the aberrant salience inventory (Cicero et al., 2010). We chose items 27, 21, 1, 16, 
and 5 based on their factor loadings (Cicero et al., 2010). We adapted the items slightly to 
capture current aberrant salience using the same visual analogue scale as the other items (e.g., 
“Do certain trivial things suddenly seem especially important or significant to you?”).  
Follow Ups (One Year, Bi-Weekly)  
Follow Up assessments included the aforementioned ESM items rated on the same 
visual analogue scales. Additionally, we assessed quality of sleep (“I would describe the 
quality of my sleep as >good<”) and medication adherence, (“How much of the prescribed 
medication did you take in the past two weeks?”), the latter rated on a visual analogue scale 
ranging from 0% to 100%. The remaining items on drug abuse and alcohol abuse were not 
relevant for the present analyses.  
Relapse Assessments (One Year, Bi-Monthly) 
We assessed relapse using a binary variable based on criteria proposed by Csernansky 
et al. (2002). Relapse could either be absent (none of the criteria fulfilled) or present (at least 
one criterion fulfilled). Relapse criteria were as follows. Hospitalization: Participants reported 
hospital admissions within the previous two months, including dates and the reason for 
hospitalization, which we inspected manually. Increased psychiatric care and 25% increase of 
CAPE total score: We asked participants “Compared to the start of the study, did the 
psychiatric or psychological care that you received increase within the last 2 months?” 
accompanied by an explanation of what increased psychiatric or psychological care means. 
Additionally, we calculated the difference of the CAPE total score compared to baseline to 
detect increases of at least 25%. Deliberate self-injury: We assessed deliberate self-injury 
using the item “Please state if you deliberately injured yourself in the past week; if yes how 
often” from the Borderline Symptom List (BSL-23; Bohus et al., 2009). Suicidal ideation: We 
used the suicide item from the Beck Depression Inventory-II (Beck et al., 1996). Violence 
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towards others or property damage: The item “Has there been a situation in the past 2 weeks 
where you physically attacked another person or where you destroyed the property of others?” 
was self-generated. Clinical deterioration: We included the Brief Symptom Rating Scale 
(BSI-18; Derogatis & Fitzpatrick, 2004) as a measure of overall clinical deterioration (50% 
increase compared to baseline).  
Participants’ Relapse Expectations (One Year, Bi-Weekly) 
We used the self-generated item “Do you think that you might experience a relapse in 
the near future?” to examine relapse expectations (we provided an explanation of relapse). 
Response options were “rather yes”, “rather no”, and “I don’t know”.  
Statistical Analyses 
Power 
We aimed for a target sample size of n = 40 participants based on previous studies in 
the field (see trial registration for a detailed description; Identifier osf.io/em6v9). We failed to 
reach the target sample size by 25% resulting in a sample of n = 30 participants.  
Reliability 
We report the momentary Cronbach’s α at the first completed ESM assessment, 
corresponding to the classical cross-sectional internal consistency. As the momentary 
Cronbach’s α does not account for the nested structure of the data, we computed two 
additional indices of multilevel reliability proposed by Bonito et al. (2012). The occasion 
level reliability describes the consistency of responses across the items, whereas the person 
level reliability describes the reliability of a person’s mean response across occasions 
(Nezlek, 2017).  
Lagged Regression Analyses 
All confirmatory analyses represent variants of mixed models, which account for the 
nested structure of repeated measurements clustered within participants. We did not impute 
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missing values because mixed models are flexible in handling missing data (Twisk, 2019, p. 
150). We person-mean centered all time-variant predictor variables (e.g., aberrant salience) 
separately for ESM and Follow Up assessments by computing the within-person mean and 
subtracting it from each value. All models included random intercepts but no random slopes. 
We assessed the effect of negative affect (t-1) as well as aberrant salience (t-1) on subsequent 
psychotic symptoms (t0), controlling for preceding psychotic symptoms (t-1). Subsequently, 
we added the assessment type (ESM vs. Follow Up) as well as the interaction of precursor 
and assessment type. The interaction term indicated whether the effect of the respective 
precursor on subsequent symptoms differed between ESM and Follow Up assessments. The 
statistical models on relapse were variants of logistic mixed models with relapse (yes/no) as 
the outcome and different predictor variables (adherence to medication, quality of sleep, 
negative affect, and aberrant salience) measured at least one week and up to four weeks prior 
to the outcome. The logistic mixed model relied on a binomial probability distribution and a 
logit link function. We used two-sided tests and conventional p-values of .05 and applied the 
Benjamini and Hochberg correction to control for the false discovery rate (FDR) due to 
multiple tests in linear models (Benjamini & Hochberg, 1995).  
Results 
Sample Characteristics and Adherence 
See Table 1 for sample characteristics. A PANSS total score of approximately 45 
indicated that participants were rather healthy (Leucht et al., 2005). Nonetheless, 40% had a 
current psychotic episode.  
Thirty participants fulfilled the inclusion criteria, completed the baseline assessment 
and differing proportions of the ESM assessments. The ESM period encompassed 70 planned 
assessments but the assessments did not terminate automatically after 7 days. Instead, 
assessments continued until the experimenter deactivated the smartphone. For two 
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participants, the ESM assessment period significantly exceeded 7 days. One participant kept 
the smartphone for 19 days because they encountered technical difficulties and asked for an 
extension of the assessment period. Another participant got sick during participation, resulting 
in a period of 28 days until they returned the smartphone. Without these two outliers, the 
mean number of ESM assessment days was M = 7.43 days (SD = 1.32), with a median and 
mode of 7 days. On average, participants provided 57.07 ESM assessments (range: 8 to 105), 
resulting in 1712 data points. We only considered data points in the analyses if they were not 
less than 10 minutes and not more than 4 hours apart, resulting in 1194 valid data points 
(70%).  
Twenty-eight participants completed at least one Follow Up assessment, resulting in 
554 Follow Up assessments, corresponding to M = 18.47 assessments on average (SD = 8.78; 
median = 23.5). If each participant had provided all 24 assessments, there would have been 
744 assessments. As for the ESM assessments, we used a time criterion to identify valid data, 




Sample characteristics at baseline (n = 30) 
Characteristics M (SD) or proportion (%)  
Demographics  
Age in years 42.87 (12.11) 
Gender female  16/30 (53%) 
At least 11 years of education 22/30 (73%) 
Clinical variables  
Diagnosis of current psychotic episode 12/30 (40%) 
Taking antipsychotic medication 25/30 (83%) 
Cumulated antipsychotic dosage 56.38 (38.22) 
PANSS total score 45.59 (14.31) 
PANSS positive 13.03 (7.22) 
PANSS negative 11.00 (5.17) 
Note. SD = Standard Deviation. All participants fulfilled criteria of a lifetime psychotic 
episode according to the MINI interview. PANSS positive and negative subscales calculated 
according to the 5-factor solution by Vandergaag et al. (2006). Cumulated antipsychotic 
dosage refers to the percentage of the maximum dosage of the antipsychotic drugs that a 
participant received. 
Internal Consistency 
We examined internal consistencies of the negative affect scale as well as the aberrant 
salience scale. The momentary Cronbach’s α values (α = .866 for both scales) as well as the 
person level consistencies (negative affect: α = .994; aberrant salience: α = .993) were good to 
excellent. Only the occasion level consistency was insufficient (negative affect: α = .108; 





We hypothesized that negative affect and aberrant salience predicts subsequent 
psychotic symptoms. As shown in Table 2, both scales predicted subsequent paranoia in 
within-day ESM assessments, but not auditory verbal hallucinations. Next, we examined 
whether negative affect as well as aberrant salience likewise predicted psychotic symptoms in 
bi-weekly Follow Up assessments. In Follow Ups, only the effect of aberrant salience on 
subsequent paranoia remained significant after the FDR correction, indicating that aberrant 
salience functions as a predictor of paranoia consistently within days and across weeks. This 
interpretation was supported by a non-significant interaction of aberrant salience and 
assessment type, indicating that the effect of aberrant salience on paranoia was not different 
between ESM and Follow Up assessments (b = 0.103, SE = 0.077, t(1167.07) = 1.340, p 
= .181). The effect of negative affect on subsequent paranoia, on the other hand, was lower in 
Follow Up assessments, as indicated by a significant interaction (b = -0.186, SE = 0.087, 
t(1172.36) = 2.147, p = .032). In short, aberrant salience predicted paranoia within the same 
day and over the course of weeks, whereas the effect of negative affect was limited to ESM 
data.  
As typical for ESM studies (e.g., Kasanova et al., 2020), we do not provide 
standardized effect sizes due to the multilevel structure of the data. Nonetheless, the 
unstandardized effects can be interpreted easily because we used uniform Likert scales. For 
example, an effect of b = 0.187 indicates that if a person scores one point higher on the 100-
point Likert scale for aberrant salience, they score 0.187 higher on the 100-point Likert scale 
for paranoia approximately two weeks later. This means that an increase of 10 points of 
aberrant salience corresponds to 1.87 points of paranoia. Consequently, one might argue that 
effects are rather small. However, given that these small within-person effects can accumulate 




Lagged effects of negative affect and aberrant salience on subsequent paranoia and auditory verbal 
hallucinations (AVHs), separately for ESM and Follow Up assessment periods. 
Precursor  coefficient (b) SE t p FDR 
Smartphone ESM assessments  
Negative affect, outcome paranoia 0.184 0.057 3.255 .001 .003 
Aberrant salience, outcome paranoia 0.187 0.043 4.395 < .001 < .001 
One-year Follow-Up assessments 
Negative affect, outcome paranoia 0.026 0.074 0.353 .724 .724 
Aberrant salience, outcome paranoia 0.366 0.068 5.387 < .001 < .001 
Smartphone ESM assessments 
Negative affect, outcome AVHs 0.058 0.036 1.623 .105 .168 
Aberrant salience, outcome AVHs 0.038 0.027 1.406 .160 .183 
One-year Follow-Up assessments 
Negative affect, outcome AVHs 0.093 0.043 2.198 .029 .057 
Aberrant salience, outcome AVHs 0.069 0.043 1.621 .106 .141 
Note. Precursors are participant-mean-centered; all models contain participant-mean-centered 
outcome symptoms at t-1 as covariates. FDR = False Discovery Rate-corrected values based on 
8 tests, according to Benjamini and Hochberg (1995).  
 
Occurrences and Prediction of Relapse 
 Thirteen participants (43%) relapsed at least once during the one-year follow-up 
period. We counted consecutive reports of relapse that occurred in short succession (≤ 8 
weeks distance) as one incidence of relapse. Eight participants relapsed once (62%), one 
participant relapsed twice (8%), three participants relapsed three times (23%), and one 
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participant relapsed four times (8%). We examined whether aberrant salience or any of the 
other candidate precursors predicted the occurrence of relapse. We conducted a logistic mixed 
model analysis with relapse (no/yes) as the outcome and person-mean centered negative 
affect, aberrant salience, quality of sleep, and medication adherence as the predictors. The 
analysis relied on 77 occasions of relapse vs. no relapse. None of the predictor variables 
reached significance (see Table 3), which was not surprising, given the low number of 
relapses and thus power. We planned to examine whether participants could anticipate an 
upcoming relapse but we had to waive the analysis because of insufficient cell counts (there 
was only one incident of a participant indicating that they expected a relapse). Finally, we 
calculated a binary extreme affect score, which was coded “1” if a participant scored two 
Standard Deviations above or below person-mean centered emotional valence or arousal 
(otherwise, it was coded “0”). A chi-square test revealed no association of extreme affect and 
subsequent relapse (χ2 (1) = 1.316, p = .350).  
Table 3 
Logistic mixed model with the outcome relapse (no/yes). 
Precursor Coefficient  SE t p OR 
Intercept  2.286 .5188 4.406 < .001 9.835 
Adherence to medication  -.116 .0887 1.309 .195 .890 
Quality of sleep  .008 .0163 .476 .636 1.008 
Negative affect  -.027 .0293 .916 .363 .973 
Aberrant salience scale .012 .0297 .392 .696 1.012 
Note. Precursors are person-mean centered, measured at the occasion prior to the event 





We recently found that worry preceded paranoia several days later during a 
psychological online intervention for psychosis (Lüdtke et al., in press). We therefore 
examined worry as a stand-alone predictor of paranoia in the present study as well. Worry was 
a significant predictor both in ESM (b = 0.093, SE = 0.038, t(760.43) = 2.412, p = .016) and 
Follow Up assessments (b = 0.094, SE = 0.048, t(388.91) = 1.980, p = .048), which was 
confirmed by a non-significant interaction of worry and assessment type (b = -0.033, SE = 
0.058, t(1171.33) = 0.572, p = .567). Consequently, worry could be another long-term 
predictor of paranoia, similar to aberrant salience.  
Next, we examined the influence of antipsychotic medication on the association of 
aberrant salience and subsequent paranoia, given that aberrant salience relates to 
dopaminergic processes (Miyata, 2019). Adding adherence to medication as a covariate 
changed the effect of aberrant salience on paranoia from b = 0.366 (p < .001) to b = 0.519 (p 
< .001), which corresponds to a 42% increase. We subsequently examined medication 
(no/yes) as a moderator of the effect. A significant interaction indicated that the effect of 
aberrant salience on paranoia was significantly lower when participants were medicated 
compared to unmedicated participants (interaction coefficient: b = -0.763, SE = 0.158, 
t(386.08) = 4.827, p < .001). Hence, the effect of aberrant salience depends on medication in 
two ways. First, it is stronger in people who do not receive antipsychotic medication. Second, 
adherence to medication is a confounder, meaning that it influences both aberrant salience and 
paranoia in longitudinal analyses.  
Discussion 
ESM studies have identified numerous short-term self-report predictors of psychotic 
symptom fluctuations in assessment periods of few days. Interestingly, these short-term 
predictors resemble long-term warning signs of psychotic relapse (e.g., depressed mood or 
compromised sleep). Hence, there is reason to believe that one can draw on ESM-based 
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predictors to predict long-term symptom fluctuations and potentially relapse. In order to 
examine whether ESM-based predictors are as effective in long-term assessments as they are 
in short-term assessments, we compared precursor-symptom associations between a one-week 
ESM assessment period and a one-year Follow Up period, using the same predictors (aberrant 
salience, negative affect) and outcomes (paranoia, auditory verbal hallucinations). Only 
aberrant salience was a significant predictor of subsequent paranoia consistently in ESM and 
Follow Up assessments. Given this promising result, we expected that aberrant salience also 
predicts actual relapse. However, contrary to our expectations, we found no effect of aberrant 
salience or any of the other predictors (adherence to medication, sleep, negative affect) on 
subsequent relapse. We interpret null findings in relapse prediction with great caution due to 
insufficient power and consider aberrant salience a very worthwhile candidate precursor in 
future studies nonetheless. The most evident implication of our study is that it is promising to 
monitor aberrant salience in bi-weekly intervals because it can signal subsequent increases of 
paranoia.  
Short- Versus Long-Term Effects of Aberrant Salience 
Aberrant salience consistently predicted paranoia irrespective of the distance between 
predictor and outcome assessment (hours vs. weeks). This result appears counterintuitive at 
first sight. One might argue that if the effect is short-term, it should be long gone after a 
couple of hours and if it is long-term, it should not yet be visible after a few hours. As a 
possible explanation for this contradiction, we propose that short-term and long-term 
fluctuations co-occur, meaning that variables, such as aberrant salience or paranoia, fluctuate 
rapidly throughout the day while these rapid fluctuations occur around slower-paced long-
term trends. Under the aforementioned assumption, it is possible that ESM assessments 
capture associations between rapid fluctuations of variables, whereas infrequent Follow Ups 
capture associations between slower trends of the same variables. For purely descriptive 
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purposes, we illustrated this assumption graphically based on one-week ESM data from one 
of our participants (Figure 2 depicts Loess-curves with different degrees of smoothing to 
visualize rapid vs. slow fluctuations). In the example data depicted in Figure 2, paranoia 
fluctuates heavily within few hours, but these fluctuations occur around a slower trend of 
changing paranoia, which only becomes apparent across days. The correspondence of short- 
and long-term effects of aberrant salience on paranoia implies that it is promising to apply 
variable sampling rates in clinical practice to obtain high-frequency assessments when 
needed. For example, participants could change from bi-weekly assessments to frequent ESM 








Note. Y-axis displays raw scores from the visual analogue scale for paranoia, ranging from 0–
100. Here, we present data from participant no. 6 to illustrate short-term fluctuations around 
slower-paced trends of paranoia over time. 
 
Aberrant Salience as a Predictor of Long-Term Symptom Fluctuations 
To our knowledge, there are no studies on aberrant salience as a predictor of relapse. 
However, there are studies on the emergence of psychosis (e.g., Freeman et al., 2019) or the 
transition from high risk states to psychosis (e.g., Howes et al., 2020), which acknowledge 
aberrant salience as a contributing factor. Instruments such as the Schizophrenia Proneness 
Instrument assesses basic symptoms that – in part – resemble aberrant salience. For example, 
one item captures captivation of attention: “Sometimes an object really seems to stand out 
from the rest of what I see…” (Schultze-Lutter, 2009, p. 7). A recent feasibility trial found 
that basic symptoms improve the prediction of psychotic symptoms beyond early signs of 
relapse in weekly smartphone assessments (Eisner et al., 2019). In sum, aberrant salience and 
related constructs have not received much attention as predictors of relapse, so far, but results 
are promising.  
As proposed by Kapur (2003), aberrant salience emerges as a consequence of a 
stimulus-unrelated hyperdopaminergic state in the brain. Animal studies and neuroimaging 
studies in humans support this hypothesis in that dopamine neurons in the midbrain-striatum 
respond to stimulus salience (for a review, see Miyata, 2019). According to Kapur (2003), 
antipsychotic medication, which mainly targets dopamine receptors (Wang et al., 2018), is 
effective because it dampens aberrant salience. Given this theoretical background, we 
examined the influence of antipsychotic medication on the relationship between aberrant 
salience and paranoia in exploratory analyses. Medication served as both a moderator and 
confounder of aberrant salience’s effect on paranoia. These findings are preliminary but they 
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have important implications. First, aberrant salience as a predictor of paranoia seems to be 
most potent in unmedicated participants, possibly because antipsychotics dampen salience 
(Kapur, 2003). Second, our findings suggest that self-reported aberrant salience could be a 
good indicator of underlying dopaminergic processes, which further strengthens the validity 
of aberrant salience as a theory-driven predictor of psychotic symptoms. Our exploratory 
findings also substantiate the importance of persistent antipsychotic medication after 
remission (Leucht et al., 2012; Pelayo-Teran et al., 2017).  
Null Effect of Negative Affect in Follow Up Assessments 
Negative affect (i.e., sadness, anxiety, low self-esteem, and worrying) predicted 
paranoia only during the one-week ESM phase but not during bi-weekly Follow Ups. This 
result was surprising because it contradicts findings that negative affective states are 
somewhat successful predictors of relapse (Gaebel & Riesbeck, 2007). Consequently, we have 
to revise our assumption that the established early signs anxiety and dysphoria (Eisner et al., 
2013) predict relapse through long-term effects on paranoia, which we would have expected 
based on short-term ESM studies (Ludtke et al., 2017; So et al., 2018). Instead, there must be 
other pathways, through which sadness and anxiety predict relapse at least partially. In the 
following, we discuss how the randomness of momentary anxiety, mood, and self-esteem 
could have been responsible for the lack of long-term effects on paranoia and hallucinations. 
People with psychosis experience heightened negative affect following stressful events 
(Myin-Germeys & van Os, 2007), and assuming that stressful events occur randomly, people 
with psychosis should experience random bursts of negative affect over time. Referring back 
to Figure 2, this implies that negative affective states do not follow a general long-term trend. 
Instead, both short- and long-term fluctuations of negative affect could be dependent on 
random stressors, making negative affect unsuited as a predictor of long-term fluctuations of 
paranoia. Likewise, self-esteem fluctuates rapidly in people with psychosis, especially in 
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people with paranoia (Murphy et al., 2018). The Attribution-Self-Representation Cycle Model 
(Bentall et al., 2001) of self-esteem predicts random fluctuations of negative affect in 
paranoia, again ruling out the possibility of long-term predictions.  
The last item of the negative affect scale captured worry (“my worries overwhelm 
me”). Unlike mood, anxiety, or self-esteem, worrying represents both a momentary action as 
well as a more stable worry thinking style (Freeman & Garety, 2014), rendering it a suited 
long-term predictor of paranoia. In hindsight, it was not ideal to add worry to the negative 
affect scale to reduce the number of confirmatory tests, so we analyzed worry as a stand-alone 
predictor in exploratory analyses. We found that worrying in fact preceded paranoia 
consistently in ESM and Follow Up assessments, supporting the presumption that worry 
represents another worthwhile long-term predictor of paranoia. This result corresponds to a 
recent finding indicating that worry predicts symptom fluctuations during an online 
intervention for psychosis (Lüdtke et al., in press). In addition, the result further substantiates 
the now well-established notion that worry is a primary treatment target in cognitive 
behavioral face-to-face (Freeman et al., 2015) and online interventions (Westermann et al., 
2020) for psychosis. Therefore, null findings regarding the negative affect scale must be 
interpreted with caution. While momentary sadness, anxiety, and self-esteem might represent 
purely short-term predictors of paranoia, worry could be another suitable long-term symptom 
predictor besides aberrant salience.  
Limitations and Conclusion 
All analyses were regression-based (prohibiting causal conclusions) and relapse 
analyses relied on a small sample size, thus awaiting replication in future studies. Further, our 
analyses relied on firm theoretical assumptions regarding the direction of effects, namely 
negative affect preceding psychotic symptoms. We did not consider the opposite direction 
although the concept of postpsychotic depression is well established in psychiatry (Moritz et 
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al., 2019) and studies indicate that depressive symptoms serve as both a predictor and an 
outcome of paranoia (Moritz et al., 2017).  
To conclude, our study was a first attempt to improve the prediction of relapse using 
predictors and methods derived from ESM research. It was optimistic to assume that any 
ESM-derived predictor generalizes to long-term assessments but at least some ESM-based 
variables (i.e., aberrant salience in our study) are worthwhile candidates of long-term 
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Complete list of measured constructs of study 4 (ESM 
Study) 
ESM Study – Baseline assessment 
TARGET  MEASURE 
DEMOGRAPHICS Self-generated questionnaire assessing gender, age, nationality, 
marital status, housing situation, education, occupation, 
diagnoses, begin of psychotic disorder, number of psychotic 
episodes, number of hospitalizations, antipsychotic medication, 
adherence to antipsychotic medication, other 
psychopharmacological medication, status of treatment 
DEPRESSION Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001) 
PSYCHOTIC SYMPTOMS Community Assessment of Psychic Experiences (CAPE; Stefanis 
et al., 2002) 
ACCEPTANCE / PSYCHOLOGICAL 
FLEXIBILITY 




Bullshit receptivity scale (Pennycook et al., 2015) 
POSITIVE AND NEGATIVE 
AFFECT 
Positive and negative affect schedule (PANAS; Watson et al., 
1988) 
EMOTION REGULATION Emotion regulation questionnaire (ERQ; Gross & John, 2003) 






ESM Study – ESM Smartphone assessments 
TARGET  MEASURE 
VALENCE OF AFFECT Self-generated visual analogue scale item ranging from pleasant 
to unpleasant 
AROUSAL OF AFFECT Self-generated visual analogue scale item ranging from relaxed 
to tense 
SYMPTOM DISTRESS Self-generated visual analogue scale item ranging from not 
distressed to distressed by symptoms 
ANXIETY Self-generated visual analogue scale item ranging from “not at 
all” to “completely” 
SELF-WORTH Self-generated visual analogue scale item ranging from “not at 
all” to “completely” 
SADNESS  Self-generated visual analogue scale item ranging from “not at 
all” to “completely” 
ANGER Self-generated visual analogue scale item ranging from “not at 
all” to “completely” 
COMPANY Participants could indicate who they were with at the moment 
(e.g., friends or family) 
PLACE Participants could indicate where they were (e.g., at home) 
ACTIVITY Participants could indicate what they were doing currently (e.g, 
working) 
PARANOIA Visual analogue scale item ranging from “not at all” to 
“completely” 
WORRY Visual analogue scale item ranging from “not at all” to 
“completely” 
JTC  Visual analogue scale item ranging from “not at all” to 
“completely”  
VOICE HEARING Self-generated visual analogue scale item ranging from “not at 
all” to “completely” 






ESM Study – Follow Up Assessments 
TARGET  MEASURE 
VALENCE OF AFFECT Self-generated visual analogue scale item ranging from pleasant 
to unpleasant 
AROUSAL OF AFFECT Self-generated visual analogue scale item ranging from relaxed 
to tense 
SYMPTOM DISTRESS Self-generated visual analogue scale item ranging from not 
distressed to distressed by symptoms 
ANXIETY Self-generated visual analogue scale item ranging from “not at 
all” to “completely” 
SELF-WORTH Self-generated visual analogue scale item ranging from “not at 
all” to “completely” 
SADNESS  Self-generated visual analogue scale item ranging from “not at 
all” to “completely” 
ANGER Self-generated visual analogue scale item ranging from “not at 
all” to “completely” 
COMPANY Participants could indicate who they were with at the moment 
(e.g., friends or family) 
PLACE Participants could indicate where they were (e.g., at home) 
ACTIVITY Participants could indicate what they were doing currently (e.g, 
working) 
PARANOIA Visual analogue scale item ranging from “not at all” to 
“completely” 
WORRY Visual analogue scale item ranging from “not at all” to 
“completely” 
JTC  Visual analogue scale item ranging from “not at all” to 
“completely”  
VOICE HEARING Self-generated visual analogue scale item ranging from “not at 
all” to “completely” 
ABERRANT SALIENCE Five visual analogue scale items ranging from “not at all” to 
“completely” 




SELF-ESTEEM Visual analogue scale item ranging from “not at all” to 
“completely” 
ABILITY TO USE ABC SCHEMA Visual analogue scale item ranging from “not at all” to 
“completely” 
DEPRESSION Visual analogue scale item ranging from “not at all” to 
“completely” 
HAPPINESS Visual analogue scale item ranging from “not at all” to 
“completely” 
MINDFULNESS Visual analogue scale item ranging from “not at all” to 
“completely” 
SOCIAL COMPETENCE Visual analogue scale item ranging from “not at all” to 
“completely” 
QUALITY OF SLEEP Visual analogue scale item ranging from “not at all” to 
“completely” 
STRESSFUL EVENT Visual analogue scale item ranging from “not at all” to 
“completely” 
ANTIPSYCHOTIC MEDICATION Yes/no question 
ADHERENCE TO ANTIPSYCHOTIC 
MEDICATION 
Visual analogue scale item ranging from “0%” to “100%” 
ALCOHOL CONSUMPTION Open Answer in text box 
AMOUNT OF CIGARETTES Open Answer in text box 
DRUG USE Yes/no qusetion 
FREQUENCY OF DRUG USAGE Scale ranging from 1 to 14 within past two weeks 
RELAPSE EXPECTATION Rather yes/ I don’t know/ rather no 
RELAPSE EXPECTAION 
RATIONALE 








ESM Study – Relapse Assessment (part of Follow Ups) 
TARGET  MEASURE 
DEPRESSION Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001) 
GENERAL SYMPTOMS  Brief Symptom Rating Scale (BSI-18; Derogatis & Fitzpatrick, 
2004a) 
PSYCHOTIC SYMPTOMS Community Assessment of Psychic Experiences (CAPE; Stefanis 
et al., 2002) 
PSYCHOTIC SYMPTOMS Delusion and Voices Self-Assessment (DV-SA; Pinto et al., 
2007) 
WORK INABILITY Open Answer in text box 
HOSPITALIZATION Yes/no item 
REASON FOR HOSPITALIZATION Open Answer in text box 
DURATION OF HOSPITALIZATION Open Answer in text box 
INCREASED PSYCHIATRIC CARE Yes/no item 
SUICIDAL TENDENCIES suicide item from the Beck Depression Inventory-II (BDI-II; 
Beck et al., 1996) 
SELF-HARM Item from the Borderline Symptom List (BSL-23; Bohus et al., 
2009) 
VIOLENCE TOWARDS OTHERS Yes/no item 
 
 
 
 
 
 
 
 
 
 
